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Anions are key components in many biological and industrial processes. They 
play crucial roles in both health and the environment. In many cases, it is important to 
control the concentration of anions or their removal in order to mediate their deleterious 
effects. Therefore, recognition of anions is of interest to researchers. However, the 
recognition of many anions remains challenging due to their relative large size-to-charge 
ratios, diverse geometries, and higher energies of solvation. This doctoral Dissertation 
summarizes the author's effort to design, synthesize, and study various receptors that 
were intended to overcome those challenges. In Chapter 1, a brief introduction to anion 
binding chemistry is provided with a particular focus on phosphate anion recognition. 
The common defining feature of the receptors reviewed is the pyrrole ring. The new 
structures are often designed via modification of known macrocyclic molecules. In 
 vii 
Chapter 2, structural modifications of a Schiff-base receptor (2,6-diamidopyridine 
dipyrromethane) and incorporation of that modified receptor into polymeric materials are 
discussed. These polymeric materials were studied for their anion binding properties in 
methylene chloride and tested for their ability to extract dihydrogenphosphate from 
water. In Chapter 3, a series of four-fold formylated bisdipyrromethane (tetrakis(1H-
pyrrole-2-carbaldehyde)) receptors is reported. The anion binding properties of these 
receptors were studied with dihydrogenphosphate along with other possibly competitive 
anions (e.g., chloride and hydrogensulfate). Data to support the contention that the 
receptors undergo conformational reorganization in order to accommodate the bound 
oxoanions both in chloroform solution and in the solid state are also provided. In Chapter 
4, an electroactive analogue of the systems, discussed in Chapter 3, along with a new 
binding-site-enriched analogue are presented. These analogues exploit the binding 
characteristics of the tetrakis(1H-pyrrole-2-carbaldehyde) series. Taken in concert the 
findings detailed in these Chapters are expected to lead to a greater understanding of 
phosphate binding in the case of formylated dipyrromethane based anion receptors. 
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1. Introduction to Anion Binding Chemistry 
Supramolecular chemistry is chemistry beyond the molecule. Some of the early 
examples in this field come from Pedersen, Lehn, and Cram in late 1960s.1–3 Pedersen 
prepared salt-polyether complexes in which various cations were bound via ion-dipole 
interactions involving the lone pairs of the polyether oxygen atoms.1 After the birth of 
this new field, increasing emphasis was placed on the recognition of transition metals, 
organic cations, neutral species, and anionic species.4 Recognition of a guest may be 
studied by measuring changes in one or more defining properties of a host (e.g., light 
absorption, the nuclear magnetic resonance (NMR) chemical shift, solubility, 
conductance, chemical reactivity, etc.) as a function of the ligand concentration.5 In this 
context, one defines a molecular complex as a non-covalently-bound species of definite 
substrate-to-ligand stoichiometry that is formed in a reversible equilibrium process in 
solution. 
A large number of acyclic and cyclic compounds have been used to coordinate 
metal cations and have been evaluated for their ability to recognize these and other 
positively charged guests, including alkylammonium cations. Some of this work dates 
back to the days of Werner, an early Nobel Prize winner.  Overtime, the importance of 
anions in biological systems became increasingly recognized. As a result, in recent years, 
attention has been paid to design and construct anion receptors.6  
Anion receptors, the main focus of this Dissertation, are species that interact 
specifically with anions. Anions play essential roles in many biological processes. They 
are also of critical interest in the areas of synthetic and industrial chemistry.6 They are 
prevalent in many enzymatic active sites and are among the most pervasive of known 
pollutants. Among the most widespread anionic pollutants are phosphate and nitrate that 
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arise from an overuse of agricultural fertilizers. They lead directly to eutrophication of 
lakes and waterways.7 In coastal areas, occurrences of dead zones, which are caused by 
eutrophication, have increased from 10 documented cases in 1960 to 405 documented 
cases in 2008.8  
Anion concentration imbalances are also of medical relevance and, indeed are 
associated with several conditions. Hyperphosphatemia is a disturbance in electrolyte 
levels that results from abnormally high concentrations of phosphate in human serum. It 
affects nearly all patients suffering from end-stage renal disease (ESRD).9 Unfortunately, 
70% of individuals with ESRD are unable to process this accumulated excess phosphate 
through hemodialysis; as a result, these patients often suffer from deleterious symptoms, 
including soft tissue calcification, cardiovascular complications, and even death.10  
Development of molecular constructs capable of binding anions efficiently, 
especially phosphate in its various protonated forms, is of critical interest as it may 
provide a first step towards solving various problems related to anion detection, 
extraction, removal, and separation.11,12 To date, a number of recognition motifs have 
been exploited to achieve anion recognition, including coulombic interactions, hydrogen 
bonding, halogen bonding, and anion-π interactions.13–17 A brief history of the 
development of these recognition motifs now follows. 
  
1.1. HISTORY OF SYNTHETIC ANION BINDING RECEPTORS 
In 1949, Walker discussed the relatively insoluble behavior of the carboxylic acid 
salts of amidines.18 The complementary nature of the cation (amidines) and anion 
(acetates, benzoates) led Walker to suggest that complex formation might occur even in 
the solution state. In 1954, Tanford investigated the association of the acetate with the 
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ammonium and guanidinium cations.19 Tanford was particularly interested in these 
complexes because he appreciated that the interactions between guanidinium and 
carboxylate ions could be playing a key role in protein chemistry.20 
 
 
 
Although it was concluded that association between the ions in complex 1.1 
together was weak, it became clear that non-covalent interactions involving anions were 
possible. One early example involved the chelated complex (1.2) between the methoxide 
anion and a bidentate boron Lewis acid.21  
More than a decade later, Park and Simmons reported encapsulation of halide ions 
by macrobicyclic amines.22 On the basis of 1H NMR spectroscopic analyses, it was 
concluded that the out,out-1,11-diazabicyclo[9,9,9]nonacosane bis(hydrochloride) (1.3) 
converts to the in,in-isomer (1.4) upon the addition of trifluoroacetic acid (TFA) (cf. 
Scheme 1.1). A second equilibrium between 1.4 and 1.5 becomes established more 
slowly, over the course of several days, as inferred from the emergence of a third signal 
in the 1H NMR spectrum. The equilibrium could be driven in the forward direction by 
adding chloride (Cl–) salts and by heating. This caused the signals of 1.5 to sharpen. 
Crystallographic support  that a Cl– anion occupied the central cavity of the in,in- isomer 
was also mentioned.22 
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Scheme 1.1: Schematic representation of equilibriums converting from out,out- 
isomer (1.3) to in, in- isomer (1.4) and diffusion of Cl– ion into the 
cavity of in,in- isomer (1.5). 
Following the study reported by Park and Simmons, many researchers began 
focusing on the problem of anion recognition. Many known interactions have been 
studied in this context. In general, interactions that may be used to drive complex 
formation between two molecules include: 
• Electrostatic interactions (e.g., dipole-dipole interactions) 
• Polarization interactions (e.g., dipole-induced dipole interactions) 
• Exchange repulsion (repulsion of overlapping short-range electron distributions) 
• Charge transfer (from HOMO to LUMO, for example) 
• Higher order interactions 
Morokuma23 has discussed these various interactions and typical contributions to 
complex formation in his paper “ Why Do Molecules Interact? The Origin of Electron 
Donor-Acceptor Complexes, Hydrogen Bonding, and Proton Affinity.” 
Each of the main bonding motifs (e.g., classically defined hydrogen bonding, CH 
hydrogen bonding, coulombic attractions, anion-π interactions) is composed of a unique 
combination of the interactions listed above. One example of very strong hydrogen 
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bonding is the complex H3N···HF with stabilizing electrostatic (-25.6 kcal/mol), charge-
transfer (-4.1 kcal/mol), and polarization component (-2.0 kcal/mol), as well as a 
destabilizing exchange repulsion contribution (16.0 kcal/mol).23 While each of these five 
components contributes to the total interaction energy, there is an indication that very 
strong hydrogen bonding is primarily electrostatic. 
Since this Dissertation is about formylated-dipyrromethane based structures as 
phosphate anion receptors, a brief introduction is given here that details 1) anion binding 
in the content of pyrrole-based anion receptors and 2) phosphate receptors and sensors. 
 
1.2.  BRIEF REVIEW OF PYRROLE-BASED ANION RECEPTORS 
The chemistry of pyrrole-based anion recognition dates to 1990. At that time, 
Sessler and coworkers serendipitously found15 the presence of electron density in the 
center of the pentapyrrolic macrocycle during an X-ray diffraction analysis of what was 
assumed to be the bis HPF6 salt of sapphyrin 1.6.15 What was found was that a fluoride 
ion (F–) was bound in the sapphyrin core, giving rise to the observed X-ray scattering. 
The aromatic 22-π-electron sapphyrin (1.6) system has a core size of roughly 5.5 Å 
diameter, and its core is big enough to bind a fluoride ion (F–) with strong hydrogen 
bonding interactions. In comparison, an 18-π-electron porphyrin system does not bind a 
F– ion, since the trans nitrogen distances are too short (about 4 Å).15 The fully protonated 
sapphyrin, acting as an F– receptor, was the first example of a rapidly increasing class of 
a pyrrole-based anion receptor. 
Subsequent to the 1990 discovery of the anion binding properties of sapphyrin 
research with pyrroles as anion receptors began to diverge. Two general directions 
emerged. One direction was focused on understanding the fundamentals more deeply by 
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considering structurally simpler pyrrole-based systems, whereas the other direction was 
toward the development of more advanced and complex receptor systems that could 
potentially target anions other than F–. 
 
 
Figure 1.1: Structure of a Sapphyrin 1.6 and X-ray crystal structure of the doubly 
protonated 1.6 ([1.6 + 2H]2+) showing the bound F– ion. Also shown is the 
hexafluorophosphate counter anion. This structure was originally reported 
by Sessler et al.15 and was redrawn using data from the Cambridge 
Crystallographic Data Centre (CCDC) (CCDC number 1184078). 
In 1992, The second example of a protonated macrocyclic poly-pyrrole system, 
namely rosarin (1.7) was prepared.24 X-ray diffraction analysis showed that this triply 
protonated non-planar system, [1.7+3H]3+, bound two Cl– anions in its core in solid 
state.24 
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Figure 1.2: Structure of a rosarin 1.7 and X-ray crystal structure of the triply protonated 
1.7 ([1.7 + 3H]3+) with three Cl– counter anion. This structure was originally 
reported by Sessler et al.,24 and was redrawn using data from the CCDC 
(CCDC number 1190538). 
An example of an effort toward simpler structures was presented by Sessler and 
coworkers in 1994.25 This study involved the first structurally characterized linear 
hexapyrrin 1.8, which was obtained by the acid catalyzed condensation of 
diformylbipyrrole with a bis-α-free bipyrrole. The resultant product had direct 
resemblance to prodigiosins (a three pyrrole-containing natural oligomer, e.g., 1.9). The 
linear hexapyrrin system 1.8 can be thought as an α,α’-linked prodigiosin dimer 
containing not one, but two potential Cl– anion binding clefts. The crystal structure of 
hexapyrrin bis HCl salt showed that two bound Cl– anions were tethered to the flat 
diprotonated hexapyrrin via two sets of three hydrogen bonds thereby providing direct 
structural conformation for the mode of binding presumed to be operative in prodigiosin 
and its analogues.25 Prodigiosins, a set of naturally occurring, open-chain 
pyrrolylopyrromethene-type oligopyrroles, have been proposed to affect the into-cell 
transport of HCl and studied as potential antineoplastic and immunosuppressive agents.26 
N
H
N
HN
NNH
N
Ph
PhPh
1.7
 8 
Interestingly, the suggestion that protonated prodigiosin can act as a Cl– receptor and 
carrier came after Sessler’s work on 1.8 was published. 
 
 
In 1996, Gale and Sessler27 reported the anion binding properties of a class of  
pyrrolic macrocycles called porphyrinogens that were first synthesized by Baeyer28 in 
1886. These macrocycles were renamed as calix[4]pyrroles (C[4]P) to stress the analogy 
to calixarenes. Porphyrinogens (or C[4]Ps) are macrocyclic compounds consisting of four 
pyrrole rings linked at the α-positions via sp3-hybridized carbon atoms. Porphyrinogens 
with hydrogen atoms at the meso-position are prone to oxidize into the corresponding 
porphyrins. On the other hand, fully meso-substituted porphyrinogens were claimed to be 
not only stable crystalline materials but also readily obtainable. The report by Gale and 
Sessler included anion binding studies of two C[4]P derivatives, octamethyl C[4]P (1.10) 
and tetraspirocyclohexyl C[4]P (1.10’), with halides in solution and in solid state (cf. 
Figure 1.3).  
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Since then, considerable attention has been paid to C[4]Ps as anion receptors and 
increasing effort has been devoted to enhancing the binding affinity and selectivity for 
specific anions.27,29,30 Chapter 3 presents studies that show an improvement in the 
recognition of tetrahedral anions by new constructs prepared from the same building 
blocks as C[4]P but possessing very different structural forms. 
 
     
Figure 1.3: X-ray crystal structures of octamethyl C[4]P 1.10 free in 1,3-alternate 
conformation (left) and 1.10 co-crystallized with TBACl in the cone 
conformation (right). These structures were originally reported by Gale et 
al.,27 and were redrawn using data from the CCDC (CCDC numbers 
1288397 and 1269267, respectively). 
In 2001, Gale et al. reported that pyrrole (1.11) itself could act as an anion 
receptor.31 In this report, tetramethylammonium (TMA+) Cl– was recrystallized from 
pyrrole to provide a co-crystal wherein two pyrrole molecules interact with a single Cl– 
anion. The pyrrole·Cl– complex in question was characterized crystallographically (cf. 
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Figure 1.4). Comparison to the C[4]P·Cl– complexes showed marked similarities (Table 
1.1), both in the interaction distances and in the angles between the adjacent pyrrole 
donors.31  
 
 N-H···Cl distance 
 in Å 
Dihedral angle  
of coordinating pyrroles 
1.10·Cl– (C[4]P)27  3.264 – 3.331 60.36° 
1.11·Cl– (pyrrole)31  3.241 61.73° 
Table 1.1: Comparison of selected crystallographic values for 1.10·Cl– and 1.11·Cl– 
complexes. 
 
Figure 1.4: X-ray crystal structure of the complex31 formed between TMACl and 
pyrrole (1.11). The two N-H···Cl distances are equal at 3.24 Å while TMA+ 
cation is disordered. This structure was redrawn using data from the CCDC 
(CCDC number 173101). 
Cyclo[8]pyrrole 1.12 is another protonated expanded porphyrin system that 
complexed with an anionic guest by binding it within its cavity.32 Macrocyclic 1.12 was 
obtained by a highly efficient one-step synthesis, based on the use of FeCl3 as the oxidant 
and readily accessible α,α’-unsubstituted bipyrrole as the only organic precursor. The 
 11 
doubly protonated cyclo[8]pyrrole derivative, [1.12 + 2H]2+, was shown to host a sulfate 
counter ion (SO42–) in its cavity (Figure 1.5).  
 
  
Figure 1.5: Structure of a cyclo[8]pyrrole 1.12 and X-ray crystal structure of the doubly 
protonated form ([1.12 + 2H]2+) showing the bound sulfate counter anion. A 
half molecule of CH3OH is omitted for clarity. This structure was originally 
reported by Sessler et al.32 and was redrawn using data from the CCDC 
(CCDC number 176189). 
Ballester et al., have contributed to anion recognition by exploring anion-π 
interactions since 2002.33–36 Many α,α,α,α-meso-tetraaryl-C[4]P derivatives (1.13–1.15) 
were prepared by this group and studied in solution and in the solid state. Physical 
organic chemical studies were employed to quantify the proposed anion-π interactions.34 
Based on the upfield chemical shift of the arene signals observed via 1H NMR 
spectroscopy, as well as X-ray crystallographic studies, it was concluded that the Cl––
arene interactions observed in these complexes were established exclusively via the π-
aromatic system. Quantitative Hammett free-energy relationships, derived from a library 
of derivatives with varying R groups (1.13–1.15), were presented in support of the 
conclusion that the inferred Cl–-π interactions are dominated by electrostatic effects. 
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Figure 1.6: Chemical structures of three α,α,α,α-meso-tetraaryl-C[4]P derivatives 1.13–
1.15 and X-ray crystal structure of 1.15 with TEACl.34 This structure was 
originally reported by Ballester et al.,34 and was redrawn using data from the 
CCDC (CCDC number 677142). 
Acyclic oligopyrrole receptors have been suggested to be versatile because of 
their enhanced conformational flexibility. However, the number of such alternatives to 
the calixpyrrole receptors is still limited. Maeda et al. studied the anion recognition 
properties of boron-appended dipyrrolyldiketones (e.g., 1.16).37–40 Compound 1.16 
containing fluorine atoms in the β-positions of the pyrrole rings was shown to be an 
efficient anion receptor by UV-Vis and fluorescence spectroscopic changes, especially 
for acetate anion (as TBA+ salt) in CH2Cl2. Scheme 1.2 illustrates the proposed 
conformational change of 1.16 upon binding a halide ion. 
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Scheme 1.2: Schematic representation of the conformational changes associated with 
halide binding by 1.16 as proposed by Maeda and coworkers.40  
In 2014, Ghosh et al. reported an o-phenylenevinylene-bridged tetrapyrrolic 
macrocycle (1.17) that was obtained by means of a Horner–Wadsworth–Emmons 
reaction between benzylbisphosphonate and 2-(trimethylsilyl)ethoxymethyl (SEM)-
protected diformylpyrrole, followed by deprotection of the SEM groups.41 This 
“conformationally flexible” tetrapyrrole can be considered as an expanded C[4]P. It was 
found to act as a receptor for the Cl– and Br– anions in THF-d8. However, it was found to 
undergo deprotonation upon exposure to F–.41  
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 Kim et al. published a series of C[4]P-based ion pair receptors.42–44 Receptor 1.18 
containing both cation- and anion-recognition sites was shown to complex ion pairs (i.e., 
salts) both in solution and in the solid state. This class of receptors is made up a C[4]P 
capped with a crown ether-strapped calix[4]arene. The 1:1 1.18·CsF complex was shown 
to be stable despite the large distance between anionic and cationic constituents of the 
bound ion pair. In this system, hydrogen bonding and coulombic interactions involving 
cation-π interactions are thought to lead to the observed binding. Kim et al., also 
prepared slightly modified derivatives in order to elucidate the binding mode and to 
effect anion extraction. 
 
1.3. PHOSPHATE RECEPTORS AND SENSORS 
After the discovery of F– anion in the core of a sapphyrin macrocycle, subsequent 
studies provided support for the contention that sapphyrin also interacts with other 
anions, including H2PO4–.45,46 Crystallographic data and 31P NMR spectroscopic studies 
were used to understand the binding interactions with phosphate derivatives. It was 
concluded that doubly protonated and positively charged sapphyrin, [1.19+2H]2+, 
interacts with monobasic phosphoric acid, H2PO4– to form a 1:1 salt with the second 
H2PO4– present in the salt not interacting directly with the macrocycle (Figure 1.7). The 
simple observation of coprecipitation of sapphyrin 1.20 with a double-stranded DNA 
from an aqueous solution led Sessler, Iverson, and co-workers to study the interaction of 
sapphyrins with DNA and other phosphate derivatives.45 
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Figure 1.7: Structure of sapphyrins 1.19 and 1.20 and X-ray crystal structure of the 
doubly protonated 1.19 ([1.19 + 2H]2+) with two H2PO4– ions, one “sitting 
atop” of the central cavity. The structure was originally reported by Sessler 
et al.,46 and was redrawn using data from the CCDC (CCDC number 
1315691). 
In 2003, Anslyn and co-workers reported C3v-symmetric tripodal receptors which 
recognize tetrahedral oxyanions.47 Receptor 1.21 was reported to have the highest affinity 
for HPO42– in water containing 2% (v/v) CH3OH among all known anion binding agents. 
The binding isotherm obtained from UV-Vis spectroscopic analysis was indicative of a 
1:1 binding with a Ka of 2.5 x 104 M-1 at pH = 7.4 (5 mM HEPES). It was concluded that 
the shape, size, and charge of receptor 1.21 led to the observed high affinity and 
selectivity for HPO42– relative to other anions (e.g., SO42–, NO3–, Cl–) that were included 
in the study.  
Although pH effects were discussed in the paper, there are two points that were 
not well clarified in the eyes of the present author. First, the protonation state of the 
bound phosphate derivative was not well defined in the report. Moreover, it was not clear 
whether pH was taken into account in calculating the binding affinity of 1.21 with HPO42–
. At pH = 7.4, only 61% of the total phosphate concentration is expected to exist in the 
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form of HPO42–.48 The second point that needs clarification involves the protonation state 
of the receptor 1.21. All three free amine groups were assumed to be protonated based on 
a general pKa comparison to an ammonium ion (pKa approximately 10). However, this 
assumption was not tested. 
 
 
Later in the same year, Tobey et al. presented a receptor system, 1.22, that proved 
useful for phosphate sensing in saliva samples.49 Receptor 1.22 was used in an indicator-
displacement assay made up from 1.22 and a colored organic molecule, 5(6)-
carboxyfluorescein (1.23). Sensing was achieved by monitoring the colorimetric response 
induced by an analyte-driven change in the microenvironment of the dye 1.23.  
 
 
Figure 1.8: Schematic representation of the indicator (1.23) displacement assay used by 
Anslyn and coworkers to quantify phosphate concentrations in saliva.49  
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A 2,6-diamidopyridinedipyrromethane hybrid macrocycle (1.24) has been 
reported50 to show a high selectivity for H2PO4– and HSO4– relative to NO3– in acetonitrile 
(CH3CN) as inferred from solution phase UV-Vis spectrophotometric titrations. This 
finding by Sessler and co-workers led them to suggest51 that 1.25 or related systems 
might find use in nuclear waste remediation applications requiring the selective removal 
of HSO4– from NO3–-rich waste mixtures.  
It was concluded that 1.24 binds H2PO4– as a 1:2 (1.24:H2PO4–) complex.50 This 
was attributed to the existence of two binding sites of 1.24 for this particular anion, 
H2PO4–. The inherent flexibility of 1.24, especially within the DPM subunit, was thought 
to allow the NH hydrogen bond donors in the receptor to orient in such a way that 
multiple, disparate NH-anion interactions are possible. 
 
Cyclic polyamines have been extensively studied and their structures have been 
tailored for the recognition of inorganic phosphate. The actual recognition takes 
advantage of a combination of intermolecular forces, namely hydrogen bonding and 
coulombic interactions. Some examples of cyclic polyamine receptors are provided 
below. A detailed review can be found in the literature.52 One protonated polyaza-
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cryptand ligand (1.26) was studied for size- and temperature-dependent encapsulation of 
tetrahedral ClO4– and H2PO4– anions.53 Another example of cyclic polyamines is 
compound 1.27.54 It was synthesized from three equivalents of dialdehyde and two 
equivalents of the constituent triamine (which is a precursor of 1.26) to form a Schiff-
base cage like-structure. The Schiff-base cage was then reduced to give 1.27. The amide 
analogue 1.26 (obtained from diacyldichloride starting material instead of a dialdehyde) 
was reported to be selective for nitrate.55 Receptor 1.27 was shown by X-ray structural 
analyses to form anion complexes with both nitrate and tetrahedral oxyanions sulfate and 
phosphate. 
 
 
 
A dicationic C[4]P system (1.28) was studied as a pyrophosphate sensing56 using 
a version of the indicator-displacement assay that was defined49 earlier in this section.  
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In 2012, Sessler and coworkers reported two tripodal receptors based on pyrrole- 
and DPM-functionalized derivatives of a sterically geared precursor, 1,3,5-
tris(aminomethyl)-2,4,6-triethylbenzene.57 These systems display high affinity and 
selectivity for tetrahedral anionic guests as inferred from solution phase isothermal 
titration calorimetric (ITC) analyses carried out in CH3CN, as well as solid state single 
crystal X-ray diffraction analyses. Both receptors (1.29 and 1.30) were constructed from 
the well-known tripodal core, a subunit that confers a high degree of preorganization 
within receptors built up from it. 
In 2013, Cai et al. published a pyrrole-based triazolium-phane, 1.31, with pyrrole 
NH and cationic CH donor groups as a receptor that functions in polar media for 
tetrahedral oxyanions.58 Macrocyclic receptor 1.31 is positively charged and was 
prepared via the tetraalkylation of a macrocycle originally prepared by click chemistry 
using the non-coordinating counter anion BF4–. The prepared salt displays a high 
selectivity for tetrahedral oxyanions, such as HSO4–, H2PO4–, and HP2O73–, over spherical 
and trigonal planar anions in mixed polar organic-aqueous media. The selectivity for 
tetrahedral oxyanions is lost in CH3CN. Both experimental and theoretical results from 
the study provided support for the seemingly counterintuitive conclusion that, in CH3OH, 
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triazolium (CH)+–anion interactions are energetically less important than neutral aromatic 
CH–anion interactions. 
 
 
Very recently, Lin and coworkers reported a multi-functional mechanically 
interlocked switchable [2]rotaxane, 1.32.59 The system was synthesized by means of a 
CuAAC click reaction and consists of two molecular stations and rotaxane arms that are 
terminated with boron-dipyrromethane (BODIPY) fluorophores. The dumbell-shaped 
BODIPY-based “axel” displays an on-off-on fluorescence bahviorur and thus functions 
as an acid-base controllable molecular switch. This switching has its origins the 
supramolecular energy transfer between the macrocycle and BODIPY stoppers. The 
underlying photoinduced electron transfer process could be driven not only by the 
addition of acid-base but also via the addition of the H2PO4– anion. Rotaxane 1.32, both 
as is and without the macrocycle threaded, was reported to display fluorescence 
quenching selectively in the presence of H2PO4–. 
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 In this Chapter, we have tried to provide some background information about 
anion receptors, more specifically pyrrole-based systems and phosphate binding motifs. 
This has been illustrated with examples taken from the literature. Our contributions in 
these areas will be presented in Chapters 2, 3, and 4. 
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2. Schiff-base Appended Polymers for Phosphate Removal 
The remediation of phosphate-contaminated water bodies and the effective 
treatment of hyperphosphatemia are two big challenges in which phosphate recognition 
could play a useful role. Chapter 1 presents synthetic organic receptors that achieve 
phosphate recognition. In this chapter, we briefly introduce the state of the art in 
phosphate removal. Next, we present findings from synthetic and phosphate extraction 
studies that involve polymeric materials with pendent Schiff-base macrocycles designed 
to function as phosphate anion receptors. 
 
2.1. CHALLENGES IN ANION EXTRACTION 
In Chapter 1, some of the challenges associated with anion recognition were 
outlined. These derive in part from the larger size of anions relative to their isoelectronic 
cations, the diverse geometries that anions often display, and the higher energies of 
solvation that must typically be overcome.1 
Anions are generally larger than cations. Therefore, larger hosts are required for 
recognition of anions.2 A F– anion has a radius of 1.2–1.4 Å.3 A porphyrin system with 
trans-nitrogen distances4 of about 4 Å is too small to bind F– ions. However, an early 
solid state study involving the sapphyrin-F– complex ((1.6+2H)2+·F–) revealed4 a F– ion in 
the pentapyrrolic core of the sapphyrin (Figure 2.1). Sapphyrin 1.6 has a core size of 
roughly 5.5 Å in diameter and therefore, its core is large enough to accommodate a bound 
F– anion. 
Figure 2.1 shows two macrocyclic systems, sapphyrin and cyclo[8]pyrrole, each 
with an anionic guest in its central cavity. In this Figure, the sapphyrin-F– complex 
(1.6+2H)2+·F–) is shown on the left, while the cyclo[8]pyrrole-H2SO4 salt (1.12 + 
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2H]2+·SO42–) is shown on the right. While a size comparison of differently shaped anions 
such as F– versus SO42– is difficult, the sulfur (S) oxygen (O) bond distance5 of about 1.5 
Å in SO42– is such that a tetrahedral SO42– is bigger than a spherical F–. As can be seen in 
Figure 2.1, a SO42– anion was hosted in octapyrrolic macrocycle 1.12, which has a larger 
cavity diameter of roughly 7.5–7.7 Å.6 
 
      
Figure 2.1:  Single crystal structures of the sapphyrin-F– complex (1.6+2H)2+·F–) to the 
left and the cyclo[8]pyrrole-H2SO4 salt (1.12 + 2H]2+·SO42–) to the right. 
These structures were originally reported by Sessler et al. 4,6 and were 
redrawn using data from the CCDC (CCDC numbers 1184078 and 176189, 
respectively).  
Targeting anions with tetrahedral geometry is likely to require not only larger 
hosts but also appropriately shaped binding sites for selective recognition. Consistent 
with this thinking is the fact that there are more tripodal or cage-like synthetic receptors 
for phosphate recognition than planar cyclic systems, as noted in Chapter 1. 
Another hurdle associated with anion binding is that certain anions, including 
tetrahedral oxoanions such as H2PO4– and HSO4–, are susceptible to proton transfer.7 The 
receptor itself can undergo deprotonation as one manifestation of this problem. For 
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example, Gale et al. reported unusual titration profiles obtained upon introduction of 
electron withdrawing groups on his previously reported systems. Detailed solution and 
solid state studies revealed that an increase in the acidity of pyrrolic hydrogens, as a 
result of the structural modifications, led to deprotonation by basic anions such as F–, 
H2PO4–, and benzoate.8 
In polar media, including water, anion recognition is rendered further challenging 
both because of solvation (e.g. ΔGh = -300 kJ/mol for NO3– and ΔGh = -465 kJ/mol for 
H2PO4–, where ΔGh = Gibbs free energy change of hydration)9 and competitive hydrogen 
bond donation associated with the solvent shell.10 Gabbaï and coworkers have been 
successful in meeting this challenge. They described11 the synthesis of a cationic Lewis 
acidic borane which forms a highly stable zwitterionic ammonium/fluoroborate complex 
by a C-H···F-B hydrogen bond in aqueous media. They also demonstrated the use of a 
cationic borane receptor for the extraction of F– from water.11 The same group recently 
employed a neutral bidentate Lewis acid system containing two antimony(V) centers to 
“squeeze out” the F– ions from water, overcoming the hydration barrier.12 However, to 
our knowledge, there is no reported artificial receptor capable of extracting H2PO4– out of 
water into an organic phase even though it has the exact same hydration enthalpy value as 
F–.9 
 
2.2. CURRENT STATE OF ART FOR PHOSPHATE REMOVAL 
In 1997, crystallographic data was presented for a phosphate residing in the 
pocket of a phosphate-binding protein (PBP) from E. coli bacteria (Figure 2.2).13 This 
periplasmic PBP is involved in the highly selective uptake and active transport of 
phosphate into bacteria cells. The binding site of PBP is located in a deep pocket far from 
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the protein surface. In this deep pocket, phosphate is bound in a fully dehydrated form 
and is completely and efficiently shielded from the solvent. The binding pocket of the 
PBP provides for twelve stabilizing hydrogen bonding interactions. These have their 
origin surrounding amino acid residues, namely residues Thr10, Phe11, Ser38, Gly140, 
Thr141, and the side chains of residues Ser38, Arg135 (2 hydrogen bonds), Ser139, 
Thr141. Also involved is a negatively charged carboxylate group from Asp56 that is 
thought to be specifically dedicated to the binding of a protonated form of phosphate. 
Presumably, as a result of these highly oriented bonds, PBP is unable to bind sulfate.  
 
 
Figure 2.2: X-ray crystal structure of E. Coli phosphate-binding protein (PBP) (left) and 
the binding site of the PBP (right). This structure was originally reported by 
Quiocho and coworkers13 and was redrawn using the program QtMG using 
data from the protein data bank (PDB) (PDB code: 1IXH, 0.98 Å 
resolution). 
This protein structure is presented as an example of naturally occurring phosphate 
recognition and transport (essentially, extraction) in nature. Some structural elements that 
 30 
researchers may use to guide their own receptor designs include the complex three-
dimensional structure of the PBP, the presence of cooperative attractive interactions, the 
presence of repulsive interactions for the sake of selectivity, and the absence of solvent in 
the bound form.  
Although the PBP shown above is a great example of effective phosphate binding 
found in nature, it is unlikely this protein will see application in the area of wastewater 
remediation due to its rather high cost. However, some biological methods are used in 
wastewater processing. One of these, called “enhanced biological phosphate removal” 
(EBPR), involves storage of phosphate as polyphosphates (poly-P) in the forms of 
biomass.  
 
 
Scheme 2.1:  Basic concept of the anaerobic-aerobic process known as enhanced 
biological phosphate removal (EBPR). 
The underlying mechanism, known as “luxury uptake”,14 involves circulation of 
activated sludge through anaerobic and aerobic phases, with the wastewater added during 
the anaerobic phase.15 By means of the alternating anaerobic-aerobic cycles 
microorganisms accumulate phosphate in the form of poly-P (Scheme 2.1). Efficient 
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phosphate removal is achieved by the physical removal of the microorganisms.16 This 
method is well established in its engineering but little-studied in terms of its 
microbiology.17 Although EBPR is suitable for treating industrial wastewater and polluted 
waterways, and has the potential to reduce the impact of eutrophication, it is not a viable 
approach phosphate removal in applications, such as hyperphosphatemia, that require 
biocompatibility with human subjects. 
As noted earlier, patients with end-stage renal disease (ESRD) suffer from 
elevated phosphate concentrations in their serum as explained in Chapter 1.18 This 
condition known as hyperphosphatemia. The current methods for treating 
hyperphosphatemia are three-hour long daily dialysis session,19 dietary restrictions, 
consumption of hard cations or Sevelamer (a cross-linked poly(allylamine) (PAA), e.g., 
Renagel®).  
 
 
Oral administration of cross-linked PAA serves to control the concentration of 
phosphorus available for absorption in the gastrointestinal track. This polymer is not 
selective for phosphate and it also binds chloride. Rather high ingested doses are thus 
needed. Adverse effects are also seen sometimes in patients undergoing such therapy. We 
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thus believe there remains a need for biologically compatible materials capable of 
binding phosphate under conditions associated with the treatment of hyperphosphatemia. 
 
2.3. SCHIFF-BASE MACROCYCLE APPENDED POLYMERIC MATERIAL FOR 
PHOSPHATE EXTRACTION 
Schiff-base macrocycles 1.24 and 1.25, reviewed in Chapter 1, were chosen as 
models for the development of polymeric materials containing pendent 2,6-
diamidopyridine dipyrromethane receptors for the purpose of phosphate extraction from 
aqueous media. The structural modification needed to attach the 2,6-diamidopyridine 
dipyrromethane systems to polymeric material is discussed in the following section.  
 
 
Polymeric materials with pendent phosphate receptors were proposed based on a 
prior study wherein polymers with pendent C[4]P anion receptors were used to extract 
halide anion salts from aqueous phases. In that study, Aydogan and Sessler used a meso-
functionalized C[4]P system as pendent receptors on a poly-(methyl methacrylate) 
(pMMA) backbone to obtain the co-polymer 2.1.20 This co-polymer was shown to be 
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 33 
capable of extracting TBACl and TBAF salts from aqueous media into CH2Cl2, whereas 
the control compounds 1.10 (octamethyl C[4]P) and 2.4 (pMMA without the receptor 
pendants) were not effective. 
Aydogan and Sessler improved their first generation C[4]P-pMMA material (2.1) 
by creating a co-polymer (2.2) that also contained a pendent cation-binding receptor  
(benzo-15-crown-5, 2.5).21 Co-polymer 2.2, containing both pendent anion and cation 
receptors, was found capable of extracting halide salts from water as ion-pairs, namely 
KF and KCl, into an organic phase. The anion extraction could be followed visually 
observed by using a cationic dye with a Cl– counter anion (2.6). This colored agent was 
shown to be carried from the aqueous solution into the organic phase (CH2Cl2) by the 
polymer 2.2. This was not true for any control systems, including monomer 1.10, crown 
ether 2.5, or the monofunctionalized polymer 2.1, and pMMA 2.3.21 The extraction 
events were also monitored by various analytical methods, e.g., 1H and 19F NMR 
spectroscopy and flame emission spectroscopy (FES). 
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2.4. RESULTS AND DISCUSSION 
2.4.1. Syntheses and Structures 
Two new Schiff-base macrocycles, 2.15a and 2.15b, were constructed by 
cyclization of the dialdehydes 2.9a and 2.9b with diamine 2.14 via diimine formation 
(Scheme 2.2). The dialdehydes 2.9a and 2.9b and the diamine 2.14 were prepared 
according to literature procedures.22,23 All structures were characterized by 1H and 13C 
NMR spectroscopy and high-resolution mass spectrometry (HRMS). 1H NMR 
spectroscopy was used to monitor the formation of imine bonds in the final step. Imine 
bond formation was confirmed by absence of a signal at 9.4 ppm (the resonance 
frequency for the aldehyde CH proton of 2.9b) and the presence of a signal at 8.3 ppm 
ascribed to the imine CH proton (cf. Figure 2.3). Figure 2.4 shows the X-ray crystal 
structures of two precursors 2.9b and 2.14 and the two Schiff-base macrocycles 2.15a 
and 2.15b.  
While macrocycle 2.15a was designed as a control compound, macrocycle 2.15b 
was designed to serve as a precursor that would allow attachment of the Schiff-base 
macrocyclic framework to a polymeric support. In other words, it was expected that 
macrocycle 2.15b would allow access to polymeric materials with pendent Schiff-base 
receptors. 
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Scheme 2.2:  The synthesis of Schiff-base macrocycles 2.15a and 2.15b. 
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Figure 2.3: Stacked partial 1H NMR spectra of 2.9b (bottom), 2.14 (middle), and 2.15b 
(top) in CD3CN. 
Solid state structural studies were carried out using single crystals of 2.15a co-
crystallized with CH3OH and 2.15b co-crystallized with DMF. Both structures revealed 
similar conformations in which the aryl moiety of the DPM subunit (originating from 
2.9b) and the pyridine moiety (originating from 2.14) are in cis positions relative to the o-
phenylene rings. Based on the conformational similarity between the single crystal 
structures of 2.15a and 2.15b, it was inferred that the methyl group did not have a 
substantial impact on the conformation of the macrocyclic framework. This lack of 
difference was considered to augur well for the use of macrocycles functionalized in the 
phenolic position as precursors for polymer formation. 
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a) b)  
c)  d)  
Figure 2.4: Single crystal structures of a) 2.9b, b) 2.14, c) 2.15a·2CH3OH, and d) 
2.15b·2 DMF. 
It is also instructuve to compare the conformations of these two new Schiff-base 
macrocycles (2.15a and 2.15b) with those of similar macrocycles reported previously, 
namely 1.2422 and 1.25.24 Reported modeling studies24 showed that the free ligands 1.24 
and 1.25 could exist in two different conformations. In the case of 1.25, the tolyl and 
pyridine fragments were calculated to adopt either in trans or cis positions relative to the 
o-phenylene rings. However, single crystal structures of both 2.15a and 2.15b revealed a 
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cis-like conformation. The contrast was thought to arise from two structural differences 
in the DPM subunits. Compound 1.25 has a tolyl ring, a hydrogen atom, and two fully β-
substituted pyrrole rings in the meso-position,24 whereas the new system 2.15b has an aryl 
ring, a methyl group, and two β-free pyrrole rings. 
  
 
It is likely that these structural differences, particularly those involving the meso-
positions and the β-substituents of the pyrrole rings, are reflected in the actual 
conformations observed for macrocycles 1.24, 1.25, 2.15a, and 2.15b.  
 
2.4.2. Anion binding studies of 2.15a and 2.15b 
It was considered possible that the anion binding affinities could emerge because 
of these inferred structural differences. The anion binding affinities of the new systems, 
2.15a and 2.15b, were thus tested. 
Figure 2.5 shows partial 1H NMR spectra of 2.15a recorded in CD2Cl2 in the 
presence of varying molar equivalents of TBAH2PO4. Major changes observed in the 
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chemical shifts of the pyrrole NH signal and the imine CH signal (cf. Figure 2.5). 
Saturation behavior in signal shifts is observed at approximately 2.5 molar equivalents of 
TBAH2PO4.  
For quantification of the binding affinities, UV-Vis spectroscopic studies, in 
which receptor 2.15a was titrated with TBAH2PO4 and TBAHSO4 in CH2Cl2, were 
conducted. Experimental details and spectra are presented in Section 2.6.2 (page 66). 
Table 2.1 shows the binding affinities obtained from the titration studies, as well as the 
affinities previously reported for 1.2422 and 1.2524 in CH3CN. 
 
Figure 2.5: Stacked partial 1H NMR spectra of 2.15a in CD2Cl2 at varying molar ratio of 
TBAH2PO4. 
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Anion 2.15aa 2.15bb 1.24b,c 1.25 b,d 
H2PO4– (2.1 ± 0.3) x 105 1.7 x 105 K1 = 3.4 x 105 (2.9 ± 0.2) x 104 
K2 = 2.6 x 104 
HSO4– (1.2 ± 0.2) x 104 nd (6.4 ± 0.3) x 104 (1.1 ± 0.2) x 105 
a in CH2Cl2, b in CH3CN, c reported in reference-22, d in reported in reference-24, nd: not determined. 
Table 2.1: Binding affinity constants (in M-1) for 2.15a, 2.15b, 1.24, and 1.25 with 
TBA+ salts of oxyanions by UV-Vis spectroscopy in specified solvents. 
From the binding affinity constants listed in Table 2.1, the order of anion 
selectivity of 2.15a for the oxyanions H2PO4– and HSO4– in CH2Cl2 is the same as that of 
the receptor 1.24 in CH3CN. However, the H2PO4– binding stoichiometries of the two 
systems (2.15a and 1.24) differ. A 1:2 binding stoichiometry for H2PO4– was reported for 
1.24. Formation of 1.24·2H2PO4– complex was supported22 by a competition study in 
which a solution of 1.24 containing 10 molar equivalents of HSO4– was titrated with 
H2PO4–.22 Spectral changes from that study were interpreted in terms of that 1.24 having a 
second binding site for H2PO4– that was effective for complexation even in the presence 
of 10 molar equivalents of HSO4–.22  
Receptor 2.15a, on the other hand, displayed a 1:1 binding stoichiometry for 
H2PO4– anion in CH2Cl2. The isosbestic point observed* at 327 nm in the UV-Vis spectral 
titration is most easily interpreted in terms of two absorbing species at this wavelength 
(namely, the free receptor 2.15a and the bound form of the receptor, 2.15a·H2PO4–) that 
are interconverting between one another. A Job plot obtained from the same experiment 
(cf. Figure 2.14) likewise proved a 1:1 binding stoichiometry. Additionally, the data 
                                                
* The total concentration of the receptor species was held constant throughout the titration of 2.15a with 
TBAH2PO4. 
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obtained from UV-Vis spectra could be fit well to a 1:1 binding isotherm (cf. Figure 
2.15). Based on these observations, we conclude that receptor 2.15a has high affinity and 
selectivity for H2PO4– anion and binds this target with a 1:1 binding stoichiometry in 
organic media (i.e., CH2Cl2). 
Among the receptors listed in Table 2.1, 1.25 displays the greatest affinity for 
HSO4–. This was explained by the “frozen” conformation of 1.25 that results from the fact 
that substituting the β-positions of the pyrrole units are substituted and a tolyl group is 
present on one of these “meso-like” positions of the DPM subunit. 
One of the most substantial differences between the two new receptors, 2.15a and 
2.15b, was their relative solubilities. In fact, derivative 2.15b, the putative precursor for 
polymeric materials, displayed low solubility in organic solvents (e.g., CH2Cl2, CHCl3, 
CH3OH, CH3CN), whereas 2.15a was freely soluble at the mM level in typical 
halogenated solvents. This low solubility precluded quantitative analyses in the case of 
2.15b in CH2Cl2. It could be studied in CH3CN, the same conditions under which 1.24 
and 1.25 were studied. The affinity constant of 2.15b for H2PO4– was determined (Ka = 
1.7 x 105 M-1 via UV-Vis spectroscopy and Ka = 1.6 x 105 M-1 via ITC) proved 
competitive with those of previous receptors. Although it was proposed that structure 
2.15b will be modified by further substitution at the phenolic position, it was gratifying 
that the core macrocycle proved effective for H2PO4– binding. 
 
2.4.3. Synthesis of Polymeric Material with Pendent Schiff-base 
Macrocycles 
In order to obtain polymeric materials containing pendent Schiff-base 
macrocycles, two general synthetic approaches were considered. The first approach 
involves attachment of DPM subunits to a polymer backbone (or to a polymerizable 
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moiety) before formation of the Schiff-base macrocycle (Scheme 2.3). The second 
approach involves attachment of pre-formed Schiff-base systems (e.g., 2.15b) to a 
polymer backbone (or to a polymerizable moiety) (Scheme 2.4). 
 
 
Scheme 2.3: The first synthetic approach that was considered for the synthesis of 
polymeric materials containing Schiff-base macrocyclic pendants. It 
starts from DPM precursors. 
  
Scheme 2.4: The second synthetic approach considered for the synthesis of polymeric 
materials containing Schiff-base macrocyclic pendants. This approach 
relies on the use of precursors containing the preformed macrocycle. 
The approach involving the attachment of a preformed functionalized Schiff-base 
to a functionalized polymer backbone was considered. The functionalized Schiff-base 
2.15b, prepared in 93% yield (see Experimental Section 2.6.1, page 55), was attached to 
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the commercially available functionalized-polystyrene 2.16 (poly(vinylbenzyl chloride), 
60/40 mixture of 3- and 4- isomers) under SN2 reaction conditions (Scheme 2.5). 
 
   
Scheme 2.5: Preparation of the polymer 2.17 by post-polymerization modification of 
commercially available functionalized polystyrene 2.16 with 2.15b. 
As inferred from integration of the 1H NMR spectrum (the ratio of the signal at 
9.5 ppm to those at 9–5.5 ppm), it was concluded that the new polymeric material 2.17 
bears one pendent Schiff-base macrocycle for every 3.5 phenyl groups present on the 
styrene backbone (cf. Figure 2.6). In other words, the reaction between equimolar 
amounts of 2.15b and 2.16 yielded about 30% substitution of 2.16 with 2.15b. The net 
result is a co-polymer 2.17 bearing pendent Schiff-base macrocycles (Scheme 2.5). Co-
polymer 2.17 proved appreciably soluble in CHCl3. It could thus be used for liquid-liquid 
and solid-liquid extraction studies as detailed in the next section. 
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Figure 2.6: 1H NMR spectra of 2.15a in CD2Cl2 (bottom), commercially available 
functionalized polystyrene 2.16 in CDCl3 (middle), and co-polymer product 
2.17 in CD2Cl2 (top). 
 
2.4.4. Anion Binding Studies of Co-polymer 2.17 in CHCl3 via UV-Vis 
Spectroscopy 
UV-Vis spectroscopy was used to confirm the presence of the pendent Schiff-base 
macrocycles in the case of co-polymer 2.17. Polymer 2.16, lacking absorbance features in 
the 300–400 nm spectral range, reacted with compound 2.15b, which is insoluble in 
CHCl3. The product, assumed to be co-polymer 2.17, proved soluble in CHCl3. 
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Moreover, it displayed UV-Vis spectral features between 300 and 400 nm in CHCl3 that 
are characteristic of a Schiff-base macrocycle such as 2.15b (cf. Figure 2.7a). 
 
 
Figure 2.7: UV-Vis spectral changes observed in CHCl3 under conditions where a) the 
polymer 2.16 (7.5 mg/L) and co-polymer 2.17 (18.6 mg/L), b) addition of 
various TBA+ halide salts into solutions of 2.17, c) addition of various TBA+ 
anion salts into solutions of 2.17, d) addition of TFA into a solution of 2.17. 
Solutions of 2.17 in CHCl3 were screened for spectral changes when treated with 
various TBA+ anion salts. Among the halide anions, F– induced the biggest spectral 
change (Figure 2.7b). The spectrum of 2.17 that resulted upon exposure to TBAH2PO4 
was similar to those produced when 2.15a was treated with H2PO4– (cf. Figure 2.7c and 
Figure 2.13). On the other hand, the addition of TBAHSO4 addition caused a spectral 
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change in 2.17 that differed from what was observed when 2.15a was exposed to the 
same salt (Figure 2.7c). The effect of TFA on the spectrum of 2.17 in CHCl3 was also 
tested. The spectral change (Figure 2.7d) was attributed to protonation of the two imine 
groups present in the Schiff-base macrocycle framework. 
 
2.4.5. Extraction Studies with Co-polymer 2.17 
Copolymer 2.17 was tested for its ability to extract H2PO4– anion salts using two 
experimental techniques. The first of this involves a liquid-liquid extraction. In this case, 
a solution of co-polymer 2.17 in CDCl3 was layered with a solution of TBAH2PO4 in D2O 
(Figure 2.8). After shaking† and separating the phases, changes in the H2PO4– anion 
concentration in both phases were quantified via 31P NMR spectroscopy using PhPO3H 
(in D2O) and TBAPF6 (in CDCl3) as the internal standards.  
 
Figure 2.8: Graphical presentation of the liquid-liquid extraction approach used to test 
co-polymer 2.17 as a possible phosphate anion extractant (using TBA+ as 
the anion source). Left: H2PO4– solution in D2O, Right: Biphasic mixture 
obtained by adding a solution of co-polymer 2.17 in CDCl3 to the solution 
on the left. 
In the second method, a solid-liquid extraction, solid co-polymer 2.17 was added 
into a solution of TBAH2PO4 in CD3OD (or in D2O in a separate experiment). After 
                                                
† Shaking a biphasic mixture co-polymer 2.17 in CDCl3 and TBAH2PO4 in D2O causes gelation as 
discussed later in this Section. Gelation occurs in bottom layer (i.e., CDCl3). A photo of formed gel is 
shown in Figure 2.11. 
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shaking and separating solution phase, the change in the H2PO4– anion concentration in 
CD3OD was quantified via 31P NMR spectroscopy using PhPO3H as the internal standard. 
The results are summarized in Table 2.2. 
 
Figure 2.9: Graphical presentation of solid-liquid extraction approach used to test co-
polymer 2.17 as a possible phosphate anion extractant (using TBA+ as the 
anion source). Left: H2PO4– solution in CD3OD, Right: Biphasic mixture 
obtained by adding solid co-polymer 2.17 into the solution on the left. 
Extraction 
type 
Source 
solvent 
Extractant 
solvent % change ([H2PO4–]) 
 [H2PO4–] a, V [2.17], V 
in 
source 
in 
extractant 
Liquid-liquid D2O CDCl3   
 50 mM, 1.0 mL 10 mg/1.0 mL +13% 0% 
Solid-liquid CD3OD Solid 2.17   
 20 mM, 1.5 mL 10 mg -6% - 
 50 mM, 1.5 mL 10 mg +4% - 
Solid-liquid D2O Solid 2.17   
 50 mM, 1.0 mL 11 mg +6% - 
a TBAH2PO4 was used as the H2PO4– source. V stands for volume. % changes were quantified by 
using internal standard (PhPO3H or TBAPF6) via 31P NMR spectroscopy. 
Table 2.2: Results of extraction studies conducted with co-polymer 2.17 as a putative 
extractant. 
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The results summarized in Table 2.2 proved hard to interpret. The common result 
among four entries was an increase in the concentration of H2PO4– in the source phase 
(i.e., stock H2PO4– solution that is tested for extraction). Although removal of H2PO4– 
from its original source phase was the desired outcome, the unexpected increase in 
H2PO4– concentration in the source can be explained by the removal of water from the 
H2PO4– source phase, leading to a more concentrated H2PO4– solution. 
 
 
Figure 2.10: UV-Vis spectra of 2.17 (25 mg/L) in CHCl3 (black), 2.17 in CHCl3 after 
vigorous shaking with deionized (DI) water (red), and 2.17 in CHCl3 after 
shaking with aqueous TBAH2PO4 solution (green). 
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Figure 2.10 shows the UV-Vis spectra of 2.17 in CHCl3 before exposing to water, 
after shaking with water, and after shaking with aqueous TBAH2PO4 solution. The major 
spectral change was the change observed in the relative intensity of the two maxima of 
the co-polymer 2.17 after contacting with water, independent of the H2PO4– content. 
 
 
Figure 2.11: Photos of gel formed during the extraction study with the co-polymer 2.17. 
Bottom layer was initially a solution of the co-polymer 2.17 in CHCl3 and 
top layer is aqueous solution.  
 During the liquid-liquid extraction study conducted with 2.17, gelation behavior 
regardless of the content of the aqueous solutions was observed. On the basis of this 
observedgelation behavior and the UV-Vis spectral changes seen when 2.17 in CHCl3 is 
brought into contact with water, we propose that this polymeric material can absorb 
water. Removing water from the aqueous phase under conditions of liquid-liquid would 
serve to increase the effective TBAH2PO4 concentration in that source phase, thus 
accounting for the results in Table 2.2. 
Although gelation behavior is not observed in solid-liquid extractions using 2.17 
as extractant, these studies served to the same cause, an increase in the effective 
TBAH2PO4 concentration in that source phases (D2O, and CD3OD) 
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2.4.6. Synthesis of Cross-linked Polymeric Material with Pendent Schiff-
base Macrocycles 
Since the attachment of 2.15b to 2.16 to obtain co-polymer 2.17 using substitution 
chemistry (vide supra) worked well, various other modifications in the phenolic position 
of 2.15b were tested. Macrocycle 2.15b was regioselectively substituted in its phenolic 
position with a polymerizable styrene unit, a clickable propargyl group, and a cross-
linker, epichlorohydrin (EPI), to give 2.15c, 2.15d, and 2.15e, respectively (Scheme 2.6). 
 
Scheme 2.6: Syntheses of 2.15c–2.15e by nucleophilic substitution. 
In order to incorporate the new macrocyclic framework into a cross-linked PAA 
network, the synthetic route shown in Scheme 2.7 was followed. The control system 
(2.21), an EPI (2.19) cross-linked PAA, was prepared along with a pendent Schiff-base 
containing derivative, 2.22. Both hydrogels were prepared via an aqueous reaction of a 
20% w/v solution of linear PAA·HCl chains and EPI, which served as the crosslinking 
agent.25 The commercially available PAA·HCl (Alfa Aesar) used in the synthesis of the  
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Scheme 2.7: Synthetic route for preparation of a cross-linked polymeric material with 
pendent Schiff-base macrocycles (2.22). Also shown is a synthesis of a 
control system without the pendants (2.21). 
gels had molecular weights of 120000-200000 g/mol. Before crosslinking the polymer 
chains, a fraction of the HCl groups of PAA·HCl was neutralized by adding NaOH 
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solution. This provides free NH2 sites for the subsequent EPI cross-linking reaction. For 
the synthesis of 2.22, Schiff-base 2.15e was added along with EPI in the cross-linking 
step. Two insoluble systems, 2.21 and 2.22, resulted. Both were tested as possible H2PO4– 
extractants using a solid-liquid extraction approach. 
2.4.7. Extraction Studies with 2.22 
Figure 2.12 shows three 31P NMR spectra arising from the solid-liquid extraction  
 
Figure 2.12: Stacked partial 31P NMR spectra (in D2O) of a stock KH2PO4 solution (46 
mM) containing phenylphosphonic acid (PhPO3H, 33 mM) as the internal 
standard (bottom), the stock KH2PO4 solution (1.0 mL) after treatment with 
cross-linked PAA 2.21 (15 mg) containing a PhPO3H (33 mM) internal 
standard (middle), and the stock KH2PO4 solution (1.0 mL) after treatment 
with Schiff-base appended cross-linked PAA 2.22 (15 mg) containing a 
PhPO3H (33 mM) internal standard (top). 
 53 
studies in which 2.21 and 2.22 were used in conjunction with KH2PO4. The bottom 
spectrum is of a stock KH2PO4 solution (46 mM) in D2O containing phenylphosphonic 
acid (PhPO3H, 33 mM) as the internal standard. 
The spectrum in the middle is of the KH2PO4 (1.0 mL) aliquot after it had been 
treated with control cross-linked PAA 2.21 (15 mg). A decrease in H2PO4- concentration 
from 46 mM to 35 mM was observed. The top spectrum is of a separate KH2PO4 (1.0 
mL) aliquot after having been treated with Schiff-base appended cross-linked PAA 2.22 
(15 mg). A decrease in H2PO4- concentration from 46 mM to 38 mM was observed. On 
this basis, it was concluded that the functionalized solid hydrogel 2.22 (15 mg) was less 
effective at extracting H2PO4- than the same amount of solid hydrogel 2.21. This 
discrepancy can be explained by the increased molecular weight of binding sites in 2.22 
due to the presence of heavy Schiff-base units. 
 
2.5. CONCLUSIONS 
A new functionalized Schiff-base macrocyclic framework, which relies on a 
formylated-DPM as a precursor, was prepared. Control compound 2.15a, bearing this 
new framework, was studied for its anion binding properties in CH2Cl2. It was concluded 
that 2.15a displays higher affinity for H2PO4– than it does for HSO4– in CH2Cl2. In this 
solvent, the H2PO4– anion is bound with a binding stoichiometry 1:1 (2.15a: H2PO4–). 
Covalent attachment of the new framework to a polymeric backbone was achieved using 
derivative 2.15b. It was shown that 2.15b could be attached to many different systems via 
substitutions involving the phenolic position of 2.15b. In this way, derivatives 2.15c–
2.15e were prepared. The co-polymer 2.17, also obtained via a substitution reaction, was 
studied for its anion binding potential in CHCl3 via UV-Vis spectroscopy and for its 
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extraction ability. Little change in the feature of co-polymer 2.17 was seen in CHCl3 with 
all anions tested, including the common halides, H2PO4– and HSO4– (all as their TBA+ 
salts). Under conditions of liquid-liquid extraction, co-polymer 2.17 forms gels, 
independent of whether an anion is present in the aqueous phase. Extraction studies did 
not reveal a reduction in the H2PO4– concentration in the aqueous solution when 2.17 was 
tested as an extractant. 
A hydrogel containing pendent Schiff-base macrocycles (2.22) was also prepared. 
In hydrogel 2.22, pendent Schiff-bases were covalently attached to a PAA backbone by 
adding a mixture of 2.15e and EPI during the cross-linking step. Solid-liquid extraction 
studies revealed that 2.22 is less efficient for KH2PO4 extraction than the control hydrogel 
2.21. presumably due to large molecular weight of pendent receptor (Schiff-base, 2.15e) 
in 2.22. 
The bottom line for this project is that a tremendous amount of synthetic effort 
was invested. Unfortunately, although some synthetic challenges were overcome, no 
improvement over existing systems was achieved. In light of this development, we 
directed our efforts to understanding the contribution the core DPM subunit to H2PO4– 
binding. The ensuing Chapters present the results of these efforts. 
 
2.6. EXPERIMENTAL 
All solvents and chemicals were purchased from Aldrich, TCI, Acros, or Alfa Aesar 
unless otherwise noted. Pyrrole was distilled at 80 °C under reduced pressure (100 mbar) 
prior to use. Other solvents and reagents were used without further purification. The NMR 
spectra were referenced to residual solvent proton peaks. The NMR solvents were purchased 
from Cambridge Isotope Laboratories. Chemical ionization (CI) and electrospray ionization 
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(ESI) mass spectra were recorded on a VG ZAB-2E instrument and a VG AutoSpec 
apparatus, respectively. Thin-layer chromatography (TLC) analyses were carried out using 
silica gel (200 mm) glass-backed sheets obtained from Sorbent Technologies. Column 
chromatography was performed on Sorbent Technologies silica gel 60 O (40–63 mm). For all 
micro-calorimetric titrations was used a MicroCal VP-ITC instrument. 
2.6.1. Synthesis and Characterization 
 
   
2,2'-(1-(4-Methoxyphenyl)ethane-1,1-diyl)bis(1H-pyrrole) (2.8a): This 
intermediate was prepared using a slightly modified procedure first reported by Lindsey 
et al.26 Briefly, in a 500 mL round bottom flask, 4’-methoxyacetophenone (2.7a) (8.0 g, 
53.3 mmol, 1 equiv.) was added to freshly distilled pyrrole (100.0 g, 1490.3 mmol, 25 
equiv.). TFA (650 mg, 5.7 mmol, 10 mol%) was then added to the reaction mixture. This 
caused a color change from colorless to pale yellow.  The resulting solution was stirred at 
90 °C for 2 h. Unreacted pyrrole‡ and TFA were removed at 80 °C under reduced 
pressure (100 mbar). The resulting dark green oil was dried in vacuo overnight to give a 
brown solid. This product, 2.8a (Rf = 0.8§), was separated from non-reacted starting 
material 2.71 (Rf = 0.7) by column chromatography (silica gel, CH2Cl2). This gave 
                                                
‡ 86 g of pyrrole was recovered. 
§ TLC plates were stained by I2 to aid visualization. 
O
O
H
N TFA (10 mol%)
90 °C, 2h
O
HNNH
2.7a                       1.11                                                      2.8a
                          (25 equiv)                                                (44%)
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compound 2.8a in purified from as a white-solid (6.3 g, 44% yield). 1H NMR (300 MHz, 
CDCl3) δ 7.76 (bs, 2H, NH), 7.03 (d, 2H), 6.81 (d, 2H), 5.96 (m, 2H), 6.64 (m, 2H), 6.17 
(m, 2H, pyrrole CH), 3.78 (s, 3H), 2.02 (s, 3H) ppm. 13C NMR (125 MHz, CDCl3) δ 
158.1, 139.4, 137.7, 128.4, 116.8, 113.3, 108.1, 106.1, 55.2, 44.0, 28.9 ppm. HRMS 
(CI+) m/z for C17H18N2O [M]+ calcd 266.1419, found 266.1418. 
 
  
5,5'-(1-(4-Methoxyphenyl)ethane-1,1-diyl)bis(1H-pyrrole-2-carbaldehyde) (2.9a): 
A slightly modified literature procedure22 was employed. Briefly, a solution of 2.8a (6.3 
g, 23.7 mmol, 1 equiv.) in DMF (25 ml, 350 mmol, 15 equiv.) was cooled to 0 °C in an 
external ice bath. To the solution, phosphoryl chloride (POCl3) (21.7 g, 142 mmol, 6 
equiv.) was added dropwise via an addition funnel. A color change from colorless to 
orange was observed during the addition. The mixture was stirred at 0 °C for 1 h.   The 
solution was then heated to 60 °C and stirred for 3 h.  The solution was allowed to cool to 
room temperature and then to 0 °C in an ice bath. Aqueous Na2CO3 (52 g in 100 ml) was 
added slowly until a pH of 10 was reached. The solution was then stirred at 80 °C for 2 h. 
The solution was allowed to cool to room temperature. This gave a mixture containing 
insoluble solid material. This reaction mixture was extracted with EtOAc. The resulting 
organic phase was dried over anhydrous sodium sulfate (Na2SO4) before being subjected 
to column chromatography (silica gel, CH2Cl2:EtOAc (5:4)). Product 2.9a (Rf  = 0.8) was 
O
HNNH
1.POCl3, DMF
0 to 60 °C, 4h
2. Na2CO3, H2O
80 °C, 2h
O
HNNH
OHC CHO
2.8a                                                                   2.9a
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obtained as a white solid (6.3 g, 82%) after collecting the appropriate fractions and 
precipitating by treating with hexanes. 1H NMR (400 MHz, CDCl3) δ 10.46 (bs, 2H), 
9.26 (s, 2H), 7.00 (d, 2H), 6.89 (m, 2H), 6.82 (d, 2H), 6.14 (m, 2H), 3.81 (s, 3H), 2.11 (s, 
3H) ppm. 13C NMR (125 MHz, CDCl3) δ 178.78, 158.48, 146.50, 136.91, 132.58, 128.20, 
121.77, 113.68, 110.29, 55.14, 44.86, 28.50 ppm. FTIR: 3268, 1667, 1651, 1614, 1481, 
1434, 1410, 1266, 1216, 1200, 1177, 1045, 1021, 788, 760 cm-1. HRMS (ESI+) m/z for 
C19H18N2O3 [M+H]+ calcd 323.13170, found 323.13902. 
 
 
 
In a 500 ml Shlenck flask flushed with argon, formyl-methoxy-dipyrromethaned 
(1.53 g, 4.75 mmol, 1 equiv.) was dissolved in dry, degassed, CH2Cl2 (60 ml).  The 
solution was cooled to 0 °C using an ice bath, and a 1 M boron tribromide (BBr3) solution 
in CH2Cl2 (2.97 g, 12.0 mmol) was added slowly via syringe.  The resulting solution was 
stirred at 0 °C for 2 h.  The solution was then warmed to room temperature and stirred for 
an additional 2 h. The precipitation of an orange solid was observed immediately upon 
BBr3 addition. To this mixture, 100 ml of water was added. Stirring was then continued 
for another 2 h. The mixture was extracted with EtOAc, giving a dark red solution.  This 
red solution was dried over Na2SO4 and the volatiles removed by means of a rotary 
evaporation.   The product was purified by column chromatography over silica gel using 
1 M BBr3
CH2Cl2
OH
HNNH
OHC CHO
2.9a                                                                      2.9b
O
HNNH
OHC CHO
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a mixture of CH2Cl2 and EtOAc (3:1) as the eluent. Due to the poor solubility of the 
crude, the column was loaded using silica gel, the crude product supported on. The 
product 2.9b was isolated as an off-white solid (1.2 g, 82.1%). 1H NMR (400 MHz, 1% 
CD3OD in CDCl3) 2.04 (s, 3H, meso-CH3), 6.12 (m, 2H, pyrrole CH), 6.73 (d, 2H, Ar H), 
6.85 (d, 2H, Ar H), 6.90 (m, 2H, Ar H), 9.30 (s, 2H, formyl protons), 10.23 (br s, 2H, 
pyrrole NH). 13C NMR (100 MHz, CD3OD) δ 179.54, 156.41, 147.34, 136.43, 133.24, 
133.19, 128.37, 115.03, 110.71, 45.15, 27.32 ppm. FTIR: 3284, 3208, 1630, 1482, 1435, 
1318, 1295, 1201, 1172, 1052, 785, 771, 698.   
Alternatively, 2.9b could be prepared by the following reaction sequence: 
 
For the synthesis of 2.8b, a procedure identical to that used to prepare 2.8a (vide 
supra) was used, albeit starting with 2.7b. For the synthesis of 2.9b, a procedure identical 
to that used to prepare 2.9a (vide supra) was used, albeit starting with 2.8b. 
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The mono-protected form (2.11) of o-phenylenediamine (2.10) is a known 
compound.27 The same procedure used to obtain 2.11. Briefly, o-phenylenediamine (5 g, 
46.3mmol) was dissolved in 200 ml CHCl3. A 100 ml aqueous solution containing 2.33 g 
of sodium bicarbonate (27.78 mmol) and 2.77 g of sodium chloride (47.4 mmol) was 
prepared. These solutions were combined in a 500 ml round bottom flask and cooled in 
an ice-bath. Di-tert-butylpyrocarbonate (10.33 g, 47.4 mmol) was dissolved in 100 ml 
CHCl3 and added slowly to the reaction mixture cooled in an external ice-bath. The 
resulting mixture was stirred in an ice-bath for 30 minutes. The reaction vessel was first 
heated to room temperature and then heated at reflux (73.6 0C) for 12 h. The reaction 
mixture was left standing and phase separation was observed. The aqueous phase was 
extracted with CHCl3 (2x 50 ml). Combined organic extracts were dried over anhydrous 
sodium sulfate. Solvent was removed under reduced pressure. The resulting solids were  
re-dissolved in a 3:1 mixture of CH2Cl2 and EtOAc. The resulting solution was subjected 
to column chromatography (silica gel) using a 3:1 mixture of CH2Cl2 and EtOAc as the 
eluent. The doubly protected side product elutes first with (Rf = 0.92), followed by mono-
protected, desired product (2.11) (Rf = 0.8). After removal of the solvent, this desired 
product was obtained as a white solid (6.64 g, 67%). 
Bis(2-aminophenyl)pyridine-2,6-dicarboxamide (2.13) was synthesized using the 
procedure reported by the Sessler group.24 Compound 2.11 (6.64 g, 32 mmol) was 
dissolved in 30 ml dry tetrahydrofuran (THF). To this solution, 4.45 ml of dry 
triethylamine (TEA) was added under Ar. The resulting solution was placed in a water-
bath and 2,6-pyridine-dicarboxylic acid chloride (2.12) (3.26 g, 16 mmol, 0.5 equiv.) in 
dry THF (40 ml) was added. The ensuing mixture was stirred for 4 h. It was then filtered 
to remove insoluble by products. After removal of solvent under reduced pressure, the 
reaction product was passed through a very short column eluting with CH2Cl2. This 
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procedure was used to remove a material that did not migrate under conditions of TLC 
analysis. 
N2,N6-Bis(2-aminophenyl)pyridine-2,6-dicarboxamide (2.14): Compound 2.13 
(6.37 g, 12 mmol) in CH2Cl2 (100 ml) was placed in a water-bath. TFA (19 ml) was 
added slowly to this solution. The resulting mixture was stirred for 3.5 h. TLC analysis 
(CH2Cl2:EtOAc 3:1) revealed conversion of material that moved at the solvent front spot 
to one that did not move. To neutralize the TFA, an aqueous solution of NaOH (10.77 g, 
300 mL DI water) was added slowly to the reaction mixture with vigorous stirring in an 
external ice-bath. In order to ensure that all TFA was neutralized, the pH of the aqueous 
solution checked. The desired pH value of 10 was reached. After separating the phases, 
organic phase was dried over anhydrous Na2SO4. Volatiles were removed and dried in 
vacuo to give yellow crystalline product (2.14) (2.7 g, 60%).  
 
 
(4E,13E)-2-(4-Methoxyphenyl)-2-methyl-11H,31H-5,7,11,13-tetraaza-9(2,6)-
pyridina-1,3(2,5)-dipyrrola-6,12(1,2)-dibenzenacyclotetradecaphane-4,13-diene-8,10-
O
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dione (2.15a): In a 50 ml round bottom flask, 2.9a (46.4 mg, 0.144 mmol, 1 equiv.) and 
2.14 (50 mg, 0.144 mmol) were dissolved in dry methanol (20 ml). Concentrated H2SO4 
(16.9 μL, 0.317 mmol, 2.2 equiv.) was then added using a syringe.  The resulting solution 
was heated at reflux under argon for 15 min. The volatiles were removed under reduced 
pressure. The resulting residue was washed with CHCl3 to give a salt-like orangish-brown 
solid. This crystalline solid was redissolved in CH3OH. An excess of TEA (0.1 ml) was 
added to this solution. The resulting mixture was heated at reflux for 15 min then was 
cooled to room temperature. The product was collected in the form of a light pink 
precipitate, which was washed with cold methanol to yield the free-base macrocycle. 1H 
NMR (500 MHz, CD2Cl2) δ 1H NMR (500 MHz, CD2Cl2) δ 9.52 (bs, 2H), 8.27 (d, 2H, J 
= 7.8 Hz), 8.23 (s, 2H), 8.02 (t, 1H, J = 7.9 Hz), 7.59 (dd, 2H, J = 7.8 Hz, J = 1.7 Hz), 
7.24 (dt, 2H J = 7.4 Hz, J = 1.6 Hz), 7.20 (dt, 2H, J = 7.4 Hz, J = 1.6 Hz), 7.11 (dd, 2H, J 
= 7.8 Hz, J = 1.7 Hz), 6.82 (d, 2H, J = 8.8 Hz), 6.74 (d, 2H, J = 3.8 Hz), 6.65 (d, 2H, J = 
8.8 Hz), 6.33 (d, 2H, J = 3.8 Hz), 3.67 (s, 3H), 2.01 (s, 3H) ppm. 13C NMR (126 MHz, 
CD2Cl2) δ 163.95, 159.12, 151.61, 150.41, 146.24, 143.66, 139.44, 138.70, 131.25, 
131.03, 128.64, 127.65, 127.23, 126.38, 125.98, 119.61, 119.36, 114.26, 109.71, 55.68, 
45.38, 29.51 ppm. HRMS (ESI+) m/z for C38H32N7O3 [M]+ calcd 634.25565, found 
634.25611.   
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(4E,13E)-2-(4-Hydroxyphenyl)-2-methyl-11H,31H-5,7,11,13-tetraaza-9(2,6)-
pyridina-1,3(2,5)-dipyrrola-6,12(1,2)-dibenzenacyclotetradecaphane-4,13-diene-8,10-
dione (2.15b): The procedure reported for the formation of other Schiff-base macrocycles 
was used, albeit with 2.9b and 2.14 as the starting materials.24 In a 100 ml round bottom 
flask, compound 2.9b (352 mg, 1.1 mmol) and compound 2.14 (347 mg, 0.98 mmol) 
were dissolved in distilled methanol (60 ml). H2SO4 conc. (115 μL, 2.1 mmol) was then 
added dropwise using a syringe. The resulting solution was heated at reflux under argon 
for 15 min. The solution was cooled to room temperature and an excess of TEA was 
added via syringe. The solution was stirred at room temperature for 15 min.  The product 
was collected in the form of a very pale yellow precipitate and washed with cold 
methanol to yield 490 mg of macrocycle 2.15b (93% yield). 1H NMR (400 MHz, DMSO-
d6) δ 10.99 (bs, 2H), 10.33 (s, 2H), 9.26 (s, 1H), 8.14–8.16 (m, 3H), 8.05 (s, 2H), 7.35 (d, 
2H), 7.26 (t, 2H), 7.16 (t, 2H), 7.04 (d, 2H), 6.57–6.59 (m, 6H), 6.12 (d, 2H), 1.88 (s, 3H) 
ppm. 13C NMR (150 MHz, DMSO-d6) δ 163.20, 155.79, 151.53, 149.20, 149.02, 142.83, 
139.29, 137.74, 130.66, 129.37, 128.12, 127.62, 127.33, 124.91, 124.44, 119.81, 117.31, 
OH
HNNH
OHC CHO
N OO
NH HN
NH2 H2N
1. H2SO4
MeOH
reflux, 2h
2. TEA
MeOH
reflux, 2h
OH
HNNH
N OO
NH HN
N N
2.9b                                   2.14                                                             2.15b
                                                                                                              (93%)
 63 
114.73, 108.67, 44.22, 29.65 ppm. HRMS (ESI+) m/z for C37H29N7O3 [M+H]+ calcd 
620.24063, found 620.24046. 
  
 
A similar substitution procedure used to obtain co-polymer 2.17 was used, albeit 
compounds 2.15b and 2.19 as starting materials. The product 2.15e is stable enough to 
characterize but not to store on bench top. 1H NMR (400 MHz, CDCl3) δ 9.51 (bs, 2H), 
8.23 (d, J = 7.8 Hz, 2H), 8.19 (s, 2H), 7.91 (t, J = 7.8 Hz, 1H), 7.59 (dt, J = 7.2 Hz, J = 
2.0 Hz, 2H), 7.17 (m, 4H), 7.04 (dd, J = 7.2 Hz, J = 2.0 Hz, 2H), 6.80 (d, J = 8.9 Hz, 2H), 
6.68 (d, J = 3.7 Hz, 2H), 6.63 (d, J = 8.8 Hz, 2H), 6.29 (d, J = 3.7 Hz, 2H), 4.08 (dd, J = 
11.0 Hz, J = 3.0 Hz, 1H), 3.76 (dd, J = 11.0 Hz, J = 5.8 Hz, 1H), 3.22 (m, 1H), 2.81 (t, J 
= 4.9 Hz, 1H), 2.64 (dd, J = 4.9 Hz, J = 2.7 Hz, 1H), 2.0 (s, 3H) ppm. 13C NMR (101 
MHz, CDCl3) δ 163.48, 157.22, 150.73, 149.67, 149.65, 142.68, 138.90, 138.62, 130.56, 
128.12, 127.05, 126.46, 125.88, 125.59, 125.56, 118.77, 118.63, 114.36, 109.21, 68.67, 
50.02, 36.52, 31.25, 29.28 ppm. HRMS (ESI+) calcd for C40H33N7O4 [M+H]+ 676.26670, 
found 676.26750.  
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Co-polymer 2.17: To a solution of 2.15b (340 mg, 0.55 mmol) in DMF (5 mL), 
were added Cs2CO3 (185 mg, 0.56 mmol) and CsBr (2 mg). The resultant mixture was 
stirred for 15 minutes at room temperature. A solution of polymer 2.16 (85 mg, 0.55 
mmol Cl) was then added. The mixture was heated to 80 °C for 12 h. The reaction 
mixture was then allowed to cool to room temperature. Before being sparged into 
CH3OH, the insoluble were collected by filtration. The filtrate was precipitated in CH3OH 
(200 mL).  The precipitate that resulted was filtered and dried in vauo. The solid obtained 
was dissolved in CH2Cl2 and insoluble inorganics and non-reacted 2.15b were removed 
by filtration. CH2Cl2 was removed under reduced pressure. Compound 2.17 was 
solidified with CH3OH and dried in vacuo to give a light yellow powder (210 mg). 
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Randomly cross-linked PAA·HCl (2.21) and the randomly cross-linked PAA·HCl 
derivative with Schiff-base pendants (2.22) were prepared as follows: A 20% w/v 
solution of PAA·HCl (160 mg, 0.8 ml) was mixed with a 10 M solution of NaOH (68 
mg) until the exotherm subsided and the reaction vessel cooled down to room 
temperature. This mixture was split into two equal parts. To one, the cross-linker (EPI, 
2.19) (40 mg) was added. To the other one, precursor 2.15e (49 mg) along with EPI 
(2.19) (40 mg) was added. Both mixtures formed gels within an hour.  The dried gel slabs 
were ground into small pieces for use in solid-liquid extraction studies. 
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2.6.2. UV-Vis Spectroscopic Studies 
 
Figure 2.13: Stacked UV-Vis spectra corresponding to the titration of 2.15a (2.43 x 10-5 
M) with TBAH2PO4 (1.27 x 10-3 M) in CH2Cl2. 
 
Figure 2.14: Job plot for 2.15a binding with TBAH2PO4 derived using the spectra shown 
in Figure 2.13 at 306.7 nm. The observed maximum near a 0.5 mole fraction 
supports a value of 1:1 binding stoichiometry.   
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Figure 2.15: Binding curve and 1:1 fit generated from the titration data shown in Figure 
2.13 using the spectral changes at 306.7 nm. Ka = (2.1 ± 0.3) x 105 M-1. 
 
Figure 2.16: Stacked UV-Vis spectra corresponding to the titration of 2.15a (2.43 x 10-5 
M) with TBAHSO4 (1.97 x 10-3 M) in CH2Cl2.  
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Figure 2.17: Binding curve and 1:1 fit generated from the titration data shown in Figure 
2.16 using the spectral changes at 300 nm. Ka = (1.2 ± 0.2) x 104 M-1. 
 
Figure 2.18: Job plot for 2.15a binding with TBAHSO4 derived from the spectral data 
shown in Figure 2.16 at 300 nm. The maximum at a mole fraction of about 
0.67 is consistent with a 1:2 (2.15a:TBAHSO4) binding stoichiometry.  
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a)  
b)  
Figure 2.19: a) Stacked UV-Vis spectra for the titration of 2.15b (1.8 x10-5 M) with 
TBAH2PO4 in CH3CN. Binding curve derived from the spectral changes 
observed in (a) at 326 nm. b) Also shown is a 1:1 (2.15b: TBAH2PO4) 
simulation with association constant Ka = 1.7 x 105 M-1.  
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a)  
b)  
Figure 2.20: a) Stacked UV-Vis spectra corresponding to Job plot of 2.15b with 
TBAH2PO4 in CH3CN. The d ecrease in absorbance at 326 nm is plotted 
against [2.15b]+[TBAH2PO4] = 2.28 x 10-5 M at each point and Xhost = 
[2.15b]/( [2.15b]+[TBAH2PO4]). The minimum, dy/dx = 0 was seen when 
Xhost = 0.53, as would be expected for 1:1 binding.  
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2.6.3. Isothermal Titration Calorimetric Studies 
 
Figure 2.21: ITC titration of 2.15b (1 x 10-4 M) with TBAH2PO4 (2 x 10-3 M) in dry 
CH3CN. The calculated binding constant for a 1:1 binding is Ka = (1.63 ± 
0.08) x 105 M-1.  
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Figure 2.22: ITC titration of 2.15b (3 x 10-4 M) with TBAH2PO4 (6 x 10-3 M) in dry 
CH3CN. The calculated binding constant for a 1:1 binding is Ka = (1.16 ± 
0.05) x 105 M-1.  
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3. Formylated Bisdipyrromethane Receptors 
 
Reproduced in part from: 
Deliomeroglu, M. K.; Lynch, V. M.; Sessler, J. L. 
Conformationally switchable non-cyclic tetrapyrrole receptors: Synthesis of 
tetrakis(1H-pyrrole-2-carbaldehyde) derivatives and their anion binding properties  
Chemical Communications, 2014, 50 (80), 11863–11866  
Copyright 2014 Royal Society of Chemistry 
 
3.1. DIPYRROMETHANE-BASED RECEPTORS  
Calix[4]pyrrole (C[4]P) is a non-conjugated macrocyclic system. It was first 
synthesized by Baeyer in 1886.1 C[4]P consists of four pyrrole rings and four sp3 
hybridized meso-carbon atoms in an alternating pattern. In 1996, Gale et al. reported2 
anion binding studies of two C[4]P derivatives, namely octamethylcalix[4]pyrrole (1.10) 
and tetraspirocyclohexylcalix[4]pyrrole (1.10’), as mentioned in Chapter 1.  
 
 
These two systems (1.10 and 1.10’) were found to bind the F– and Cl– anions well 
in halogenated solvents (e.g., CH2Cl2), along with their counter cations in certain 
instances.3,4 However, they did not bind the H2PO4– anion well.2 The main research goal 
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underlying this Chapter was to test acyclic bisdipyrromethane (bisDPM)-based C[4]P 
analogues for H2PO4– anion recognition. 
In C[4]P, halide anion binding induces conformational change from a limiting 
1,3-alternate conformation (the free form) to a cone conformation (halide-bonded form) 
(cf. Figure 1.3). This structural switching allows the formation of four NH—anion 
hydrogen bonds in the case of F–.2 Under most analytical conditions (e.g., 1H NMR 
spectroscopy, isothermal titration calorimetry, etc.), C[4]P proved less effective as a 
receptor for larger anions, including the H2PO4–.2 
With a given C[4]P system, each meso-carbon with two neighboring pyrrole rings 
can be considered as a dipyrromethane (DPM) subunit. The simplest DPM building block 
of C[4]P 1.10 is 2,2'-(propane-2,2-diyl)bis(1H-pyrrole), 3.1 (vide supra). This acyclic 
structure was not an effective halide ion receptor according to Cho et al..5 In the case of 
F– and Cl– anion salts studied in CD2Cl2, compound 1.10 displayed association constants 
that were >2x greater than those recorded for the corresponding acyclic building block, 
dipyrromethane (DPM) 3.1 (cf. Table 3.1).  
  
 Anionsa 
Receptor F– b Cl– Br– I– H2PO4– HSO4– 
1.102 1.7 x 104 3.5 x 102 1.0 x 101 < 101 9.7 x 101 < 101 
3.15 2.1 x 103 1.1 x 102 1.9 x 101 < 101 3.1 x 103 < 101 
a All salts were used as TBA+ salts. b TBAF was used as commercially available trihydrate. 
Table 3.1: Association constants of 1.10 and 3.1 with selected anions in CD2Cl2 at 298 
K.2,5 
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This difference in association constants was ascribed to the greater pre-
organization of the cyclic system, as well as to the increased number of pyrrolic NH 
hydrogen bond donors provided by 1.10 compared to 3.1. On the other hand, compound 
3.1 displayed a higher affinity toward H2PO4– (as its tetra-n-butylammonium (TBA+) salt) 
than did 1.10 in CD2Cl2. While this apparent difference was not studied in detail, it might 
reflect the fact that the H2PO4– anion is too large to be hosted efficiently within the NH-
rich C[4]P pseudo cavity. In contrast, the presumably greater flexibility of 3.1 might 
allow it to form more favorable interactions with H2PO4– and other oxoanions as 
compared to 1.10.5 While untested, this hypothesis provides an incentive to create and 
study new DPM-based anion receptors. A goal of this effort would be to create improved 
phosphate anion receptors that are also easier to prepare than C[4]P. In this chapter we 
focus on DPM receptors that have been formylated in their so-called α-pyrrolic positions. 
In synthetic work reported in 2003, aimed at producing a C[4]P-texaphyrin 
chimera,6 the α-pyrrolic positions of 3.1 were subjected to formylation to obtain 
diformyl-DPM 3.2 (Figure 3.1). The anion binding properties of 3.2 with TBAF were 
studied by ITC in CH3CN and via X-ray crystallography in the solid state.7 Despite the 
observation that F– anion may be bound in the solid state, as inferred from an 
unpublished** crystal structure (cf. Figure 3.1), it was concluded that 3.2 was not an 
effective anion receptor. 
                                                
** Unpublished result from Dr. Michael Huggins’ post-doctoral study at the University of Texas at Austin 
(2007). 
 79 
    
Figure 3.1: Left: Structure of diformyl-DPM (3.2) and Right: Single crystal structure of 
the 2:1 (3.2)2·TBAF complex. The TBA+ counter cation is omitted for 
clarity. This structure was not reported but redrawn using data from the 
CCDC (CCDC number 186152). 
On the other hand, we have found8 that the bisdipyrromethane (bisDPM) 
structures (3.3a–3.5a) and their formylated derivatives (3.3b–3.5b) are effective and 
somewhat selective receptors for the TBA+ salts of H2PO4– and hydrogenpyrophosphate 
(HP2O73–) in CHCl3, as inferred from NMR and UV-Vis spectroscopic and X-ray 
diffraction analyses. The syntheses, structural characterization, and anion binding 
properties of a series of tetrakis(1H-pyrrole-2-carbaldehyde) receptors, consisting of 
3.3b–3.5b, are discussed in this Chapter. 
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3.2. BISDIPYRROMETHANE SYSTEMS IN THE LITERATURE  
In the previous section, the goal of using DPM-based systems as H2PO4– anion 
receptors was highlighted. There are several methods reported in the literature for the 
synthesis of DPMs. Lindsey et al., developed9 the so-called “one-flask” synthetic method 
for meso-substituted DPMs, which he and others appreciated as being key precursors for 
the syntheses of asymmetric porphyrins and porphyrinogens (i.e., C[4]P). The method 
that was developed for aldehydes was also used for terephthalaldehyde, a dialdehyde, to 
make the bisDPM 3.6.9 Such bisDPM constructs were used as precursors for dimeric 
porphyrins10 or internally bridged expanded porphyrin11 systems. 
 
 
 In another report, a diketone, 1.4-cyclohexadione, was used to obtain the bisDPM 
derivative (3.7) in high yield.12 Although these two bisDPM structures, 3.6 and 3.7, were 
readily obtained from their relative dicarbonyl compounds, Panda and coworkers found13 
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that only one of two adjacent carbonyl groups reacted with pyrrole under similar acid 
catalyzed conditions (Scheme 3.1). 
  
Scheme 3.1: Reaction of an adjacent diketone (3.8) with pyrrole (1.11).13 
To investigate a flexible alkyl-chain-linked bisDPM, diketone 3.10 was used as a 
starting material. Instead of the expected bisDPM structure 3.11, a ring annulated product 
2,3-dihydro-1H-pyrrolizine 3.12 was obtained (Scheme 3.2). This result is consistent with 
what Panda and coworkers reported.14,15 In addition to 3.12, various annulation products 
(3.12’ and 3.12’’) were detected by 1H NMR and by MS analyses (Scheme 3.2). 
 
 
Scheme 3.2: Reaction of 2,4-pentadione (3.10) with pyrrole to produce 2,3-dihydro-
1H-pyrrolizine (3.12) and further propagated derivatives (3.12’ and 
3.12’’). 
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3.3. RESULTS AND DISCUSSION 
3.3.1. Synthesis and Characterization 
Using bisDPM synthetic methods similar to those reported, we prepared a series 
of new receptors.8 The first set of these receptors, specifically the tetrakis(1H-pyrrole-2-
carbaldehyde) compounds 3.3b, 3.4b, and 3.5b, is covered in this Chapter. As detailed 
below, the precursors to these receptors (3.3a, 3.4a, and 3.5a) are open-chain analogues 
of C[4]P in that all three contain four pyrrole rings. They may be prepared in one step 
from commercially available materials. As detailed below, four-fold formylation of the 
bisDPM derivatives tunes their electronics and conformation to create systems that 
display high affinities for the H2PO4– and HP2O73– anions in CHCl3.  
 
  
Scheme 3.3: Syntheses of compounds 3.3b–3.5b. 
As shown in Scheme 3.3, compounds 3.3b–3.5b were synthesized in high yields 
from diketones (3.3c–3.5c) precursors that have two carbonyl groups bridged by rigid but 
free-to-rotate linkers. The requisite bisDPM intermediates, 3.3a–3.5a, were obtained via 
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the electrophilic aromatic substitution of pyrrole by various aromatic diketones. The 
yields for 3.3a and 3.5a were better than those for typical simple DPMs.9 This finding is 
ascribed to the fact that products 3.3a and 3.5a precipitate from the reaction solution 
(pyrrole serves as solvent) under the reaction conditions (see Experimental Section of this 
Chapter). The bisDPMs 3.3a–3.5a were then formylated by the Vilsmeier–Haack 
reaction to produce 3.3b–3.5b in relatively high yields (>80%). Purification of 3.3b and 
3.4b was carried out by recrystallization from hot dimethylformamide (DMF) at 80 °C. 
The molecular structures were fully characterized by 1H NMR and 13C NMR 
spectroscopy, HRMS, and, in the case of 3.3b and 3.4b, single crystal X-ray diffraction 
analyses. The compound 3.3b co-crystallized from DMF (cf. Figure 3.2) and from DMSO 
(CCDC-1012698) as 3.3b·2DMF and 3.3b·2DMSO, respectively.  
 
     
Figure 3.2: Left: Structure of 3.3b and Right: Single crystal structure of 3.3b. Two 
DMF molecules are omitted for clarity. (CCDC number 1012698). 
Similarly, a co-crystal of 3.4b·2DMF was also obtained and structurally 
characterized (Figure 3.3). Two formylated-DPM subunits of both 3.3b and 3.4b, 
interacting with two DMF molecules, stabilize trans-like conformations. For the meta-
HNNH
NH HN
CHOOHC
OHC CHO
3.3b
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derivative, 3.4b, the trans-like conformation leads to conformational isomerism in the 
solid state. Figure 3.3 shows only one of the atropisomers. All other synthetic details and 
procedures for the receptors can be found in the Experimental Section of this Chapter 
(page 109). 
   
Figure 3.3: Left: Structure of 3.4b and Right: Single crystal structure of 3.4b. The other 
major conformation and two DMF molecules are omitted for clarity. (CCDC 
number 1012700). 
3.3.2. Anion Binding Studies  
3.3.2.1. Solubility Inferred from Visual Changes 
Receptors 3.3b and 3.4b were purified by crystallization from DMF, and isolated 
as co-crystals with DMF. In an effort to study the anion binding of 3.3b under conditions 
involving minimal competition††, the DMF was removed from samples of 3.3b·2DMF by 
sonicating the crystals in CHCl3. The DMF-free form of 3.3b displayed noticeably lower 
solubility in CHCl3. Treatment of turbid mixtures of 3.3b with approximately 1.2 molar 
equivalents of the TBA+ salts of various test anions (H2PO4–, HP2O73–, HSO4–, C6H5CO2–, 
                                                
†† Solvent effects are discussed later, in the section entitled “Solution State Studies via 1H NMR 
Spectroscopy” and in Chapter 4. 
HNNH
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H
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Cl–, and NO3–) allowed for visual differentiation between the various anion salts (Figure 
3.4). While the vials containing TBAH2PO4 and (TBA)3HP2O7 became transparent, the 
vials containing other salts remained turbid. 
 
 
Figure 3.4: The photo of turbid mixtures of 3.3b in CHCl3 containing no added salt, 1.2 
equiv. of TBAH2PO4, (TBA)3HP2O7, TBAHSO4, TBAC6H5CO2, TBACl, 
and TBANO3, respectively, from left to right. Note that an orange 
background is used to aid in visualization. 
3.3.2.2. Gaseous State Studies Involving Mass Spectrometry 
Mass spectrometric (MS) analyses provided evidence that receptor 3.3b would 
interact with the H2PO4– anion in the gas phase. In these studies, an equimolar mixture of 
3.3b and TBAH2PO4 in CHCl3 was directly injected into the MS instrument without 
passing the species through a separation column. Two ionization methods, negative ion 
atmospheric pressure chemical ionization (Ni-APCI) and electrospray ionization in 
negative mode (ESI-), were used. Proton abstraction and anion adduction are active 
mechanisms in Ni-APCI.16 The low resolution Ni-APCI MS analysis revealed a signal at 
m/z 505.2 corresponding to [3.3b-H]- and another signal at m/z 541.2 ascribable to the 
dihydrate ([3.3b-H]-·2H2O). Another signal can be observed at m/z 603.2 which, on the 
basis of a high-resolution MS analysis with ≤1.15 ppm error was assigned to 
[3.3b·H2PO4–] (cf. Figure 3.5). 
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Figure 3.5: High-resolution mass spectra (electrospray ionization in negative mode) of 
3.3b (top) and of an equimolar mixture of 3.3b and TBAH2PO4 in CHCl3 
(bottom). 
3.3.2.3. Solid State Studies Involving X-ray Diffraction 
Further insights into the binding modes of the receptors 3.3b and 3.4b came from 
single crystal X-ray diffraction analyses.17 Diffraction-grade single crystals of the 
pyrophosphate complex 3.3b·(TBA)2H2P2O7 were obtained by layering a solution of 
3.3b·H2P2O72– in CH2Cl2 with n-pentane. The complex 3.3b·H2P2O72– in CH2Cl2 was 
prepared by treating 3.3b with (TBA)3HP2O7. This served to improve the net solubility by 
converting the poorly soluble receptor (vide supra; page 84) into the corresponding 
pyrophosphate complex. In the solid state, a 2:2 complex, [3.3b·H2P2O72–]2 is seen (cf. 
Figure 3.6). The overall complex consists of a hydrogen-bonded dimer that lies across a 
crystallographic inversion center. 
The protonation state of the bound pyrophosphate in the complex [3.3b·H2P2O72–]2 
was deduced from the presence of two TBA+ counter cations per pyrophosphate dianion. 
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The H2P2O72– anion lies parallel to the π-surface of the bridging benzene ring. Both 
diformyl-DPM arms are oriented such that four hydrogen bonds between the diformyl-
DPM units in 3.3b and the bound H2P2O72– are favored. The N-H···O distances between 
the NH protons of 3.3b and the O atoms of H2P2O72– range from 2.648 to 2.690 Å, 
separations that are short compared to typical N-H···O distances.18,19 Each bound H2P2O72– 
interacts with another H2P2O72– anion forming a hydrogen bonded dimer. In the dimer, 
four protons are shared between eight oxygen atoms. The observed O···O distances of 
2.508–2.518 Å are within the range expected for this type of proton bridged O-H···O 
interaction.19,20 
 
 
Figure 3.6: Single crystal structure of the 2:2 complex [3.3b·H2P2O72–]2 viewed from the 
side relative to the bridging benzene rings. Two TBA+ counter cations and 
the disordered CH2Cl2 solvent molecules per pyrophosphate are omitted for 
clarity (CCDC number 1444559). 
Diffraction grade single crystals of the complex 3.4b·TBAH2PO4 were obtained in 
a similar way. The resulting structure is shown in Figure 3.7. There is no evidence of 
dimerization in this case. The lack of dimerization is ascribed to the relatively tight 
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binding between the TBA+ counter cation and the bound H2PO4– guest, which precludes 
further inter-complex interactions. In the solid state, complex 3.4b·H2PO4– displays the 
same conformation for the diformyl-DPM units as observed in 3.3b·H2P2O72–. The four 
N-H···O distances that characterize the interaction between the NH protons of 3.4b and 
the O atoms of H2PO4– range from 2.704 to 2.760 Å, whereas the two O-H···O distances 
associated with this interaction are 2.681 and 2.726 Å, respectively. 
 
  
Figure 3.7: Single crystal structure of the 1:1 complex 3.4b·H2PO4– viewed from the top 
of the bound H2PO4– molecular ion. One TBA+ counter cation is associated 
with each complex. One TBA+ and one CHCl3 solvent molecule are omitted 
for clarity (CCDC number 1444560). 
 
3.3.2.4. Solution State Studies via UV-Vis Spectroscopy 
UV-Vis spectroscopy was used to characterize the formylated derivatives (3.3b–
3.5b) in CHCl3. These receptors are characterized by μM solubilities amenable to UV-
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Vis spectral analyses. Figure 3.8 displays the absorption spectra of several key 
compounds, namely 3.3a–c, 3.3b·H2PO4–, and the control compound 3.13 in CHCl3.  
 
 
Figure 3.8: UV-Vis spectra recorded in CHCl3. Black 3.3c, red 3.3a, dark blue 3.3b, 
light blue 3.3b determined in the presence of one molar equivalent of 
TBAH2PO4. The green trace corresponds to the control compound 3.13. 
The available UV-Vis wavelength range in CHCl3 is ≥250 nm since the solvent 
CHCl3 absorbs very strongly at wavelengths of <250 nm. Therefore, not all compounds 
of interest could be studied via UV-Vis spectroscopy. For instance, in CHCl3 3.3a does 
not have a Soret band between 250–800 nm, whereas the formylated derivative 3.3b has a 
clear Soret band in the 275 and 325 nm spectral region. 
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In an effort to quantify the anion selectivities, titration studies were performed. In 
these studies, the anion-induced changes (if any) were monitored by UV-Vis 
spectroscopy under conditions where compound 3.3b is fully soluble. Compound 3.3b 
(ca. 10 mM) was first titrated with TBAH2PO4 in dry CHCl3, keeping the total 
concentration of 3.3b constant throughout the study. A significant change in the 
absorption spectrum of 3.3b was observed with saturation occurring after the addition of 
approximately one equivalent of TBAH2PO4 (cf. Figure 3.9). Two isosbestic points, at 
293 and 315 nm, respectively, were seen. This is taken as evidence that only two 
absorbing species, namely the free host (3.3b) and the host–anion complex (3.3b·H2PO4–
), are interconverting under the conditions of the experiment.  
 
Figure 3.9: Stacked UV-Vis spectra corresponding to the titration of 3.3b (1.2 x 10-5 M) 
with TBAH2PO4 (1.0 x 10-3 M) in CHCl3. The molar ratio of 
[TBAH2PO4]/[3.3b] is varied from 0 to 3.9. 
To provide support for the proposed 1:1 stoichiometry, a Job plot was constructed 
using mixtures in which total concentration of 3.3b and TBAH2PO4 was held at 1.2 x 10-5 
 91 
M (method-1, see Experimental Section for details). Towards this end, the absorption 
maximum at 306 nm in the UV-Vis spectrum of 3.3b was monitored as the ratio of 
TBAH2PO4 to 3.3b was varied. Since the complex has a lower extinction coefficient than 
free 3.3b, a minimum in absorbance change was expected when complex formation was 
greatest; this minimum in the absorbance intensity was observed when the mole fraction 
of the anion was equal to 0.5 (Figure 3.10). This finding is consistent with the formation 
of a 1:1 complex, presumably 3.3b ·H2PO4–. 
 
Figure 3.10: Left: UV-Vis spectra used to produce a Job plot for the interaction of 3.3b 
with TBAH2PO4 in CHCl3. ([3.3b] + [TBAH2PO4] = 1.2 x 10-5 M). Right: 
Job plot obtained from UV spectra shown in the left panel using 306 nm as 
the monitored wavelength. 
Another method (method-2), also described in the Experimental Section (Table 
3.8) was used to obtain a second Job plot (cf. Figure 3.11). In this method, data from 
titrations carried out to determine the binding affinity are used. In this system, addition of 
H2PO4– causes a decrease in the absorption of 3.3b at 306 nm (cf. Figure 3.9). When this 
decrease is plotted against the molar fraction of H2PO4– added, a second Job plot may be 
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obtained (cf. Figure 3.11). Analysis of this plot leads to the same conclusion drawn from 
Figure 3.10, namely that a 1:1 complex is being formed. 
 
Figure 3.11: Left: UV-Vis spectra for a titration carried out with the intention of 
determining the binding affinity (cf. Figure 3.9). Right: Job plot derived 
from the spectra shown on the left using at 306 nm as the monitored 
wavelength. 
After confirming via Job plots that the interaction between 3.3b and TBAH2PO4 is 
1:1, the data at 306 nm from Figure 3.9 was fitted to a 1:1 binding profile. The fitting 
curve is shown in Figure 3.12. The data (black square points) align well with the 
theoretical binding isotherm (red line). The theoretical curve is derived for titration 
conditions in which the total receptor concentration is kept constant throughout the 
experiment. For the specific titration of 3.3b with TBAH2PO4, non-linear fitting gives a 
binding affinity of Ka = (8 ± 2) x 106 M-1. 
Similar studies were performed for 3.3b by titrating with TBAH2PO4, 
(TBA)3HP2O7, TBAHSO4, TBAC6H5CO2, TBACl, and TBANO3. The same sets of anion 
salts were also tested in the case of receptors 3.4b and 3.5b. The data were fit to a 1:1 
binding isotherm using a protocol detailed on page 117. The binding affinities (Ka) 
obtained from these studies are collected in Table 3.2 and related spectra and binding 
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curve fittings are provided in the Experimental Section (starting from page 119). Based 
on the optical titration studies involving different anions, studied as their TBA+ salts in 
CHCl3, the highest affinity was observed for H2PO4–, followed by HP2O73– (Table 3.2). 
 
 
Figure 3.12: Binding curve fitting for the interaction of 3.3b with TBAH2PO4 derived 
using the data in Figure 3.9 with monitoring at 306 nm. Ka = (8 ± 2) x 106 M-
1. 
In order to assess the importance of an intervening aromatic linker and its 
connectivity (meta-, para-) on anion binding, receptors 3.3b, 3.4b, and 3.5b were 
compared. The positions of the two diformyl-DPM units on the aromatic ring did not 
appear to affect the binding affinities significantly, nor their specificities. Support for this 
conclusion came from the finding that the isomeric para- (3.3b) and meta- (3.4b) systems 
displayed similar selectivity and anion affinity trends (cf. Table 3.2). On the other hand, 
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the pyridine-based receptor 3.5b was characterized by affinities that were an order of 
magnitude lower. 
 
  Ka (M-1)  
Anion 3.3b 3.4b 3.5b 
H2PO4– (8 ± 2) x 106 (8 ± 2) x 106 (4.6 ± 0.9) x 105  
HP2O73– (1.4 ± 0.1) x 105 (1.9 ± 0.3) x 105 (6.5 ± 0.7) x 104 
HSO4– (4.1 ± 0.2) x 103 (4.00 ± 0.09) x 103 (1.6 ± 0.1) x 103 
C6H5CO2– UD (8 ± 1) x 104 (6.7 ± 0.1) x 103 
Cl– NC NC NC 
NO3– NC NC NC 
UD: could not be determined; NC: No discernible changes in the UV-Vis spectrum were observed. 
Table 3.2: Calculated binding affinities (M-1) for 3.3b, 3.4b, and 3.5b with various 
TBA+ anion salts in CHCl3 as determined by UV-Vis spectroscopy.  
In order to understand the electronic effects of the pyrrole on the anion binding 
properties of receptor 3.3b, a series of control compounds were prepared and studied. In a 
first study, the H2PO4– binding properties of the bisDPM 3.3a were studied with 
TBAH2PO4 in chloroform. BisDPM 3.3a is the precursor to 3.3b and has hydrogen atoms, 
rather than formyl, substituents at the α-positions. Unfortunately, efforts to monitor the 
anion binding features of 3.3a via UV-Vis spectroscopy were precluded due to the fact 
that the CHCl3 absorption in the UV portion of the spectrum overlaps with that of the 
pyrrole rings. Thus, for this comparison, we turned to 1H NMR spectroscopy (cf. Section 
3.3.2.5 Solution State Studies via 1H NMR Spectroscopy). 
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A DPM control compound, 3.13, was prepared according to the literature.21,22 
Compound 3.13 lacks the second diformyl-DPM unit present in 3.3b. However, it is 
structurally more similar to 3.3b than 3.1. Therefore, we hypothesized that it should 
display a lower binding affinity. Although 3.13 is very similar to 3.3b in terms of 
electronics and may be viewed as being ‘‘half’’ of the full receptor system present, no 
spectral change was observed in the UV-Vis spectrum when 3.13 was titrated with 
TBAH2PO4 in CHCl3. On this basis, the substantial increase in the binding affinity seen 
for 3.3b compared to 3.13 can be attributed to both the increase in number of NH 
hydrogen bond donors (two in 3.13; four in 3.3b) and the creation of what may be a 
better organized system. 
 
 
Compound 3.14 was also studied as a control. This flexible tetraethylene glycol 
chain linked system has the same number of α-formylpyrroles as 3.3b; however, it lacks 
a similar degree of preorganization. It displays very little affinity for H2PO4– or the other 
test anions in CHCl3, as inferred from the lack of observed spectral changes. 
 
 
NH HN
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3.13                                                                  3.14
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Anion 3.3b 3.13 3.14 
TBAH2PO4 (8 ± 2) x106 NC NC 
TBACl  NC NS NS 
NC: No discernable spectral change, NS: not studied. 
Table 3.3: Binding affinities as calculated from UV-Vis spectral titrations of 3.3b, 
3.13, and 3.14 with TBAH2PO4 and TBACl in CHCl3. 
3.3.2.5. Solution State Studies via 1H NMR Spectroscopy 
Based on the visually observed solubility changes and UV-Vis spectroscopic 
studies discussed above, it was concluded that the formylated bisDPM receptors, 3.3b–
3.5b, display relatively high affinities for the H2PO4– anion in CHCl3. Since the 
absorption bands of bisDPM compounds 3.3a–3.5a were not observable in the solvent 
(CHCl3) used for analysis, the H2PO4– binding affinities of these compounds could not be 
determined via UV-Vis spectroscopy. Therefore, 1H NMR spectroscopy was used. 
Compounds 3.3b–3.5b were also analyzed by 1H NMR spectroscopy. This was done so 
that the two compound series (3.3a–3.5a and 3.3b–3.5b) could be compared.  
In order to find conditions under which the two series could be compared, various 
solvent systems were screened. Figure 3.13 displays 1H NMR spectra of 3.3b in various 
NMR solvents. It also became apparent that the pyrrole NH chemical shift depends on the 
presence and absence of residual solvent bound within the receptor (i.e., DMF-free 3.3b 
versus single crystal 3.3b·2DMF). Due to these solvent dependences, which were taken 
as indications of receptor-solvent interactions as inferred from the crystal structure of 
3.3b·2DMF, hydrogen-bond-accepting solvents such as DMF and DMSO were deemed 
too competitive. Therefore, the DMF-free from of 3.3b was used for the binding studies. 
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However, the solubility of 3.3b is lower than 1.0 mM in CHCl3, making the 1H NMR 
spectral studies challenging. 
 
Figure 3.13: Stacked partial 1H NMR spectra of 3.3b (in the form of a white powder and 
single crystalline (3.3b·2DMF)) in various solvent systems. 
Although solutions of 3.3b proved turbid at concentrations ≥1.0 mM, the expected 
signals in the 1H NMR spectrum could be observed in dilute solutions. Upon addition of 
TBAH2PO4, the solubility increases noticeably. In fact, upon the addition of one 
equivalent of TBAH2PO4 to a turbid 1.0 mM‡‡ mixture of 3.3b in CDCl3, the solution 
mixture became completely clear/soluble. Moreover, in the 1H NMR spectrum (in CDCl3) 
                                                
‡‡ The 1.0 mM concentration value is given here for the purposes of convenience. It is based on the 
incorrect assumption that the sample of 3.3b used was fully dissolved. The turbid nature of the mixture 
means that the actual solution phase concentration of 3.3b is <1.0 mM. 
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an additional set of signals, other than those attributed to 3.3b, appeared (Figure 3.14). 
When receptor 3.3b (turbid 1.0 mM mixture in CDCl3) was titrated with TBAH2PO4 in a 
stepwise manner, peaks corresponding to both the free host and the receptor-anion 
complex were observed in the 1H NMR spectrum. This was taken as evidence of a strong 
interaction between the receptor and the anionic guest H2PO4–, as well as a recognition 
process that involved exchange kinetics that are slow on the NMR time scale. 
Unfortunately, the incomplete solubility displayed by 3.3b at the concentrations used for 
the titrations prior to the addition of a full molar equivalent of TBAH2PO4 precluded a 
quantitative estimate of the Ka corresponding to the receptor-anion interaction in CDCl3. 
 
Figure 3.14: Stacked partial 1H NMR spectra of turbid mixtures of 3.3b without added 
TBAH2PO4 (red), 3.3b with  > 0.2 (but <1.0) equivalent TBAH2PO4 (green), 
and soluble mixture of 3.3b and 1.25 equivalent TBAH2PO4 (blue) in 
CDCl3. 
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A 1:1 binding stoichiometry was inferred from UV-Vis spectroscopic studies. The 
1:1 binding isotherms were shown to fit the data obtained from titration experiments. In 
order to rule out other binding modes other than simple 1:1 (e.g. 2:2, 3:3, or n:n), 
diffusion ordered spectroscopy (DOSY)23 studies were carried out. On the basis of these 
latter analyses, the formation of self-assembled polymeric structures is ruled out under 
the relatively high dilution conditions used for the spectroscopic studies (Figure 3.15).  
 
Figure 3.15: Left: A sample DOSY spectrum of 3.3b·TBAH2PO4 recorded at a 
concentration of 0.025 M in CDCl3. Right: Plot of DOSY spectral results for 
3.3b·TBAH2PO4 recorded at various concentrations (from 0.0125 mM to 
0.10 mM) in CDCl3. 
In this experiment, DOSY spectrum of a stock solution of 3.3b·TBAH2PO4 was 
recorded at a concentration of 0.1 M in CDCl3, as well as at lower concentrations (e.g., 
0.05 M, 0.025 M, and 0.0125 M) (Figure 3.15). The diffusion parameter trends observed 
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for the 3.3b·TBAH2PO4 and the trimethylsilane (TMS) molecule (used as an internal 
standard) were then recorded. 
 
 
Figure 3.16: DOSY spectrum of a 1:0.5 mixture of 3.3b and TBAH2PO4. The mixture 
was obtained by titrating 0.8 mM TBAH2PO4 into a turbid mixture of 3.3b 
in CDCl3 until the half-equivalent point was inferred from the ratio of the 
integration values. ^ shows free-3.3b; * shows 3.3b·H2PO4–. 
 101 
In a different experiment, DOSY was used to examine the interactions between 
anions and receptor 3.3b. Here, a different approach, in which both unbound and bound 
forms of the receptor were observed simultaneously was used.  Receptor 3.3b was chosen 
for these studies for two reasons. First, the low solubility of 3.3b in CHCl3 means that an 
equilibrium was expected to exist between species free in solution and those tied up in 
the solid state. Secondly, on the 1H NMR time scale, free receptor 3.3b and the H2PO4– 
bound complex (3.3b·H2PO4–) were subject to slow-exchange (cf. Figure 3.14) allowing 
both species to be observed concurrently. Figure 3.16 shows the DOSY spectrum of a 
mixture of 3.3b at the half-equivalence point obtained by titrating with TBAH2PO4 in 
CDCl3. The one-dimensional 1H NMR spectrum in the horizontal axis shows two sets of 
receptor signals; free 3.3b and 3.3b·H2PO4–. These are labeled with red and blue asterisks, 
respectively. 
After confirming the 1:1 binding stoichiometry in solution state via the DOSY 
analyses, binding affinities of 3.3a and 3.3b for H2PO4– were determined in order to 
understand the effect of formylation on the H2PO4– anion binding. The determination of 
Ka corresponding to the 3.3b·H2PO4– anion interaction in CDCl3 was precluded due to low 
solubility. Although 3.3a, like 3.3b, is poorly soluble in CDCl3 and forms turbid mixtures 
at the mM concentrations required for NMR spectroscopic analyses, compound 3.3a 
could be studied under the conditions (i.e., in CDCl3). Specifically, the change in the 
pyrrole NH signals of 3.3a were followed as TBAH2PO4 was added (Figure 3.17). Upon 
the addition of 7.0 molar equivalents of TBAH2PO4, a shift in the NH signal from 7.8 
ppm to 10.9 ppm was observed. No appreciable changes were seen as further equivalents 
were added. When the pyrrole NH resonance change is plotted against the concentration 
of H2PO4– added, the binding isotherm shown in Figure 3.18 was obtained. This isotherm 
was fitted to a 1:1 binding profile as explained in the Experimental Section to yield Ka =  
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Figure 3.17: Stacked partial 1H NMR spectra corresponding to the titration of 3.3a (0.6 
mM) with TBAH2PO4 (2.2 mM) in CDCl3. 
 
Figure 3.18: Pyrrole NH chemical shift change plotted against [TBAH2PO4]. The data 
were fit to a 1:1 binding curve giving Ka = (1 ± 0.1) x 103 M-1.  
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(1 ± 0.1) x103 M-1. A discussion of the 1H NMR spectra and the curve fittings for related 
studies are provided in Section 3.5.3. 
Greater changes were observed in the case of 3.3b; here, the NH signal is seen to 
undergo a change from 9 ppm to 13.6 ppm upon the addition of only one equivalent of 
TBAH2PO4 (Figure 3.14). From this disparate behavior we conclude that the affinity of 
3.3b for H2PO4– is greater than that seen for the control system 3.3a (Table 3.4). 
 
 3.3aa,b 3.5aa 3.3ba,b 1.10c 
NH δ shift 7.8–10.9a 
9.0–10.9b 
8.2–10.4 
 
9.0–13.6a 
11.3–13.3b 
7.0–NR 
Saturation ~7 equiv. a >5 equiv. ~1 equiv. NR 
Ka (M-1) (1 ± 0.1) x103a,d 
184 ± 5b 
40.8 ± 0.6 >105a,e 
3200 ± 900b 
97 ± 4 
a Study performed in CDCl3, b Study performed in CDCl3/DMSO-d6 (8/1). c Study performed in 
CD2Cl2 ref-2. d Approximate value based on an analysis of what was initially a turbid mixture. e The 
value is beyond the range that may be determined accurately by 1H NMR spectroscopy. NR: not 
reported. 
Table 3.4: Summary of 1H NMR spectral changes seen for 3.3a, 3.5a, 3.3b, and 1.10 
upon addition of TBAH2PO4. 
To determine a reliable Ka value for H2PO4– in the case of receptor 3.3b, a solvent 
mixture in which 3.3b is soluble, CDCl3/DMSO-d6 (8/1), was required. The Ka for 
receptor 3.3b proved x17 higher than that recorded for 3.3a in CDCl3/DMSO-d6 (8/1) 
mixture (cf. Table 3.4). Control compound 3.3a displayed a x10 higher H2PO4– affinity in 
CDCl3 than did C[4]P 1.10 in CD2Cl2 (cf. Table 3.4). While a direct comparison between 
3.3b and 1.10 cannot be made due to the differing conditions of analysis, overall, the Ka 
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value increases on passing from 1.10 to 3.3a and then on to 3.3b. This benefit in binding 
is ascribed to a combination of structural and electronic effects.  
 
Solvent 3.3a 3.3b 1.10a 
CDCl3 (1.0 ± 0.1) x103 ud (9.7 ± 4) x101 
CDCl3/DMSO-d6 (8/1)  (1.84 ± 0.05) x102 (3.2 ± 0.9) x103 - 
a in CD2Cl2 from reference2 ud: unable to determine (slow exchange) 
Table 3.5: H2PO4– binding affinities as calculated from 1H NMR spectral titrations of 
3.3a, 3.3b, and 1.10 with TBAH2PO4 in two solvent systems as indicated in 
this table. 
These structure-related changes appear to modulate not just the affinity, but also 
the inherent selectivity. Specifically, receptor 3.3b exhibits an inversion in selectivity 
compared to C[4]P. It displays a higher affinity for TBAH2PO4 (subject to the solvent-
related caveat noted above). However, it possesses a ~3 fold lower affinity for TBACl in 
similar halogenated solvents (i.e. CDCl3 and CD2Cl2; cf. Table 3). 
 
 3.3ba 1.10b 
TBAH2PO4 3200 ± 900c 97 ± 4 
TBACl  121 ± 7 350 ± 6 
a in CDCl3 and b in CD2Cl2 (Reference-2) c in CDCl3/DMSO-d6 (8/1)  
Table 3.6: Binding affinities calculated from 1H NMR spectral titrations of 3.3b and 
1.10 with TBAH2PO4 and TBACl in various solvent systems as indicated in 
this table.  
As a part of solution state studies, we performed a 2D-NMR study involving 
rotating frame nuclear Overhauser effect spectroscopy (ROESY). In CDCl3, no 
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correlation between the counter cation TBA+ and the receptor 3.3b was observed (red 
boxed area of Figure 3.19). Based on the crystal structure of 3.4b·H2PO4–, a heteronuclear 
cross-coupling between 31P of the bound H2PO4– and 1H of the pyrrole NH of the receptor 
3.4b was expected via heteronuclear Overhauser effect spectroscopy (HOESY). 
However, in CDCl3 , no correlation signal was seen. 
 
Figure 3.19: ROESY spectrum of a solution of 3.3b:TBAH2PO4 (1:1) in CDCl3.  
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Based on the binding mode observed in the solid state, we considered it likely that 
anion-π interactions, as well as pyrrole NH-anion hydrogen bonding interactions 
contribute to anion binding. To explore this possibility, the effect of adding TBAH2PO4 to 
the most soluble receptor of the present series, namely the meta-derivative 3.4b, was 
investigated using 1H NMR spectroscopy (Figure 3.20).  
 
 
Figure 3.20: Partial 1H NMR spectra of receptor 3.4b before (bottom) and after (top) 
addition of one molar equivalent of TBAH2PO4 in CDCl3. Dashed lines 
show the changes in the chemical shifts of selected proton signals ascribable 
to receptor 3.4b. Hydrogens marked in blue (H1, H2, and H3) are signals for 
the aromatic hydrogens on the benzene ring. Red signals (H4 and H5) 
correspond to pyrrole β-hydrogens. Hydrogen assignments are given in 
Table 3.7. 
Upon addition of one molar equivalent of TBAH2PO4 to a CDCl3 solution of 3.4b, 
discernible shifts in the proton resonances of 3.4b were observed (cf. Table 3.7). Of 
particular note were the 0.6 ppm upfield shifts seen for the proton signals of the 
intervening benzene ring. Such shifts are consistent with the presence of anion-π 
interactions, as inferred from previous studies of α,α,α,α-meso-tetraaryl-C[4]P 
derivatives reported by Ballester and co-workers.24 
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Table 3.7: Summary of chemical shift changes of some of the hydrogen signals of 
receptor 3.4b after addition of about one molar equivalent of H2PO4–. 
 
3.4. CONCLUSION 
On the basis of the results and discussions presented, we conclude that the 
macrocyclic structure of C[4]P present in 1.10 is not required for effective anion 
recognition. In fact, the new tetrakis(1H-pyrrole-2-carbaldehyde) receptors (3.3b–3.5b) 
bind the H2PO4– anion more strongly than C[4]P 1.10 in typical organic solvents. The 
higher affinity is attributed to a combination of factors, including the presence of better 
hydrogen-bond donor groups (i.e., the α-formyl pyrrole units present in receptor 3.3b–
3.5b) and a rigid aromatic linker between the individual DPM subunits that permits 
conformational flexibility and, presumably, accommodation of the bound anion, 
including stabilizing anion-π interactions. Conformational switching from trans-like 
conformations (as seen in the free receptors 3b and 4b) to the corresponding cis-like 
 δ (ppm)   
 
H-type 3.4b 3.4b·H2PO4– ∆δ (ppm) 
H1 7.25 7.10 - 0.15 
H2 7.10 6.70 - 0.40 
H3 6.90 6.30 - 0.60 
H4 6.80 6.85 + 0.05 
H5 6.00 6.30 + 0.30 
HNNH
NH
N
H
CHOOHC
CHO
CHO
H3H2
H1
H2
H5
H4
H5
H4
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conformations, dominating in the presence of a bound phosphate derivatives was revealed 
by X-ray diffraction analyses in the solid state (Figure 3.21). 
 
 
 
Figure 3.21: Views of the single crystal structures of 3.3b (top) and 3.4b (bottom) in the 
absence and presence of bound phosphate derivatives. 
 
 109 
3.5. EXPERIMENTAL 
All solvents and chemicals were purchased from Aldrich, TCI, and Acros. Pyrrole 
was distilled at 80 °C under reduced pressure (100 mbar) prior to use. Other solvents and 
reagents were used without further purification. 
3.5.1. Synthetic Procedures 
Procedure-A: BisDPM synthesis 
 
 
1,4-Bis(1,1-di(1H-pyrrol-2-yl)ethyl)benzene (3.3a): 1,4-Diacetylbenzene (3.3c) 
(1.45 g, 9.0 mmol) was dissolved in pyrrole (5.0 g, 75 mmol). A catalytic amount of TFA 
(5 drops) was then added. The mixture was stirred in an oil bath at 60 °C for 8 h. The 
solution was allowed to cool to room temperature. The desired product was precipitated 
by addition of methanol (ca. 10 ml). The resulting pale green mixture was filtered. The 
precipitate obtained was washed further with methanol (10 ml) and was dried in vacuo to 
afford bisDPM (3.3a) as a white solid (2.45 g, 70%). Based on 1H NMR spectral analysis, 
the monoDPM (3.3a’) was present as a 4% impurity. 1H NMR (400 MHz, DMSO-d6) δ 
10.28 (bs, 4H), 6.83 (s, 4H), 6.61 (m, 4H), 5.86 (m, 4H), 5.52 (m, 4H), 1.91 (s, 6H) ppm. 
13C NMR (100 MHz, DMSO-d6) δ 146.3, 137.7, 126.4, 117.1, 106.2, 105.9, 43.9, 27.9 
ppm. HRMS (ESI+) m/z for C26H26N4 [M+H]+ calcd 395.22302, found 395.22355. 
HNNH
NH HN
O
O
H
N
60°C
8h
TFA
NH HN
O
3.3c                                                            3.3a                              3.3a'
                                                                   70%                               4%
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Procedure-B: Vilsmeier–Haack formylation. This is a modified version of a 
procedure first reported by Love and coworkers.22  
 
   
5,5',5'',5'''-(1,4-Phenylenebis(ethane-1,1,1-triyl))tetrakis(1H-pyrrole-2-
carbaldehyde) (3.3b): To a solution of 3.3a (3.8 g, 9.6 mmol) in DMF (25 ml), POCl3 
(6.5 ml, 69.5 mmol) was added slowly with the vessel held in a water bath. The dark red-
colored reaction mixture was allowed to stir for an hour at room temperature and then 
overnight at 80 °C. The mixture then was added to 100 ml water to quench the excess 
POCl3. Aqueous NaOH (1-2 M) was added to the reaction mixture portion-wise until a 
pH of 10 was reached. The product precipitated out to give a solid containing an average 
of 2 DMF molecules per equivalent of 3.3b (5.58 g, 90% yield), as inferred from an 
integration of the 1H NMR spectrum and from single crystal X-ray analysis. The 
precipitate obtained in this way was dissolved in DMF at 80 °C and allowed to cool. This 
gave 3.3b·2DMF for which the solvation was fully defined by inter alia a single crystal 
X-ray diffraction analysis (vide infra). The DMF present in this solid material was 
extracted out by sonicating the crystals in chloroform. The product (3.3b) was collected 
as white powder from the surface of the CHCl3 mixture after centrifugation. 1H NMR 
1. DMF, POCl3
80 °C, overnight
2. NaOH, H2O
pH = 10
90%
HNNH
NH HN
HNNH
NH HN
OHC CHO
OHC CHO
3.3a                                                                  3.3b
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(400 MHz, DMSO-d6) δ 11.87 (bt, J = 2.2 Hz, 4H), 9.41 (s, 4H), 6.91 (dd, J = 3.8 Hz, J = 
2.2 Hz, 4H), 6.90 (s, 4H), 5.89 (dd, J = 3.8 Hz, J = 2.3 Hz, 4H), 2.08 (s, 6H) ppm. 13C 
NMR (100 MHz, DMSO-d6) δ 179.5, 146.4, 145.0, 133.7, 127.2, 110.8, 45.43, 27.6 ppm. 
HRMS (ESI+) m/z for C30H26N4O4 [M+H]+ calcd 529.18460, found 529.18300.  
 
Procedure-C: An alternative bisDPM synthesis 
 
 
1,3-Bis(1,1-di(1H-pyrrol-2-yl)ethyl)benzene (3.4a): 1,3-Diacetylbenzene, 3.4c, 
(650 mg, 4 mmol) was dissolved in freshly distilled pyrrole (1.5 g, 20 mmol). A catalytic 
amount of TFA (5 drops) was then added. The mixture was stirred at 60 °C for 2 days. To 
the resulting mixture, 0.2 ml of TEA was added and the resulting dark green solution was 
heated to distill off non-reacted pyrrole. The oily crude product obtained in this way was 
purified by column chromatography (silica gel/dichloromethane, Rf = 0.4). Product 3.4a 
was obtained in 20% yield as colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.75 (bs, 4H), 
7.19 (t, J = 7.9 Hz, 1H), 7.09 (t, J = 7.9 Hz, 1H), 6.96 (dd, J = 7.9 Hz, 2H), 6.63 (m, 4H), 
6.15 (m, 4H), 5.92 (m, 4H), 2.00 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3) δ 147.0, 
137.3, 127.8, 126.8, 125.5, 116.9, 108.1, 106.2, 44.7, 28.6 ppm. HRMS (ESI+) m/z for 
C26H26N4 [M+H]+ calcd 395.22302, found 395.22355. 
 
O
H
N
60°C
2d
20%
TFA
3.4c                                                                  3.4a
O
HNNH
NH
N
H
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5,5',5'',5'''-(1,3-Phenylenebis(ethane-1,1,1-triyl))tetrakis(1H-pyrrole-2-
carbaldehyde) (3.4b): To a solution of 3.4a (400 mg, 1 mmol) in 5 ml DMF, POCl3 (0.8 
ml, 8 mmol) was added slowly. Procedure-B was employed. The precipitated product 
was found to contain an average of 2 DMF molecules (5.58 g, 89% yield), as inferred 
from an integration of the 1H NMR spectrum and from single crystal X-ray analysis. The 
precipitate was dissolved in DMF at 80 °C and allowed to cool to provide 3.4b·2DMF as 
a solid. The DMF was extracted out by sonicating the crystals in diethyl ether. The 
resulting product was collected in the form of an off-white crystalline solid. 1H NMR 
(400 MHz, CDCl3) δ 10.48 (bs, 4H), 9.09 (s, 4H), 7.20 (t, J = 7.8 Hz, 1H), 7.07 (dd, J = 
7.8 Hz, J=1.9 Hz, 2H), 6.98 (t, J = 1.9 Hz, 1H), 6.77 (dd, J = 4.0 Hz, J = 2.4 Hz, 4H), 
6.01 (dd, J = 4.0 Hz, J = 2.4 Hz, 4H), 2.03 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3) δ  
179.1, 146.0, 145.0, 132.5, 128.6, 127.1, 125.5, 122.0, 110.5, 45.5, 28.0 ppm. HRMS 
(ESI+) m/z for C30H26N4O4 [M+Na]+ calcd 529.18460, found 529.18480.  
 
1. DMF, POCl3
80 °C, overnight
2. NaOH, H2O
pH = 10
90%
3.4a                                                                             3.4b
HNNH
NH
N
H
HNNH
NH
N
H
CHOOHC
CHO
CHO
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2,6-Bis(1,1-di(1H-pyrrol-2-yl)ethyl)pyridine (3.5a): 2,6-Diacetylpyridine, 3.5c, 
(1.0 g, 2.5 mmol) was dissolved in freshly distilled pyrrole (16.7 g, 250 mmol). A 
catalytic amount of TFA (10 drops) was then added. The mixture was stirred at room 
temperature (for one day) or at 60 °C for 8 h. Precipitation occurred. To complete 
precipitation, about 50 ml of methanol were added to the pale green reaction mixture. The 
solid obtained in this way was washed with methanol to yield 1.55 g of 3.5a as a white 
solid, 65%. 1H NMR (400 MHz, CDCl3) δ 8.26 (bs, 4H), 7.70 (t, J = 7.9 Hz, 1H), 7.33 (d, 
J = 7.9 Hz, 2H), 6.57 (m, 4H), 6.14 (m, 4H), 5.89 (m, 4H), 2.11 (s, 6H) ppm. 13C NMR 
(100 MHz, CDCl3) δ 164.4, 138.4, 136.8, 117.2, 117.1, 107.9, 105.0, 45.4, 25.6 ppm. 
HRMS (ESI+) m/z for C25H25N5 [M+Na]+ calcd 418.20020, found 418.20050. 
 
  
N
O
H
N
60°C
8h
65%
TFA
3.5c                                                                  3.5a
O
N
HNNH
NH
N
H
1. DMF, POCl3
80 °C, overnight
2. NaOH, H2O
pH = 10
95%
3.5a                                                                             3.5b
N
HNNH
NH
N
H
N
HNNH
NH
N
H
CHOOHC
CHO
CHO
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5,5',5'',5'''-(Pyridine-2,6-diylbis(ethane-1,1,1-triyl))tetrakis(1H-pyrrole-2-
carbaldehyde) (3.5b): To a solution of 3.5a (370 mg, 0.94 mmol) in 5 ml DMF, POCl3 
(0.5 ml, 5.3 mmol) was added slowly in accord with procedure-B. The compound 3.5b 
precipitates as off white/yellow solid (450 mg, 0.89 mmol). After purification by column 
chromatography (silica gel/EtOAc), product 3.5b was obtained as a yellow powder by 
treating the appropriate fractions with diethyl ether. The yield was 95% yield. 1H NMR 
(400 MHz, CDCl3) δ 10.09 (bs, 4H), 9.29 (s, 4H), 7.68 (t, J = 7.9 Hz, 1H), 7.20 (d, J = 
7.9 Hz, 2H), 6.85 (dd, J = 3.9 Hz, J = 2.5 Hz, 4H), 6.09 (d, J = 3.9 Hz, J = 2.5 Hz, 4H), 
2.16 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3) δ 179.1, 161.9, 144.8, 138.3, 132.6, 
121.7, 120.2, 110.2, 47.4, 27.1 ppm. HRMS (ESI+) m/z for C29H25N5O4 [M+Na]+ calcd 
530.17990, found 530.18010. 
 
  
5,5'-(1-Phenylethane-1,1-diyl)bis(1H-pyrrole-2-carbaldehyde) (3.13): 
Acetophenone, 3.13c, (1.5 g, 12.5 mmol) was dissolved in pyrrole (18 g, 270 mmol). 
Procedure-C was used. The product was characterized and the analytical data were found 
to match the literature.21 DPM 3.13a was passed through silica gel using dichloromethane 
as the eluent and dried in vacuo to afford yellow oil, 3.13a. This was used to obtain 3.13 
via procedure-B. The precipitated product, 3.13, was collected and purified by column 
chromatography (silica gel/EtOAc). After removal of the volatiles, product 3.13 was 
H
N
60°C
2h
30%
TFA
3.13c                                           3.13a                                                     3.13
1. DMF, POCl3
80 °C, 4h
2. NaOH, H2O
pH = 10
95%
O NH HN NH HN
OHC CHO
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obtained as white solid. The recorded 1H NMR spectrum was in agreement with that 
reported in the literature.22  
 
 
5,5'-(1-(4-hydroxyphenyl)ethane-1,1-diyl)bis(1H-pyrrole-2-carbaldehyde) (2.9b): 
Compound 2.9b was prepared similarly. It was further described in Chapter-2. 1H NMR 
(300 MHz, CD3OD residual solvent peak set to 3.31 ppm) δ 9.33 (s, 2H), 6.94 (d, J = 4.0 
Hz, 2H), 6.88 (m, 2H), 6.73 (m, 2H), 6.01 (d, J = 4.0 Hz, 2H), 2.09 (s, 3H) ppm. 13C 
NMR (75 MHz, CD3OD solvent peak set to 49.0 ppm) δ 180.6, 157.4, 148.4, 137.5, 
134.2, 129.4, 116.0, 111.7, 46.2, 28.3 ppm. HRMS (ESI) calcd for C18H16N2O3 (M+H)+ 
309.12387, found 309.12337. 
 
5,5',5'',5'''-((((((Oxybis(ethane-2,1-diyl))bis(oxy))bis(ethane-2,1-
diyl))bis(oxy))bis(4,1-phenylene))bis(ethane-1,1,1-triyl))tetrakis(1H-pyrrole-2-
carbaldehyde) (3.14): Compound 2.9b (310 mg, 1 mmol) and Cs2CO3 (390 mg; 1.2 
H
N
60°C
2h
30%
TFA
2.7b                                              2.8b                                                       2.9b
1. DMF, POCl3
80 °C, 4 h
2. NaOH, H2O
pH = 10
95%O NH HN NH HN
OHC CHO
OH OH
OH
NH HN
OHC CHO
OH
Cs2CO3
DMF
80 °C, 8 h
OTs TsO
O
O
O
NH
HN
CHO
CHO
O O
O
O
O
HN
NH
CHO
OHC
2.9b                                  3.15
3.14
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mmol, 1.2 equiv) were dissolved in DMF (5 ml). The mixture was stirred for an hour. To 
this solution, one half of a molar equivalent of tetraethyleneglycol ditosylate, 3.15, (250 
mg, 0.5 mmol) was added. The resulting mixture was stirred overnight at 80 °C. Excess 
DMF was then removed under reduced pressure. The resulting oily crude product was 
purified by column chromatography (silica gel/EtOAc, Rf = 0.7) to give a yellow oil. 
Treatment with diethyl ether then gave 3.14 as a yellow powder in 85% yield. 1H NMR 
(400 MHz, CDCl3) δ 10.07 (bs, 4 H), 9.33 (s, 4 H), 6.92 (d, J = 8.9 Hz, 4 H), 6.89 (dd, J 
= 3.9 Hz, J = 2.4 Hz, 4H), 6.80 (d, J = 8.9 Hz, 4 H), 6.17 (dd, J = 3.9 Hz, J = 2.4 Hz, 4 
H), 4.09 (dd, J = 5.2 Hz, J = 4.6 Hz, 4H), 3.87 (dd, J = 5.2 Hz, J = 4.6 Hz, 4 H), 3.68 (m, 
8 H), 2.06 (s, 6 H) ppm. 13C NMR (100 MHz, CDCl3) δ 178.9, 157.4, 146.1, 137.0, 
132.6, 128.2, 121.2, 114.5, 110.3, 70.8, 70.7, 69.7, 67.4, 44.9, 28.6 ppm. HRMS (ESI+) 
m/z for C44H46O9 [M+Na]+ calcd 797.31570, found 797.31670. 
 
  
Compound 3.12 was isolated from the reaction of 3.10 in accord with procedure-
C.  1H NMR (400 MHz, CDCl3) δ 7.94 (bs, 1H), 7.30 (bs, 1H), 6.55 (m, 2H), 6.36 (m, 
1H), 6.31 (t, J = Hz, 1H), 6.17 (q, J = Hz, 1H), 6.09 (m, 1H), 6.06 (m, 1H), 6.01 (q, J = 
H
N
TFA
or 
HCl, H2O
3.10                  1.p                                                     3.11
O O HN NH
H
N
H
N
NH
N
H
N
NH
N
H
N
N H
N
n
3.12                               3.12' (n = 1)         3.12'' (n = 2)
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Hz, 1H), 5.97 (dd, J = Hz, J = Hz, 1H), 13C NMR (100 MHz, CDCl3) δ 140.6, 138.3, 
135.7, 117.8, 116.2, 113.1, 111.7, 109.1, 107.6, 104.8, 103.7, 98.4, 60.9, 60.8, 41.6, 30.3, 
28.6 ppm. HRMS (ESI+) m/z calcd. for C17H19N3 [M+H]+ 266.16520, found 266.16510. 
For 3.12’ HRMS (ESI+) m/z calcd. for C30H33N5 [M+H]+ 464.28090, found 464.28100. 
 
3.5.2. Studies by UV-Vis spectroscopy 
All binding studies reported in Table 3.2 were carried out in commercially 
available Fisher Scientific CHCl3 containing approximately 0.75% ethanol as a 
preservative. To observe better the absorbance changes, various initial receptor 
concentrations were chosen to obtain an Amax (maximum absorption) for each individual 
receptor (3.3b–3.5b) of 0.9. All anions were studied in the form of their commercially 
available tetra-n-butylammonium salts.  
 
A match to a theoretical binding curve may be obtained for titration experiments 
wherein; 
[receptor]o = [receptor] + [receptor-guest] 
The following equation was derived and used to determine the binding affinities: 
 ∆A =  1+ 𝑎𝐾 + 𝑥𝐾 −  −4𝑎𝑥𝐾! + (−1− 𝑎𝐾 − 𝑥𝐾)!2𝐾  ∆ε  
where, 
∆A (measured change in absorbance relative to the initial solution) is the y 
variable;  
x is concentration of guest (TBA+ anion salt) added;  
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𝑎 is the initial concentration of receptor (remains constant over the course of 
titration);  
∆ ε is the extinction coefficient difference between free receptor and receptor-
guest complex (∆ ε =  ε complex - ε receptor);  𝐾 is the binding affinity (Ka) of the receptor under analysis for the guest in 
question. 
 
OriginPro 9.0 was used to fit data in a non-linear fashion in accord with the above 
equation. Iterations (choosing a fixed 𝑎 value and changing ∆ ε and 𝐾) were performed 
until an acceptable level of convergence was reached (chi-square tolerance value, 1x10-9). 
The stoichiometry of binding was determined by the Job plot method.  
Job plot method-1: 
[receptor]stock = [guest]stock 
The total concentration of the receptor and the salt of interest was kept constant 
by varying the fraction of receptor from 0 to 1. (under these conditions, all mixtures 
obtained by mixing receptor and guest stock solutions have the same numerical 
concentration value) 
[receptor] + [guest] = constant 
 
Job plot method-2: 
Data from titrations carried out to determine the binding affinities were used. 
Experimentally,  
[receptor] = constant 
Conversion of the data so that  
[receptor] + [guest] = constant 
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This conversion is formulized in the Excel formula sheet (cf. Table 3.8). 
 
 A B C D E F G H 
1 [receptor]o 1.19E-05    if Ct if Ct if Ct 
2    at λmax at λmax =$B$1 =$B$1 =$B$1 
3 [anion]o Ct Xanion A ΔA Atotal Areceptor ΔA 
4 0 =$B$1+A4 =A4/B4 0.91 =D5/$D$5 =D4*$F$2/B4 =$D$4*(1-C4) =F4-G4 
Table 3.8: Job plot method-2: Excel formula sheet to obtain a Job plot using data 
obtained from titrations carried out to determine the binding affinities.  
 
 
Figure 3.22: Left) Stacked UV-Vis spectra corresponding to the titration of 3.3b (1.2 x 
10-5 M) with TBAH2PO4 (1.0 x 10-3 M) in CHCl3. Right) Binding curve and 
fit plotted using data from plot (on the left) monitored at 306 nm. Ka = (8 ± 
2) x 106 M-1.   
 120 
a)  
b)  
Figure 3.23: a) UV-Vis spectra used to construct a Job plot of the interaction of 3.3b with 
TBAH2PO4 in CHCl3. ([3.3b] + [TBAH2PO4] = 1.2 x 10-5 M). b) Job plot 
from the data (a) monitored at 306 nm.  
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a)  
b)  
Figure 3.24: a) Stacked UV-Vis spectra corresponding to the titration of 3.3b (1.2 x 10-5 
M) with (TBA)3HP2O7 (3.9 x 10-4 M ) in CHCl3. b) Binding curve and fit 
plotted using data from (a) monitored at 306 nm. Ka = (1.4 ± 0.1) x 105 M-1.  
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Figure 3.25: Job plot of the interaction of 3.3b with (TBA)3HP2O7 in CHCl3, monitored at 
306 nm. ([3.3b] + [(TBA)3HP2O7] = 1.2 x10-5 M).  
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a)  
b)  
Figure 3.26: a) Stacked UV-Vis spectra corresponding to the titration of 3.3b (1.2 x 10-5 
M) with TBAHSO4 in CHCl3. b) Binding curve and fit plotted using data 
from (a). Ka = (4.1 ± 0.2) x 103 M-1.   
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a)  
b)  
Figure 3.27: a) Binding curve and fit corresponding to the titration of 3.4b with 
TBAH2PO4 (Ka = (8 ± 2) x 106 M-1). b) Binding curve and fit corresponding 
to the titration of 3.4b with (TBA)3HP2O7 (Ka = (1.9 ± 0.3) x 105 M-1).  
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a)  
b)  
Figure 3.28: a) Binding curve and fit corresponding to the titration of 3.4b with 
TBAHSO4 (Ka = (4.00 ± 0.09) x103 M-1). b) Binding curve and fit 
corresponding to the titration of 3.4b with TBAC6H5CO2 (Ka = (8 ± 1) x104 
M-1).   
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a)  
b)  
Figure 3.29: a) Binding curve and fit corresponding to the titration of 3.5b with 
TBAH2PO4 (Ka = (4.6 ± 0.9) x 105 M-1). b) Binding curve and fit 
corresponding to the titration of 3.5b with (TBA)3HP2O7 (Ka =(6.5 ± 0.7) x 
104 M-1).  
 127 
a)  
b)  
Figure 3.30: a) Binding curve and fit corresponding to the titration of 3.5b with 
TBAHSO4 (Ka = (1.6 ± 0.1) x 103 M-1). b) Binding curve and fit 
corresponding to the titration of 3.5b with TBAC6H5CO2 (Ka =(6.7 ± 0.1) x 
103 M-1).  
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3.5.3. Studies by 1H NMR spectroscopy 
All binding affinities reported in Table 3.4 and Table 3.5 were carried out in 
commercially available Cambridge Isotope Laboratories, Inc. CDCl3 (D, 99.8%) and 
DMSO-d6 (D, 99.9%). All spectra were recorded at 400 MHz using Varian or Agilent 
instruments. Various initial receptor concentrations were chosen based on their 
solubilities i.e., 1.0 mM in CDCl3 or 10 mM in CDCl3/DMSO-d6 (8/1). All anions were 
studied in the form of their commercially available TBA+ salts. In the case of titrations 
carried out with the intention of determining binding affinities, the receptor concentration 
was kept constant throughout the titration study. This was done by preparing the TBA+ 
anion salt solutions within these study-stock solutions of the receptor solution and using 
these solutions for the titrations. The following equation was used to determine the 
binding affinities 
 ∆δ =  1+ 𝑎𝐾 + 𝑥𝐾 −  −4𝑎𝑥𝐾! + (−1− 𝑎𝐾 − 𝑥𝐾)!2𝑎𝐾  (δ!"#$%&' − δ!!"#) 
 
where, 
 ∆δ (measured change in the chemical shift of the hydrogen signal of interest 
relative to the chemical shift of the same signal in receptor) is the y variable; 
x is concentration of guest (TBA+ salt) added; 𝑎 is the initial concentration of receptor (remains constant over the course of 
titration); 
δcomplex is the chemical shift of the hydrogen of interest in receptor-guest complex 
(e.g. 3.3b·H2PO4-) and 
δhost is the chemical shift of the same hydrogen of interest in receptor; 𝐾 is the binding affinity (Ka) of receptor for the guest in question. 
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OriginPro 9.0 was used to fit data in a non-linear fashion in accord with the above 
equation. Iterations (choosing a fixed a value and changing δcomplex-δhost and 𝐾) were 
performed until an acceptable level of convergence was reached (chi-square tolerance 
value, 1x10-9). 
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a)  
b)  
Figure 3.31: a) Stacked 1H NMR spectra corresponding to the titration of 3.3a (0.6 mM) 
with TBAH2PO4 (2.2 mM) in CDCl3. b) Binding curve obtained by fitting 
the chemical shift change of the pyrrole NH signal against [TBAH2PO4]. Ka 
= 1026 ± 126 M-1. 
 131 
a)  
b)  
Figure 3.32: a) Stacked 1H NMR spectra corresponding to the titration of 3.3a (11.4 mM) 
with TBAH2PO4 (97.6 mM) in CDCl3/DMSO-d6 (8:1). b) Binding curve 
obtained by fitting the chemical shift change of the pyrrole NH signal 
against [TBAH2PO4]. Ka = 184 ± 5 M-1.  
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Figure 3.33: Stacked 1H NMR spectra corresponding to the titration of 3.5a (19.1 mM) 
with TBAH2PO4 (0.235 M) in CDCl3. Binding curve obtained by fitting the 
chemical shift change of the pyrrole NH signal against [TBAH2PO4]. Ka = 
40.8 ± 0.6 M-1.  
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4. An Electroactive and a Binding-site Enriched Formylated-
dipyrromethane Receptors 
In Chapter 3, evidence was put forward that the bisDPM 3.3a was a better 
receptor for H2PO4– than octamethylcalix[4]pyrrole 1.10 (Ka = 103 vs 102 M-1 in CHCl3 
and CH2Cl2, respectively).1,2 Moreover, particularly high H2PO4– anion affinities were 
recorded for the four-fold formylated derivative of 3.3a, receptor 3.3b (Ka = (8 ± 2) x 106 
M-1 in CHCl3).1 Presumably, this increased H2PO4– affinity reflects the favorable 
electronic changes induced as a result of formylation of 3.3a. To exploit the binding 
characteristics of the diformyl-DPM receptors from Chapter 3, an electro-active analogue 
of the tetrakis(1H-pyrrole-2-carbaldehyde) bearing a ferrocene spacer, 4.1b was prepared 
as well as was the hexakis(1H-pyrrole-2-carbaldehyde) receptor, 4.2b. The latter was 
expected to be even more effective as a phosphate receptor than 3.3b for reasons  
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explained in detail below. 
Compound 4.1b was designed to exploit the binding sites present in a four-fold 
formylated bisDPM as well as the electrostatic interactions that may emerge upon 
oxidation of the electroactive intervening ferrocene. On the other hand, receptor 4.2b was 
prepared to determine whether the presence of a third formylated-DPM might serve to 
increase the H2PO4– binding affinity. Here, it was thought that the presence of a third 
formylated-DPM would serve to pre-organize the receptor such that two formylated-
DPM subunits are in cis-like conformation. The cis-like conformation is the one that 
interacts best with the anion of interest, H2PO4– in the case of the bisDPM analogue 3.3b, 
as concluded in Chapter 3. 
4.1. RESULTS AND DISCUSSION 
4.1.1. Synthesis and Characterization 
The new derivatives, 4.1b and 4.2b, were obtained in moderate overall yields. 
The synthetic routes to obtain 4.1b and 4.2b are shown in Scheme 4.1 and Scheme 4.2, 
respectively. In the first steps, commercially available diacetyl (4.1c) and triacetyl (4.2c) 
starting materials were converted into bisDPM 4.1a and trisdipyrromethane (trisDPM) 
4.2a, respectively, albeit in low yields (5–15%). The low yields stand in contrast to the 
high yields observed for 3.3a and 3.5a, which precipitate from the reaction mixture and 
constitute the dominant reaction products. The bisDPM (4.1a) and trisDPM (4.2a) were 
then subjected to Vilsmeier–Haack formylation to produce tetraformyl 4.1b and 
hexaformyl 4.2b in relatively high yields (ca. 80%). Purification of 4.1b was carried out 
by recrystallization from DMF at 80°C, whereas 4.2b was purified by column 
chromatography over silica gel. The molecular structures were characterized by 1H and 
13C NMR spectroscopy, HRMS, and single crystal X-ray diffraction analyses. 
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Scheme 4.1: Synthesis of receptor 4.1b. 
 
Scheme 4.2: Synthesis of receptor 4.2b. 
Receptor 4.1b co-crystallized with two solvent molecules of DMF. The single 
crystal structure revealed that the two diformyl-DPM units residing on opposite 
cyclopentadienyl (Cp) rings of the ferrocene were locked at about 90° from one another. 
This conformational restriction leads to the presence of a racemic mixture of 
atropisomers within the single crystal. One of these isomers is shown in Figure 4.1.  
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Figure 4.1: Two views of the same single crystal structure of 4.1b. Note that only one 
atropisomer is shown. Two DMF solvent molecules are omitted for clarity 
(CCDC number 1444557). 
 
 
Figure 4.2: Top: Linear assembly formed by one of the atropisomers of 4.1b. The N-
H···O hydrogen bonding distances range from 2.875 to 2.901 Å. Bottom: 
Packing of the linear ensembles shown in the top portion of this figure. 
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Compound 4.1b crystallizes as a one-dimensional hydrogen bond interlocked 
ensemble, even in the presence of DMF. The formation of these assemblies can be 
rationalized on a geometric basis. The bridging ferrocene adopts a conformation such that 
the two constituent Cp rings, each bearing a DPM substituent, are offset from one another 
by 90°. This allows for the formation of four intermolecular hydrogen bonds between the 
two diformyl-DPM subunits, as can be seen from an inspection of Figure 4.2. 
Receptor 4.2b, on the other hand, co-crystallized with CHCl3. Each of the three 
diformyl-DPM subunits on the bridging benzene is oriented in a different direction (cf. 
Figure 4.3). One of the three DPM subunits was found to resemble what is seen in the 
case of 3.3b,1 wherein two diformyl-DPM units are seen to orient towards opposite π-
faces of the intervening benzene ring. On the other hand, two of the diformyl-DPM units 
present in 4.2b adopt conformations in which pyrrole NH groups point away from one 
another.  
 
Figure 4.3: Single crystal structure of 4.2b. Solvent molecules (CHCl3) are omitted for 
clarity (CCDC number 1444558). 
As a result, 4.2b forms dimers stabilized by four hydrogen bonds that extend to 
create two-dimensional layers (Figure 4.4). The assemblies formed by 4.1b and 4.2b may 
be viewed as being examples of Gale and co-worker’s “narcissistic dimer”3 that are 
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extended into one and two-dimensional space, respectively. The hydrogen bond 
interlocked aggregates seen in the solid state structures of 4.1b and 4.2b may account for 
the low solubility of these species in many solvents. 
 
Figure 4.4: Hydrogen bond linked dimers of 4.2b and their further self-assembly into 
layers. Each color indicates one dimer made up from 4.2b. The N-H···O 
distances for the dimer are 2.850 and 2.888 Å. The dimer in the center is 
drawn in a wireframe representation. The space between the layers is filled 
with CHCl3. 
4.1.2. Anion Binding Studies  
4.1.2.1. Solubility Changes monitored by Electrochemistry 
To exploit the binding characteristics of the diformyl-DPM receptors (3.3b–3.5b) 
presented in Chapter 3 for the purposes of anion sensing, analogue 4.1b was prepared. It 
incorporates a ferrocene spacer and was designed to perform as an electro-active 
analogue of the tetrakis(1H-pyrrole-2-carbaldehyde) receptor series, 3.3b–3.5b. This new 
derivative, 4.1b, displayed low solubility in typical organic solvents used for 
electrochemical studies (e.g., CH3CN, DMF, CH2Cl2). However, as found true for 3.3b 
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(cf. Chapter 3), an increase in its solubility was observed upon the addition of 
TBAH2PO4. This was realized as a “useful property”4 that could be exploited to obtain 
insights into the H2PO4– binding events under conditions of electrochemical analysis. It 
was found, for instance, that initial turbid mixtures of free receptor 4.1b in CH3CN 
containing 10% (v/v) DMF give rise to a quasi-reversible cyclic voltammogram (CV) 
(black line in Figure 4.5). The oxidation wave for 4.1b becomes increasingly irreversible  
 
 
Figure 4.5: Stacked cyclic voltammogram of 4.1b in CH3CN containing 10% (v/v) 
DMF. The initial turbid mixture of 4.1b contained a quantity of material 
sufficient to produce a 1.0 mM solution once completely dissolved. This 
mixture was titrated with TBAH2PO4 until the TBAH2PO4 concentration 
reached 2.8 mM. TBAPF6 (0.1 M) was used as the supporting electrolyte. 
Glassy carbon was used as the working electrode, a Pt wire as the counter 
electrode, and a Ag/AgCl couple as the reference electrode. 
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as the relative concentration of TBAH2PO4 increases. Eventually, the CV becomes 
characterized by a relatively intense anodic peak and a near-absence of a corresponding 
cathodic feature. 
The observed enhancement in the anodic peak current is ascribed to the increase 
in the concentration of 4.1b (both free and anion-complexed) during the course of the 
titration. Since 4.1b is not completely soluble in the solvent mixture in the absence of 
H2PO4–, the concentration of free 4.1b in the titration mixture should be constant up until 
the point where all traces of solid 4.1b are dissolved. Therefore, the increase in 4.1b 
concentration is presumably due to the formation of the corresponding 
dihydrogenphosphate complex, 4.1b·H2PO4–. To the extent such a supposition is correct, 
it would account for the observed increase in the peak current, which could be attributed 
directly to the formation of the readily oxidizable species, 4.1b·H2PO4–. When the 
increase in the anodic peak current is plotted against the added H2PO4– concentration, a 
binding isotherm could be obtained (cf. Figure 4.6) from which an approximate H2PO4– 
affinity, (1.0 ± 0.1) x 103 M-1, could be calculated (cf. experimental section, Table 4.2). 
The loss in reduction signal intensity is believed to reflect a strong interaction between 
the oxidized ferrocenium receptor (4.1b+) and H2PO4–. 
A control experiment was performed using ferrocene under the same experimental 
conditions used to study 4.1b. In the control experiment, no anodic peak current increase 
was observed. This was presumably because ferrocene in the initial solution was 
completely soluble. However, upon addition of TBAH2PO4, a new reduction signal at 280 
mV appeared in the cyclic voltammogram (cf. Figure 4.7). 
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Figure 4.6: The change in anodic peak current at around 600 mV is plotted against 
concentration of TBAH2PO4 added. Titration voltammograms are presented 
in Figure 4.5. 
 
Figure 4.7: Stacked cyclic voltammogram of a 1.0 mM solution of ferrocene in CH3CN 
containing 10% (v/v) DMF (black line). This solution was titrated with 
TBAH2PO4 until the TBAH2PO4–concentration reached 2.8 mM. TBAPF6 
(0.1 M) was used as the supporting electrolyte. Glassy carbon was used as 
the working electrode, a Pt wire as the counter electrode, and a Ag/AgCl 
couple as the reference electrode. 
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4.1.2.2. Solid State Studies via X-ray Diffraction Analysis 
Single crystals of complex 4.2b·H2PO4– were obtained by using TBAH2PO4 to 
solubilize receptor 4.2b in CHCl3 (by conversion to the corresponding H2PO4– complex) 
and then layering with n-pentane. The resulting crystal structure is shown in Figure 4.8. 
The structure of 4.2b·H2PO4– resembles to that of 3.4b·H2PO4– discussed in Chapter 3, 
particularly in terms of the (diformyl-DPM)-H2PO4– interactions. However, in 
4.2b·H2PO4–, the third diformyl-DPM of 4.2b is too distant to interact well with the 
bound H2PO4– anion. It thus interacts in an intermolecular sense with a H2PO4– anion 
bound to a second receptor. The result is a dimeric complex with overall 2:2 
stoichiometry. The four pyrrole NH-to-deprotonated phosphate oxygen N-H···O distances 
range from 2.730 to 2.827 Å. The intermolecular hydrogen bond that is presumed to play 
a role in stabilizing the 2:2 complex is characterized by an O-H···O distance of 2.598 Å. 
 
Figure 4.8: Single crystal structure of the 2:2 complex [4.2b·H2PO4–]2. One TBA+ 
counter cation per H2PO4– and 1.5 molecules of CHCl3 per 4.2b have been 
omitted for clarity. The CCDC number is 1444561. 
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Bill et al., reported two tripodal receptors5 (1.29 and 1.30) that show structural 
similarity to receptor, 4.2b. Receptors 1.29 and 1.30 were based on pyrrole- and DPM-
functionalized derivatives of a sterically geared precursor, 1,3,5-tris(aminomethyl)-2,4,6-
triethylbenzene (Figure 4.9). These systems displayed high affinity and selectivity for 
tetrahedral anionic guests as inferred from solution studies involving ITC analyses 
carried out in CH3CN and solid state single crystal X-ray diffraction analyses. Both 
receptors (1.29 and 1.30) were constructed from a well known tripodal core that confers 
preorganization on the receptors.5 Single crystal structures of co-crystals 4.2b·TBAH2PO4 
and 1.29·TBAH2PO4 were compared. The shortest distance between the phosphrous (P) 
of the H2PO4– anion and the intervening benzene ring of 4.2b is 3.92 Å in the single 
crystal structure of [4.2b·H2PO4–]2. On the other hand, this distance is 4.7 Å in the crystal 
structure of 1.29·TBAH2PO4.5 Based on the crystal structures, it was concluded that the 
H2PO4– resides closer to the aromatic π-surface in 4.2b. 
 
         
Figure 4.9: Left: Structures of 1.29 and 1.30. These compounds were presented in 
Chapter 1. Right: Single crystal structure of 1.29 and H2PO4–anion complex. 
The TBA+ counter cation has been omitted for clarity. This structure was 
originally reported by Bill et al.5 and was redrawn using data from the 
CCDC (number 833333). 
NH
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4.1.2.3. Solution State Studies Involving 1H NMR Spectroscopy     
An 1H NMR spectroscopic study of 4.2b carried out in a competitive solvent 
mixture, CDCl3:DMSO-d6 (8:1), revealed an upfield shift in the intervening benzene 
resonance (cf. Figure 4.10). Such a shift is consistent with the presence of anion-π 
interactions, as inferred from previous studies of α,α,α,α-meso-tetraaryl-C[4]P 
derivatives reported by Ballester and co-workers.5  
 
 
Figure 4.10: Stacked partial 1H NMR spectra of receptor 4.2b (15.6 mM) with varying 
quantities of H2PO4–recorded in CDCl3:DMSO-d6 (8:1). Dashed lines show 
changes in the chemical shifts for the aromatic hydrogen atoms of the 
benzene ring of receptor 4.2b (∆δ = -0.19 ppm). 
The signal for the aromatic hydrogen atoms of 4.2b is subject to peak broadening 
when TBAH2PO4 is added (Figure 4.10). On the other hand, the H3 signal ascribed to 
3.4b, remained sharp after the addition of TBAH2PO4 (cf. Chapter 3). Based on the 
crystal structure of 3.4b·TBAH2PO4, the H2PO4–anion is thought to reside very close to 
H3. In the case of receptor 4.2b, there are three equivalent aromatic hydrogen atoms in 
the free form of the receptor. Upon binding H2PO4-, the chemical environment of one of 
the three aromatic hydrogen atoms is altered more due to the asymmetry of the complex, 
4.2b·TBAH2PO4 (Figure 4.8). A fast exchange between the free from of 4.2b and the 
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4.2b·H2PO4–in NMR time scale is thought to be the reason for the signal broadening 
observed for the aromatic hydrogen signals in the case of 4.2b. 
 
4.1.2.4. Solution State Studies Involving UV-Vis Spectroscopy 
Receptor 4.2b proved even less soluble in neat, non-hydrogen bonding solvents, 
such as CHCl3, than its congeners 3.3b–3.5b. This made it impossible to carry out 
binding studies that were directly comparable to 3.3b–3.5b. However, in analogy to what 
was seen in the case of these other receptors (3.3b–3.5b), it was found that the solubility 
of 4.2b increased upon the addition of TBAH2PO4. Dilute solutions of 4.2b·H2PO4– in 
CHCl3 could thus be prepared by mixing single crystals of 4.2b with ca. 2.75 molar 
equivalents of TBAH2PO4. The UV-Vis spectrum of this solution was characterized by 
features similar to those seen in the reported spectrum of 3.3b·H2PO4– at analogous 
concentrations. Thus, the observed spectral features were ascribed to the complex 
4.2b·H2PO4–. When the CHCl3 solution made up from 4.2b and TBAH2PO4 was titrated 
with CH3OH, spectral changes and isosbestic behavior were observed. On this basis, we 
conclude that the H2PO4– affinity of 4.2b decreases in the presence of increasing 
quantities of CH3OH (Figure 4.11).  
However, it was also apparent that large quantities of CH3OH were required to 
disrupt the complex completely. It was thus decided that a solution of 3% (v/v) CH3OH 
in CHCl3 would provide a good balance between solubility and binding affinity and allow 
for quantitative analyses. In a first set of experiments, an 11 µM solution of 4.2b in 3% 
(v/v) CH3OH in CHCl3 was prepared and then subjected to titration with TBAH2PO4 (cf. 
Figure 4.12). 
 
 148 
 
Figure 4.11: Stacked UV-Vis spectra of 4.2b (solubilized by adding 2.75 molar 
equivalents of TBAH2PO4 in neat CHCl3; 0% added CH3OH) and increasing 
percentages of added CH3OH. Spectra are normalized to eliminate the effect 
of dilution. 
 
 
Figure 4.12: Left: Stacked UV-Vis spectra corresponding to the titration of 4.2b (1.1 x 
10-5 M) with TBAH2PO4 (2.9 x 10-4 M) in CHCl3 containing 3% (v/v) 
CH3OH. Right: Binding curve and fit generated from the titration data 
obtained by monitoring the absorbance changes at 302 nm. Ka = (1.4 ± 0.2) 
x 105 M-1.   
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 The induced spectral changes were then fit to a 1:1 binding profile and used to 
calculate the binding constant corresponding to H2PO4– binding (Figure 4.12) in accord 
with the methods described previously (see experimental section of Chapter 3). Similar 
UV-Vis titrations were carried out with a series of anions in the form of their respective 
TBA salts. It was found that titration with either the H2PO4– or HP2O73– anions gave rise 
to significant spectral changes with saturation behavior being observed in the presence of 
fewer than ten molar equivalents of these two anions. On the other hand, no discernable 
spectral changes were seen upon titration with HSO4–, Cl–, or NO3–. 
In the initial studies of 3.3b–3.5b, CHCl3 was used as the solvent. To allow for a 
comparison between the original tetrakis(1H-pyrrole-2-carbaldehyde) anion receptors and 
the newer hexakis analogue 4.2b, compound 3.3b was subject to titration with H2PO4– in 
3% (v/v) CH3OH-CHCl3. The results from this comparison are summarized in Table 4.1.  
 
Anionsa 3.3bb 3.3bc 4.2bc 
H2PO4– (8 ± 2) x 106 (2.1 ± 0.3) x 103 (1.4 ± 0.2) x 105 
HP2O73– (1.4 ± 0.1) x 105 (3.8 ± 0.6) x 103 (3.6 ± 0.2) x 104 
HSO4– (4.1 ± 0.2) x 103 nd nd 
NO3– nd nd nd 
Cl– nd nd nd 
nd: No discernable spectral change. a The anions were studied as their TBA+ salts. b In CHCl3 c In 
CHCl3 containing 3% (v/v) CH3OH. 
Table 4.1: Summary of calculated binding affinities, Ka (M-1) as determined by UV-Vis 
spectroscopy in two separate solvent systems. 
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Briefly, 4.2b is characterized by a ca. 2 orders of magnitude higher H2PO4– anion 
affinity. This increase agrees with the design expectations underlying 4.2b, namely that 
the presence of a third DPM subunit would force this system to adopt a preorganized 
conformation in a way that is not possible for 3.3b. 
 
4.2. CONCLUSIONS 
The tetrakis (1H-pyrrole-2-carbaldehyde) receptor family was extended by 
including a new electroactive derivative, 4.1b, incorporating a ferrocene linker and a 
binding-site enriched hexaformyl trisDPM derivative, 4.2b. The anion binding properties 
of these new systems were studied by monitoring the increase in solubility 
electrochemically, via single crystal X-ray diffraction analyses, as well as by means of 1H 
NMR and UV-Vis spectroscopic titrations. Conformational switching from trans-like 
conformations as seen in the free receptors 3.3b and 3.4b to the corresponding cis-like 
conformations upon interacting with phosphate derivatives was revealed by X-ray 
diffraction analyses in the solid state for the hexakis-(1H-pyrrole-2-carbaldehyde) 
receptor (4.2b) (Figure 4.13). 
In mixed CH3OH-CHCl3 solution, the new hexakis -carbaldehyde derivative 4.2b 
was found to exhibit an affinity for H2PO4– that is roughly 100x higher than that 
displayed by the tetrakis analogue 3.3b. This increase in binding affinity is rationalized in 
terms of a receptor design that overcomes in part the conformational penalty that needs to 
be paid in order to achieve substrate binding. As such, the present findings provide 
experimental insights that might prove useful in the design of anion receptors based on 
rather simple binding motifs, such as pyrroles and dipyrromethane subunits. 
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Figure 4.13: Views of the single crystal structures of 4.2b without (left) and with (right) a 
bound H2PO4– anion. 
4.3. EXPERIMENTAL 
1,1’-Diacetylferrocene was obtained from Ark Pharm, Inc. All other solvents and 
chemicals were purchased from Aldrich, TCI, and Acros. Pyrrole was distilled at 80 °C 
under reduced pressure (100 mbar) prior to use. Other solvents and reagents were used 
without further purification. 
4.3.1. Synthetic Procedures 
 
   
Fe
NH
NH
HN
HN
Fe O
O H
N Fe NH
NH
OTFA
(2 equiv)
80 °C
4h
4.1c                     1.11                                               4.1a                                      4.1a'
                       (100 equiv)                                         16%                                      34%
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1,1'-Bis(1,1-di(1H-pyrrol-2-yl)ethyl)ferrocene (4.1a):   
1,1’-Diacetylferrocene (500 mg, 1.85 mmol) was dissolved in pyrrole (12 mL, 
185 mmol). Dry nitrogen gas was bubbled through this solution for 10 min. TFA (0.3 
mL, 3.9 mmol) was added to the mixture and the mixture was heated to 80°C for 4 hours 
while bubbling with N2.§§ The reaction mixture was then cooled to room temperature and 
dissolved in dichloromethane (DCM). The organic solution was extracted with 0.5 M 
NaOH to remove the TFA. The organic layer was dried over anhydrous MgSO4 and the 
solvent was removed. Unreacted pyrrole was recycled from this crude product mixture by 
distillation at 80 °C and 100 mbar. Column chromatography (silica gel) was performed 
using 15:1 DCM:EtOAc as the eluent. The yellow fraction (Rf = 0.95) was collected and 
gave yellowish green oil upon evaporation (150 mg, 16%). The oil was solidified in 1 ml 
of CH3OH. 1H NMR (400 MHz, CDCl3) δ 7.78 (bs, 4H), 6.59 (m, 4H), 6.11 (m, 4H), 
5.93 (m, 4H), 4.08 (t, J = 1.9 Hz, 4H), 3.96 (t, J = 1.9 Hz, 4H), 1.95 (s, 6H) ppm. 13C 
NMR (100 MHz, CDCl3) δ 138.32, 116.51, 107.97, 105.48, 98.08, 68.97, 67.90, 39.48, 
28.64 ppm. HRMS (CI+) m/z for C30H30FeN4 [M]+ calcd 502.1820, found 502.1826. 
 
1-Acetyl-1'-(1,1-di(1H-pyrrol-2-yl)ethyl)ferrocene (4.1a’): 
This product was obtained as a side product from the above product mixture. The 
product is a red solid (240 mg, 34%) that elutes from the column after 4.1a (for 4.1a’ Rf = 
0.5). 1H NMR (400 MHz, CDCl3) δ 7.99 (bs, 2H), 6.66 (m, 2H), 6.12 (m, 2H), 5.91 (m, 
2H), 4.73 (t, J = 2.0 Hz, 2H), 4.46 (t, J = 2.0 Hz, 2H), 4.22 (t, J = 1.9 Hz, 2H), 4.00 (t, J = 
1.9 Hz, 2H), 2.31 (s, 3H), 2.00 (s, 3H) ppm. 13C NMR (100 MHz, CDCl3) δ 203.05, 
                                                
§§ Proper ventilation is required since TFA is a corrosive and low boiling substance. 
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137.60, 117.02, 107.87, 105.76, 100.32, 79.47, 75.53, 70.62, 69.53, 68.86, 39.40,29.00, 
27.62 ppm. HR-MS-CI+ m/z for C22H22FeN2O [M]+ calcd 386.1082, found 386.1072. 
 
 
5,5',5'',5'''-(1,1'-Ferrocenylenebis(ethane-1,1,1-triyl))tetrakis(1H-pyrrole-2-
carbaldehyde) (4.1b):  
A Vilsmeier–Haack formylation procedure identical to that reported in Chapter 3 
(Procedure-B) was used, albeit starting with 4.1a. The product, 4.1b, was obtained in 
80% yield. 1H NMR (400 MHz, DMSO-d6) δ 11.63 (bs, 4H), 9.41 (s, 4H), 6.83 (m, 4H), 
5.67 (m, 4H), 4.07 (m, 4H), 3.87 (m, 4H), 2.02 (s, 6H) ppm. 13C NMR (100 MHz, 
DMSO-d6) δ 178.7, 146.9, 132.3, 109.7, 95.7, 68.1, 67.9, 55.3, 25.0 ppm. 13C NMR (100 
MHz, DMF-d7) δ 179.3, 147.7, 133.6, 110.5, 96.8, 69.1, 68.9, 41.0, 26.0 ppm. HRMS 
(ESI+) m/z for C34H30FeN4O4 [M+H]+ calcd 615.16900, found 615.16930. 
 
  
Fe
NH
NH
HN
HN
4.1a                                                                                      4.1b
                                                                                             80%
Fe
NH
NH
HN
HN
OHC
OHC
CHO
CHO1. POCl3,DMF
 
80 °C, 48h
2. NaOH,H2O
O
O
O
 TFA 
(1 equiv)
CH2Cl2
rt, 6h
HNNH
NH
N
H
HN
N
H
H
N
4.2c                     1.11                                                           4.2a 
                       (100 equiv)                                                    5–15%
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1,3,5-Tris(1,1-di(1H-pyrrol-2-yl)ethyl)benzene (4.2a): 
A modification of the published dipyrromethane-forming procedure was 
employed starting with 1,3,5-teiacetylbenene and using CH2Cl2 as a co-solvent and 
carrying out the reaction at room temperature. A co-solvent is used to reduce the 
formation of insoluble side products. The desired product 4.2a was obtained as a 
colorless oil in 15% yield. 1H NMR (400 MHz, CDCl3) δ 7.65 (bs, 6H), 6.90 (s, 3H), 6.54 
(m, 6H), 6.13 (m, 6H), 5.89 (m, 6H), 1.95 (s, 9H) ppm. 13C NMR (100 MHz, CDCl3) δ 
146.5, 137.4, 124.8, 117.1, 108.0, 106.3, 44.7, 28.5 ppm. HRMS (ESI+) m/z for C36H36N6 
[M+H]+ calcd 553.30740, found 553.30730. 
 
 
5,5',5'',5''',5'''',5'''''-(Benzene-1,3,5-triyltris(ethane-1,1,1-triyl))hexakis(1H-pyrrole-
2-carbaldehyde) (4.2b): 
The Vilsmeier–Haack formylation procedure identical to that reported in Chapter 
3 (Procedure-B) was used, albeit starting with 4.2a. Product 4.2b was obtained in 80% 
yield. 1H NMR (400 MHz, DMSO-d6) δ 11.68 (s, 6H), 9.34 (s, 6H), 6,75 (m, 6H), 6.42 
(s, 3H), 5.74 (m, 6H), 1.91 (s, 9H) ppm. 13C NMR (100 MHz, DMSO-d6) δ 178.87, 
4.2a                                                                                         4.2b
                                                                                                80%
1. POCl3,DMF
 
80 °C, 48h
2. NaOH,H2O
HNNH
NH
N
H
HN
N
H
HNNH
NH
N
H
HN
N
H
OHC CHO
CHO
CHOOHC
OHC
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145.67, 145.26, 133.03, 124.63, 110.43, 109.59, 45.38, 26.95 ppm. HRMS (ESI+) m/z for 
C42H36N6O6 [M+Na]+ calcd 743.25890, found 743.25920. 
 
4.3.2. Electrochemical Studies 
For the titration of 4.1b with TBAH2PO4 in CH3CN containing 10% (v/v) DMF, 
two chemical equilibria can be written as follows. 
4.1b (s) ⇌ 4.1b (org)   Ksp 
4.1b (org) + H2PO4–(org) ⇌ 4.1b·H2PO4–(org)  Ka 
The concentration of 4.1b is expected to be constant during the titration as long as 
4.1b is present in the solid form. This approximation is especially valid for the earlier 
data points.  
Ksp = [4.1b] 
 
The peak current (ip) is a function of concentration as defined by the following 
equation: 
ip = 2.69x105 n3/2v1/2ADC 
ip = κ C 
 
Where n is the number of electrons transferred, v is the scan rate, A is the 
electrode surface area, C is the concentration and D is the diffusion coefficient. In the 
simplified equation, κ is a derived parameter that is held constant. 
 
ip,o = κ4.1b.[4.1b] 
ip = κ4.1b.[4.1b] + κcomplex.[4.1b·H2PO4-] 
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Δip = κcomplex.[4.1b·TBAH2PO4-] 
 𝐾!  =  [𝟔𝐛 · H!PO!–]𝟔𝐛 . [H!PO!–]  𝐾!  =  Δ𝑖!/𝜅!"#$%&'!!,!!𝟔𝒃 . [H!PO!–]  
 
[4.1b·H2PO4-]max = 1 mM 
ip,max = κcomplex  [4.1b·H2PO4-]max 
 
It is assumed that all of the initial sample of 4.1b is solubilized upon formation of 
complex (4.1b·H2PO4-) and κcomplex = κ4.1b 
For the calculations, 
[4.1b]sat = ip,max/[4.1b]max 
[4.1b·H2PO4-] = Δip ([4.1b·H2PO4-]/ ip,max) 
[H2PO4-] = [H2PO4-]o – [4.1b·H2PO4-] 
A plot of Δip against added H2PO4–([H2PO4-]o) is shown in Figure 4.6 and the 
calculated equilibrium composition is presented in Table 4.2.  
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Experimental conditions Unit  Calculated Unit  
[4.1b]max 1.0E-03 M  [4.1b]sat 3.50E-04 M  
ip,max 13.1 uA      
        
Experimental Calculated 
[H2PO4-]o IiI (μA) Δi 
[4.1b·H2PO4-
] [4.1b] [4.1b]t [H2PO4-] Ka 
0.00E+00 4.589 0.00E+00 0.00E+00 3.50E-04 3.50E-04 0.00E+00 n/a 
3.09E-04 4.592 3.00E-03 2.29E-07 3.50E-04 3.51E-04 3.08E-04 outlier 
6.10E-04 6.495 1.91E+00 1.45E-04 3.50E-04 4.96E-04 4.64E-04 8.95E+02 
9.04E-04 7.615 3.03E+00 2.31E-04 3.50E-04 5.81E-04 6.73E-04 9.80E+02 
1.19E-03 9.057 4.47E+00 3.41E-04 3.50E-04 6.91E-04 8.49E-04 1.15E+03 
1.47E-03 10.07 5.48E+00 4.18E-04 3.50E-04 7.69E-04 1.05E-03 1.14E+03 
1.74E-03 11.1 6.51E+00 4.97E-04 3.50E-04 8.47E-04 1.25E-03 1.14E+03 
2.27E-03 12.3 7.71E+00 5.89E-04 3.50E-04 1.00E-03 1.68E-03 9.98E+02 
2.78E-03 13.1 8.51E+00 6.50E-04 3.50E-04 1.00E-03 2.13E-03 8.72E+02 
      Ka,av 1.02E+03 
      STD 1.17E+02 
      %std 1.15E-01 
Note: ip,max  input in the Excel sheet has an influence on calculated Ka value for 4.1b·H2PO4–complex 
formation. 
Table 4.2: Excel formula sheet used to calculate the K value corresponding to the 
formation of 4.1b·H2PO4-. 
 
4.3.3. UV-Vis Spectroscopic Studies 
For the determination of binding affinities (Ka), titration experiments are carried 
out as described in Chapter 3. The spectra of these titrations are presented here.  
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Figure 4.14: Top: Stacked UV-Vis spectra corresponding to the titration of 3.3b (1.3 x 
10-5 M) with TBAH2PO4 (4.1 x 10-3 M) in CHCl3 containing 3% (v/v) 
CH3OH. Bottom: Binding curve and fit generated from the titration data 
obtained by monitoring the absorbance changes at 305 nm. Ka = (2.1 ± 0.3) 
x 103 M-1.  
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Figure 4.15: Top: Stacked UV-Vis spectra corresponding to the titration of 3.3b (1.3 x 
10-5 M) with (TBA)3HP2O7 (1.3 x 10-3 M) in CHCl3 containing 3% (v/v) 
CH3OH. Bottom: Binding curve and fit generated from the titration data 
obtained by monitoring the absorbance changes at 305 nm. Ka = (3.8 ± 0.6) 
x 103 M-1.  
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Figure 4.16: Stacked UV-Vis spectra corresponding to the titration of 3.3b (1.3 x 10-5 M) 
with TBAHSO4 (6.5 x 10-3 M) in CHCl3 containing 3% (v/v) CH3OH.  
 
Figure 4.17: Left: Stacked UV-Vis spectra of 3.3b (1.3 x 10-5 M) recorded in the 
presence and absence of TBANO3 (4.6 x 10-4 M) in CHCl3 containing 3% 
(v/v) CH3OH. Right: Stacked UV-Vis spectra of 3.3b (1.3 x 10-5 M) 
recorded in the presence and absence of TBACl (1.5 x 10-3 M) in CHCl3 
containing 3% (v/v) CH3OH. 
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Figure 4.18: Top: Stacked UV-Vis spectra corresponding to the titration of 4.2b (1.1 x 
10-5 M) with TBAH2PO4 (2.9 x 10-4 M) in CHCl3 containing 3% (v/v) 
CH3OH. Bottom: Binding curve and fit generated from the titration data 
obtained by monitoring the absorbance changes at 302 nm. Ka = (1.4 ± 0.2) 
x 105 M-1.  
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Figure 4.19: Top: Stacked UV-Vis spectra corresponding to the titration of 4.2b (1.1 x 
10-5 M) with (TBA)3HP2O7 (2.9 x 10-4 M) in CHCl3 containing 3% (v/v) 
CH3OH. Bottom: Binding curve and fit generated from the titration data 
obtained by monitoring the absorbance changes at 302 nm. Ka = (3.6 ± 0.2) 
x 104 M-1.  
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Figure 4.20: Stacked UV-Vis spectra corresponding to the titration of 4.2b (1.1 x 10-5 M) 
with TBAHSO4 (5.7 x 10-4 M) in CHCl3 containing 3% (v/v) CH3OH. No 
saturation behavior is observed. 
 
Figure 4.21 Left: Stacked UV-Vis spectra of 4.2b (1.1 x 10-5 M) recorded in the presence 
and absence of TBANO3 (2.4 x 10-4 M) in CHCl3 containing 3% (v/v) 
CH3OH. Right: Stacked UV-Vis spectra of 4.2b (1.1 x 10-5 M) recorded in 
the presence and absence of TBACl (1.2 x 10-4 M) in CHCl3 containing 3% 
(v/v) CH3OH.  
 164 
4.4. REFERENCES 
1. Deliomeroglu, M.; Lynch, V.; Sessler, J. Conformationally Switchable Non-Cyclic 
Tetrapyrrole Receptors: Synthesis of tetrakis(1H-Pyrrole-2-Carbaldehyde) 
Derivatives and Their Anion Binding Properties. Chem. Commun. 2014, 50 (80), 
11863–11866. 
2. Gale, P. A.; Sessler, J. L.; Kral, V.; Lynch, V. Calix[4]pyrroles: Old yet New Anion-
Binding Agents. J. Am. Chem. Soc. 1996, 118 (21), 5140–5141. 
3. Camiolo, S.; Gale, P. A.; Hursthouse, M. B.; Light, M. E.; Shi, A. J. Solution and 
Solid-State Studies of 3,4-Dichloro-2,5-Diamidopyrroles: Formation of an Unusual 
Anionic Narcissistic Dimer. Chem. Commun. 2002, 3 (7), 758–759. 
4. Connors, K. A. Binding Constants: The Measurement of Molecular Complex 
Stability; John Wiley & Sons: New York, 1987. 
5. Bill, N. L.; Kim, D.-S.; Kim, S. K.; Park, J. S.; Lynch, V. M.; Young, N. J.; Hay, B. 
P.; Yang, Y.; Anslyn, E. V.; Sessler, J. L. Oxoanion Recognition by Benzene-Based 
Tripodal Pyrrolic Receptors. Supramol. Chem. 2012, 24 (1), 72–76.  
6. Gil-Ramírez, G.; Escudero-Adán, E. C.; Benet-Buchholz, J.; Ballester, P. Quantitative 
Evaluation of Anion-π Interactions in Solution. Angew. Chem. Int. Ed. 2008, 47 (22), 
4114–4118.  
 165 
5. Future Directions 
The common subunit among the receptors presented in Chapters 2, 3, and 4 is a 
formylated-DPM, which contains an aryl group in its meso-position. In Chapter 2 and 3, 
it was shown that the intervening aromatic linker of bis and trisDPM receptors plays a 
role in anion-π interactions. The relative contribution of these interactions to the overall 
anion binding event can be investigated by creating electronically altered derivatives of 
receptor 3.4b. Several possible candidates are compounds 5.1–5.3. 
 
  
 
 In Chapter 4, hydrogen bound polymeric assemblies were observed for receptors 
4.1b and 4.2b. The fact that there were an equal number of hydrogen bond donating and 
accepting groups makes these receptors self-complementary.  This feature was thought to 
play role in the formation of hydrogen bound assemblies.  
  
 
NH
N
H
N
H
HN
CHO
CHOOHC
OHC
R
3.4b R = -H
5.1   R = -NO2
5.2   R = -F
5.3   R = -OMe
NH
NH
X
HN
HN
H
O
H
O
H
O
H
O
3.3b, 1,4-, X = CH,
3.4b, 1,3-, X = CH,
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 Receptors 3.3b–3.5b can be tested for their ability to cross-link polymeric 
materials bearing formylated-DPM pendants, which can be in principle prepared 
employing synthetic methods used in Chapter 2 and in former groups members research.1 
Such cross-linking is proposed based on the self-complementary nature of formylated-
DPM moiety. In addition to displaying anion binding features, these polymer should be 
susceptible to when exposed to the ditopic systems such as 3.3b, discussed in Chapter 3. 
This proposed cross-linking chemistry will most likely need to be studied in a non-
hydrogen-bonding solvent such as CHCl3. However, might show responsive behavior, 
such as deformations or disaggregation, may be seen in the presence of other solvents or 
if the anion content of the media is varied. 
 
 
Scheme 5.1: Possible scheme for supramolecular cross-linking of polymer 5.4 
illustrated with 3.3b as the cross-linker. 
1 10
O
HNNH
OHC CHO
5.4                                                    3.3b
HNNH
NH HN
CHOOHC
OHC CHO
cross-linking?
anion dependence?
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The polymeric system can be studied via UV-Vis spectroscopy. By measuring the 
viscosity2 of the polymer solutions, cross-linking behavior may be monitored in the 
presence and absence of a potential cross-linking bisDPM. 
Four-fold formylated bisDPMs 3.3b and 3.4b and six-fold formylated trisDPM 
4.2b were individually shown to adopt cis-like conformations when a phosphate 
derivative is bound. The achiral nature of 3.4b and trans-like conformation seen in 3.3b 
and 3.4b point to the possibility that the rotation needed for interconversion of 
conformations is not restricted. The use of steric gearing to fix the cis-like conformation 
may lead to higher H2PO4– affinities. One approach to achieving this goal is shown in 
Scheme 5.2 and discussed briefly below. 
 
   
Scheme 5.2: Synthetic route for a functionalized trisDPM 5.7. 
The α-hydroxylation of acetophenone derivatives using organohypervalent iodine 
reagents was developed by Moriarty.3,4 The reported conditions3 can be used to oxidize 
regioselectively 5.5 in all three α-positions to yield 5.6. Compound 5.6 could be used as a 
precursor to prepare novel trisDPM systems (e.g., 5.7). Covalent modifications of 5.7 at 
the –OH functional groups might then allow the synthesis of pre-organized cis-like 
systems. Such systems should display higher H2PO4– anion affinities, while also 
possessing more favorable solubility characteristics. 
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Given the research directions outlined above, it is the opinion of the author that 
considerable benefit could accrue from the further study of formylated-DPM derivatives. 
Further transformations involving the carbonyl (e.g., imine formation) would also be of 
interest. There thus remains much to to building off the present work. 
 
5.1. REFERENCES 
1. Silver, E. S.; Rambo, B. M.; Bielawski, C. W.; Sessler, J. L. Reversible Anion-
Induced Cross-Linking of Well-Defined Calix[4]pyrrole-Containing Copolymers. 
J. Am. Chem. Soc. 2014, 136 (6), 2252–2255. 
2. Sijbesma, R. P. Reversible Polymers Formed from Self-Complementary 
Monomers Using Quadruple Hydrogen Bonding. Science 1997, 278 (5343), 
1601–1604. 
3. Moriarty, M.; Hu, H.; Gupta, S. C. Direct α-Hydroxylation of Ketones Using 
Iodosobenzene. Tetrahedron Lett. 1981, 22 (14), 1283–1286. 
4. Moriarty, R. M. Organohypervalent Iodine: Development, Applications, and 
Future Directions. J. Org. Chem. 2005, 70 (8), 2893–2903.  
 169 
6. 1H & 13C NMR Spectra 
6.1. GENERAL 
All nuclear magnetic resonance (NMR) spectra were recorded at the University of 
Texas at Austin Department of Chemistry NMR Facility. Instruments used include: 
Varian Unity 300 (300 MHz), 
Agilent MR 400 MHz,  
Varian MR 400 MHz,  
Varian Inova 500 MHz,  
and Bru ̈ker AC 300 MHz spectrometer.  
Chemical shifts (δ) are reported in ppm and referenced to the solvent. All 
deuterated NMR solvents were purchased from Cambridge Isotope Laboratories and used 
as received. Solvent reference chemical shifts were set for values reported in the 
literature.1 Diffusion-Ordered NMR (DOSY) spectra (presented in Chapter 3) were 
recorded on Varian DirectDrive 600 (600 MHz). 
6.2. SPECTRA 
1H and 13C NMR spectra for the compounds presented in Chapters 2, 3, and 4 are 
presented here.  
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Figure 6.1: Top: 1H NMR (500 MHz), Bottom: 13C NMR (126 MHz) spectra of 2.15a in 
CD2Cl2. 
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Figure 6.2: Top: 1H NMR (400 MHz), Bottom: 13C NMR (150 MHz) spectra of 2.15b in 
DMSO-d6. 
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Figure 6.3: Top: 1H NMR (500 MHz), Bottom: 13C NMR (126 MHz) spectra of 2.15c in 
CD2Cl2. 
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Figure 6.4: Top: 1H NMR (400 MHz), Bottom: 13C NMR (100 MHz) spectra of 2.15e in 
CDCl3. 
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Figure 6.5: Top: 1H NMR (400 MHz) Bottom:13C NMR (100 MHz) spectra of 3.3a in 
DMSO-d6.  
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Figure 6.6: Top: 1H NMR (400 MHz) Bottom: 13C NMR (100 MHz) spectra of 3.3b in 
DMSO-d6. 
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Figure 6.7: Top: 1H NMR (400 MHz) Bottom:13C NMR (100 MHz) spectra of 3.4a in 
CDCl3. 
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Figure 6.8: Top: 1H NMR (400 MHz) Bottom:13C NMR (100 MHz) spectra of 3.4b in 
CDCl3. 
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Figure 6.9: Top: 1H NMR (400 MHz) Bottom:13C NMR (100 MHz) spectra of 3.5a in 
CDCl3. 
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Figure 6.10: Top: 1H NMR (400 MHz) Bottom: 13C NMR (100 MHz) spectra of 3.5b in 
CDCl3. 
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Figure 6.11: Top: 1H NMR (400 MHz) Bottom: 13C NMR (100 MHz) spectra of 3.13 in 
CDCl3. 
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Figure 6.12: Top: 1H NMR (400 MHz) Bottom: 13C NMR (100 MHz) spectra of 3.14 in 
CDCl3. 
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Figure 6.13: Top: 1H NMR (400 MHz) Bottom: 13C NMR (100 MHz) spectra of 4.1a in 
CDCl3.  
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Figure 6.14: Top: 1H NMR (400 MHz) Bottom: 13C NMR (100 MHz) spectra of 4.1a’ in 
CDCl3.  
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Figure 6.15: Top: 1H NMR (400 MHz) spectrum of 4.1b in DMSO-d6. Bottom: 13C NMR 
(100 MHz) spectrum of 4.1b in DMF-d7.  
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Figure 6.16: Top: 1H NMR (400 MHz) Bottom: 13C NMR (100 MHz) spectra of 4.2a in 
CDCl3.  
 186 
 
 
Figure 6.17: Top: 1H NMR (400 MHz) Bottom: 13C NMR (100 MHz) spectra of 4.2b in 
DMSO-d6. 
 187 
 
Figure 6.18: 1H NMR (400 MHz) spectrum of starting material 4.1c in CDCl3. 
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7. X-ray Diffraction Data 
The X-ray diffraction data collections and refinements for crystal structures of 
2.9b, 2.14, 2.15a, 2.15b, 3.3b, 3.4b, 4.1b, and 4.2b were performed by Dr. Vincent M. 
Lynch of the X-ray Diffraction Laboratory, Department of Chemistry and Biochemistry, 
University of Texas at Austin. Relevant data tables for all the refinements are included. 
 
7.1. CRYSTALLOGRAPHIC EXPERIMENTAL METHODS 
 
X-ray experimental for 2.9b (C18H16N2O3): Crystals grew as clusters of large, 
colorless prisms by slow evaporation from methanol.  The data crystal was cut from a 
larger crystal and had approximate dimensions; 0.48 x 0.32 x 0.11 mm. The data were 
collected at room temperature on a Rigaku SCX-Mini diffractometer with a Mercury 2 
CCD using a graphite monochromator with MoKα radiation (λ = 0.71073Å). A total of 
311 frames of data were collected using ω-scans with a scan range of 1° and a counting 
time of 35 seconds per frame. Details of crystal data, data collection and structure 
refinement are listed in Table 7.1. Data reduction were performed using the Rigaku 
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Americas Corporation’s Crystal Clear version 1.40.1 The structure was solved by direct 
methods using SIR20042 and refined by full-matrix least-squares on F2 with anisotropic 
displacement parameters for the non-H atoms using SHELXL-2014/7.3 Structure analysis 
was aided by use of the programs PLATON984 and WinGX.5 The hydrogen atoms on 
carbon were calculated in ideal positions with isotropic displacement parameters set to 
1.2xUeq of the attached atom (1.5xUeq for methyl hydrogen atoms). The H atoms bond 
to the pyrrole nitrogen atoms and to the hydroxyl oxygen atom were located in a ∆F map 
and refined with isotropic displacement parameters. 
The function, Σw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(σ(Fo))2 + 
(0.0558*P)2 + (0.2999*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.121, with R(F) 
equal to 0.0447 and a goodness of fit, S, = 1.02.  Definitions used for calculating R(F), 
Rw(F2) and the goodness of fit, S, are given below.6 The data were checked for secondary 
extinction but no correction was necessary.  Neutral atom scattering factors and values 
used to calculate the linear absorption coefficient are from the International Tables for X-
ray Crystallography (1992).7 All figures were generated using SHELXTL/PC.8 Tables of 
positional and thermal parameters, bond lengths and angles, torsion angles and figures are 
not published. 
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X-ray experimental for 2.14 (C19H17N5O2):  Crystals grew as yellow prisms by 
slow evaporation from CHCl3. The data crystal was cut from a larger crystal and had 
approximate dimensions; 0.30 x 0.20 x 0.10 mm.  The data were collected on a Rigaku R-
Axis Spider diffractometer with an image plate detector using a graphite monochromator 
with CuKα radiation (λ = 1.5418Å). A total of 180 images of data were collected using 
ω-scans with a scan range of 5° and a counting time of 240 seconds per image. The data 
were collected at 100 K using a Rigaku XStream low temperature device. Details of 
crystal data, data collection and structure refinement are listed in Table 7.2. Data 
reduction was performed using the Rigaku Americas Corporation’s Crystal Clear version 
1.40.1 The structure was solved by direct methods using SIR979 and refined by full-
matrix least-squares on F2 with anisotropic displacement parameters for the non-H atoms 
using SHELXL-97.10 Structure analysis was aided by use of the programs PLATON984 
and WinGX.5 The hydrogen atoms on carbon were calculated in ideal positions with 
isotropic displacement parameters set to 1.2xUeq of the attached atom. The hydrogen 
 191 
atoms bound to nitrogen were observed in a ∆F map and refined with isotropic 
displacement parameters. 
The function, Σw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(σ(Fo))2 + 
(0.054*P)2] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.130, with R(F) equal to 0.0477 
and a goodness of fit, S, = 1.29.  Definitions used for calculating R(F), Rw(F2) and the 
goodness of fit, S, are given below.6 The data were checked for secondary extinction 
effects but no correction was necessary.  Neutral atom scattering factors and values used 
to calculate the linear absorption coefficient are from the International Tables for X-ray 
Crystallography (1992).7 All figures were generated using SHELXTL/PC.8 Tables of 
positional and thermal parameters, bond lengths and angles, torsion angles and figures are 
not yet published.   
 
X-ray Experimental for 2.15a (C38H31N7O3 – 2.5 CH3OH): Crystals grew as 
long, yellow laths by slow evaporation from methanol.  The data crystal had approximate 
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dimensions; 0.30 x 0.15 x 0.08 mm. The data were collected on a Nonius Kappa CCD 
diffractometer using a graphite monochromator with MoKα radiation (λ = 0.71073Å). A 
total of 356 frames of data were collected using ω-scans with a scan range of 0.8° and a 
counting time of 174 seconds per frame. The data were collected at 153 K using an 
Oxford Cryostream low temperature device. Details of crystal data, data collection and 
structure refinement are listed in Table 7.3. Data reduction were performed using 
DENZO-SMN.11 The structure was solved by direct methods using SIR979 and refined by 
full-matrix least-squares on F2 with anisotropic displacement parameters for the non-H 
atoms using SHELXL-97.10 The hydrogen atoms were calculated in ideal positions with 
isotropic displacement parameters set to 1.2xUeq of the attached atom (1.5xUeq for 
methyl hydrogen atoms). 
One molecule of methanol was disordered about a crystallographic inversion 
center at 0, 0, ½.  It was assigned an occupancy of ½ because of the low electron density 
associated with this molecule. No H atoms for this molecule were included in the 
refinement model. One of the methanol molecules H-bound to the macrocycle appeared 
to have a disordered hydroxyl group H atom. This molecule composed of atoms O1b and 
C1b, was H-bound via the Schiff base amines, N3 and N5. The hydroxyl hydrogen 
appeared to be H-bound to the imine nitrogen atoms, N2 and N6, resulting in the 
disordered hydroxyl hydrogen bound to O1b. 
The function, Σw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(σ(Fo))2 + 
(0.0399*P)2 + (1.2999*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.169, with R(F) 
equal to 0.0794 and a goodness of fit, S, = 1.07.  Definitions used for calculating 
R(F),Rw(F2) and the goodness of fit, S, are given below.6 The data were checked for 
secondary extinction effects but no correction was needed. Neutral atom scattering 
factors and values used to calculate the linear absorption coefficient are from the 
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International Tables for X-ray Crystallography (1992).7 All figures were generated using 
SHELXTL/PC.8 Tables of positional and thermal parameters, bond lengths and angles, 
torsion angles, H-bonding interactions and figures are not yet published. 
 
 
X-ray experimental for 2.15b (C37H36N7O3 –  4 C3H7NO):  Crystals grew as 
yellow plates by slow evaporation from N,N-dimethylformamide.  The data crystal was 
cut from a larger crystal and had approximate dimensions; 0.34 x 0.24 x 0.09 mm. The 
data were collected on a Rigaku SCX-Mini diffractometer with a Mercury 2 CCD using a 
graphite monochromator with MoKα radiation (λ = 0.71075Å). A total of 1440 frames of 
data were collected using ω-scans with a scan range of 0.5° and a counting time of 21 
seconds per frame. The data were collected at 100 K using a Rigaku XStream low 
temperature device. Details of crystal data, data collection and structure refinement are 
listed in Table 7.4. Data reduction was performed using the Rigaku Americas 
Corporation’s Crystal Clear version 1.40.1 The structure was solved by direct methods 
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using SIR979 and refined by full-matrix least-squares on F2 with anisotropic 
displacement parameters for the non-H atoms using SHELXL-97.10 Structure analysis 
was aided by use of the programs PLATON984 and WinGX.5 The hydrogen atoms on 
carbon were calculated in ideal positions with isotropic displacement parameters set to 
1.2xUeq of the attached atom (1.5xUeq for methyl hydrogen atoms).  The hydrogen 
atoms on nitrogen and oxygen were observed in a ∆F map and refined with isotropic 
displacement parameters. 
The function, Σw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(σ(Fo))2 + 
(0.0484*P)2 + (4.0684*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.154, with R(F) 
equal to 0.0642 and a goodness of fit, S, = 1.06.  Definitions used for calculating R(F), 
Rw(F2) and the goodness of fit, S, are given below.6 The data were checked for secondary 
extinction but no correction was necessary.  Neutral atom scattering factors and values 
used to calculate the linear absorption coefficient are from the International Tables for X-
ray Crystallography (1992).7 All figures were generated using SHELXTL/PC.8 Tables of 
positional and thermal parameters, bond lengths and angles, torsion angles and figures are 
not yet published. 
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X-ray experimental for 3.3b·2DMF (C30H36N4O4 – 2 C3H7NO): Crystals grew as 
orange prisms by slow evaporation from DMF.  The data crystal was cut from a larger 
crystal and had approximate dimensions; 0.32 x 0.30 x 0.25 mm. The data were collected 
at -120 °C on a Nonius Kappa CCD diffractometer using a Bruker AXS Apex II detector 
and a graphite monochromator with MoKα radiation (λ = 0.71075Å). Reduced 
temperatures were maintained by use of an Oxford Cryosystems 600 low-temperature 
device. A total of 403 frames of data were collected using ω and φ-scans with a scan 
range of 2° and a counting time of 40 seconds per frame. Details of crystal data, data 
collection and structure refinement are listed in Table 7.5. Data reduction was performed 
using SAINT V8.27B.12 The structure was solved by direct methods using SIR979 and 
refined by full-matrix least-squares on F2 with anisotropic displacement parameters for 
the non-H atoms using SHELXL-2013.13 Structure analysis was aided by use of the 
programs PLATON984 and WinGX.5 The hydrogen atoms on C14 and C15 were 
observed in a ∆F map and refined with isotropic displacement parameters. The remaining 
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H atoms were calculated in idealized positions with Uiso set to 1.2xUeq of the attached 
atom (1.5xUeq for the methyl groups). 
The DMF solvate molecule was disordered. The disorder was modeled by 
assigning the variable x to the site occupancy factors for one component of the disorder, 
while (1-x) was assigned to the site occupancy factors for the alternate component. The 
geometry of the two components was restrained to be equivalent throughout the 
refinement process. A common isotropic displacement parameter was refined while 
refining x.  In this way, the major component of the disordered solvate molecule had a 
site occupancy of 80(2)%. 
The function, Σw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(σ(Fo))2 + 
(0.0425*P)2 + (0.8566*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.116, with R(F) 
equal to 0.0437 and a goodness of fit, S, = 1.03. Definitions used for calculating 
R(F),Rw(F2) and the goodness of fit, S, are given below.6 The data were checked for 
secondary extinction but no correction was necessary. Neutral atom scattering factors and 
values used to calculate the linear absorption coefficient are from the International Tables 
for X-ray Crystallography (1992).7 All figures were generated using SHELXTL/PC.8 
Tables of positional and thermal parameters, bond lengths and angles, torsion angles and 
figures may be obtained from the CCDC by referencing CCDC number 1012700. 
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X-ray experimental for 3.3b·2DMSO (C30H26N4O4 – 2 C2H6SO): Crystals grew 
as large, pale yellow plates by slow evaporation from DMSO. The data crystal was cut 
from a larger crystal and had approximate dimensions; 0.22 x 0.20 x 0.14 mm. The data 
were collected at -120 °C on a Nonius Kappa CCD diffractometer using a Bruker AXS 
Apex II detector and a graphite monochromator with MoKα radiation (λ = 0.71075Å). 
Reduced temperatures were maintained by use of an Oxford Cryosystems 600 low-
temperature device.  A total of 1342 frames of data were collected using ω and φ-scans 
with a scan range of 1.1° and a counting time of 39 seconds per frame.  Details of crystal 
data, data collection and structure refinement are listed in Table 7.6. Data reduction were 
performed using SAINT V8.27B.12 The structure was solved by direct methods using 
SIR979 and refined by full-matrix least-squares on F2 with anisotropic displacement 
parameters for the non-H atoms using SHELXL-97.10 Structure analysis was aided by use 
of the programs PLATON984 and WinGX.5 Most of the hydrogen atoms on carbon were 
calculated in idealized positions with Uiso set to 1.2xUeq of the attached atom (1.5xUeq 
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for methyl groups). The hydrogen atoms bound to N1, N2, C14 and C15 were observed 
in a ∆F map and refined with isotropic displacement parameters. 
The complex sits around a crystallographic inversion center at ¼, ¼, ½. The 
DMSO molecule is disordered.  The disorder involves the sulfur atom and the two methyl 
groups. The disorder was modeled by assigning the variable x to the site occupancy 
factors for one component of the disorder. The variable (1-x) was assigned to the site 
occupancy factors of the alternate component. The geometry of the two components was 
restrained to be equivalent throughout the refinement process. A common isotropic 
displacement parameter was refined for the S atoms and a second isotropic displacement 
parameter was refined for the C atoms while refining the variable x.  In this way, the site 
occupancy for the major component refined to 58(2)%. 
The function, Σw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(σ(Fo))2 + 
(0.0478*P)2 + (3.1524*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.107, with R(F) 
equal to 0.0391 and a goodness of fit, S, = 1.05.  Definitions used for calculating 
R(F),Rw(F2) and the goodness of fit, S, are given below.6 The data were checked for 
secondary extinction but no correction was necessary. Neutral atom scattering factors and 
values used to calculate the linear absorption coefficient are from the International Tables 
for X-ray Crystallography (1992).7 All figures were generated using SHELXTL/PC.8 
Tables of positional and thermal parameters, bond lengths and angles, torsion angles and 
figures may be obtained from the CCDC by referencing CCDC number 1012698. 
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X-ray experimental for 3.4b·2DMF (C30H26N4O4 - 2 C3H7NO): Crystals grew as 
clusters of octahedral shaped colorless prisms by slow evaporation from N,N-
dimethylformamide. The data crystal had approximate dimensions; 0.20 x 0.11 x 0.10 
mm.  The data were collected on a Rigaku AFC12 diffractometer with a Saturn 724+ 
CCD using a graphite monochromator with MoKα radiation (λ = 0.71073Å). A total of 
1104 frames of data were collected using ω-scans with a scan range of 0.5° and a 
counting time of 45 seconds per frame. The data were collected at 153 K using an Oxford 
Cryostream low temperature device. Details of crystal data, data collection and structure 
refinement are listed in Table 7.7. Data reduction were performed using the Rigaku 
Americas Corporation’s Crystal Clear version 1.40.1 The structure was solved by direct 
methods using SIR979 and refined by full-matrix least-squares on F2 with anisotropic 
displacement parameters for the non-H atoms using SHELXL-97.10 Structure analysis 
was aided by use of the programs PLATON984 and WinGX.5 The hydrogen atoms on 
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carbon were calculated in ideal positions with isotropic displacement parameters set to 
1.2xUeq of the attached atom (1.5xUeq for methyl hydrogen atoms).  The hydrogen 
atoms bound to nitrogen were located in a ∆F map and refined with isotropic 
displacement parameters. 
The function, Σw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(σ(Fo))2 + 
(0.0326*P)2 + (4.3345*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.123, with R(F) 
equal to 0.0676 and a goodness of fit, S, = 1.13.  Definitions used for calculating R(F), 
Rw(F2) and the goodness of fit, S, are given below.6 The data were checked for secondary 
extinction effects but no correction was necessary.  Neutral atom scattering factors and 
values used to calculate the linear absorption coefficient are from the International Tables 
for X-ray Crystallography (1992).7 All figures were generated using SHELXTL/PC.8 
Tables of positional and thermal parameters, bond lengths and angles, torsion angles and 
figures may be obtained from the CCDC by referencing CCDC number 1012699. 
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X-ray Experimental for 3.3b·(TBA)2H2P2O7 C30H26N4O4 - 2 C16H36N1+ H2P2O72- 
½ CH2Cl2: Crystals grew as thin, colourless prisms by layering a solution of 
3.3b·(TBA)3HP2O7 in CH2Cl2 with n-pentane. The data crystal had approximate 
dimensions; 0.16 x 0.11 x 0.06 mm. The data were collected on an Agilent Technologies 
SuperNova Dual Source diffractometer using a µ-focus Cu Kα radiation source (λ = 
1.5418Å) with collimating mirror monochromators. A total of 850 frames of data were 
collected using ω-scans with a scan range of 0.5° and a counting time of 7 seconds per 
frame using a detector offset of +/- 41.1° and a counting time of 25 seconds per frame 
using a detector offset of +/- 108.3°. The data were collected at 100 K using an Oxford 
Cryostream low temperature device. Details of crystal data, data collection and structure 
refinement are listed in Table 7.8. Data collection, unit cell refinement and data reduction 
were performed using Agilent Technologies CrysAlisPro V 1.171.37.31.14 The structure 
was solved by direct methods using SIR979 and refined by full-matrix least-squares on F2 
with anisotropic displacement parameters for the non-H atoms using SHELXL-2013.13 
Structure analysis was aided by use of the programs PLATON984 and WinGX.5 The 
hydrogen atoms were calculated in ideal positions with isotropic displacement parameters 
set to 1.2xUeq of the attached atom (1.5xUeq for methyl hydrogen atoms. 
Compound 3.3b and the pyrophosphate form H-bound dimers across a 
crystallographic inversion centre located at ½, ½, ½. The pyrophosphate dianion was H-
bound to itself across this centre. Reliable coordinates for the hydrogen atoms bound to 
the pyrophosphate could not be located in a difference electron density map. These 
hydrogen atoms were not included in the final refinement model.   
A molecule of dichloromethane was found to be badly disordered around a 
crystallographic inversion centre at 0, ½, ½. Attempts to model the disorder were 
unsatisfactory. The contributions to the scattering factors due to this solvent molecule 
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were removed by use of the utility SQUEEZE in PLATON98.  PLATON98 was used as 
incorporated in WinGX. 
The function, Σw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(σ(Fo))2 + 
(0.0827*P)2 + (5.3705*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.171, with R(F) 
equal to 0.0603 and a goodness of fit, S, = 1.03. Definitions used for calculating R(F), 
Rw(F2) and the goodness of fit, S, are given below.6 The data were checked for secondary 
extinction effects but no correction was necessary. Neutral atom scattering factors and 
values used to calculate the linear absorption coefficient are from the International Tables 
for X-ray Crystallography (1992).7 All figures were generated using SHELXTL/PC.8 
Tables of positional and thermal parameters, bond lengths and angles, torsion angles and 
figures may be obtained from the CCDC by referencing CCDC number 1444559. 
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X-ray Experimental for complex 3.4b·TBAH2PO4 (C30H26N4O4)(C16H36N)1+ 
O2P(OH)21- -1/2 CHCl3: Crystals grew as yellow plates by layering a solution of 
3.4b·TBAH2PO4 in CHCl3 with n-pentane.The data crystal had approximate dimensions; 
0.18 x 0.07 x 0.05 mm. The data were collected on an Agilent Technologies SuperNova 
Dual Source diffractometer using a µ-focus Cu Kα radiation source (λ = 1.5418Å) with 
collimating mirror monochromators. A total of 1659 frames of data were collected using 
ω-scans with a scan range of 1° and a counting time of 9 seconds per frame with a 
detector offset of +/- 40.8° and 20 seconds per frame with a detector offset of +/- 108.3°. 
The data were collected at 100 K using an Oxford Cryostream low temperature device. 
Details of crystal data, data collection and structure refinement are listed in Table 7.9. 
Data collection, unit cell refinement and data reduction were performed using Agilent 
Technologies CrysAlisPro V 1.171.37.31.14 The structure was solved by direct methods 
using SuperFlip15 and refined by full-matrix least-squares on F2 with anisotropic 
displacement parameters for the non-H atoms using SHELXL-2013.13 Structure analysis 
was aided by use of the programs PLATON984 and WinGX.5 The hydrogen atoms bound 
to carbon atoms were calculated in ideal positions with isotropic displacement parameters 
set to 1.2xUeq of the attached atom (1.5xUeq for methyl hydrogen atoms). The hydrogen 
atoms bound to the pyrrole nitrogen atoms and the hydroxyl atoms of the phosphate ion 
were observed in a ∆F map and refined with isotropic displacement parameters. 
The function, Σw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(σ(Fo))2 + 
(0.0516*P)2 + (2.5503*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.124, with R(F) 
equal to 0.0500 and a goodness of fit, S, = 1.05. Definitions used for calculating R(F), 
Rw(F2) and the goodness of fit, S, are given below.6 The data were checked for secondary 
extinction effects but no correction was necessary. Neutral atom scattering factors and 
values used to calculate the linear absorption coefficient are from the International Tables 
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for X-ray Crystallography (1992).7 All figures were generated using SHELXTL/PC.8 
Tables of positional and thermal parameters, bond lengths and angles, torsion angles and 
figures may be obtained from the CCDC by referencing CCDC number 1444560.  
 
X-ray Experimental for 4.1b (C17H15N2O)2Fe – 2 C3H7NO: Crystals grew as clear, 
yellow prisms by slow evaporation from dimethylformamide with a small amount of 
dichloromethane. The data crystal had approximate dimensions; 0.27 x 0.20 x 0.09 mm. 
The data were collected at -140 °C on a Nonius Kappa CCD diffractometer using a 
Bruker AXS Apex II detector and a graphite monochromator with MoKα radiation (λ = 
0.71073 Å). Reduced temperatures were maintained by use of an Oxford Cryosystems 
600 low-temperature device. A total of 1110 frames of data were collected using ω and φ-
scans with a scan range of 1.1° and a counting time of 43 seconds per frame. Details of 
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crystal data, data collection and structure refinement are listed in Table 7.10. Data 
reduction was performed using SAINT V8.27B.12 The structure was solved by direct 
methods using SUPERFLIP15 and refined by full-matrix least-squares on F2 with 
anisotropic displacement parameters for the non-H atoms using SHELXL-2013.13 
Structure analysis was aided by use of the programs PLATON984 and WinGX.5 The 
hydrogen atoms bound to carbon atoms were calculated in idealized positions. The 
hydrogen atoms on the pyrrole nitrogen atoms were observed in a ∆F map and refined 
with isotropic displacement parameters. 
The function, Σw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(σ(Fo))2 + 
(0.0331*P)2 + (2.7996*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.111, with R(F) 
equal to 0.0471 and a goodness of fit, S, = 1.01. Definitions used for calculating 
R(F),Rw(F2) and the goodness of fit, S, are given below.6 The data were checked for 
secondary extinction but no correction was necessary. Neutral atom scattering factors and 
values used to calculate the linear absorption coefficient are from the International Tables 
for X-ray Crystallography (1992).7 All figures were generated using SHELXTL/PC.8 
Tables of positional and thermal parameters, bond lengths and angles, torsion angles and 
figures may be obtained from the CCDC by referencing CCDC number 1444557. 
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X-ray Experimental for 4.2b C42H36N6O6 - 2 CHCl3: Crystals grew as clusters of 
yellow prisms by slow evaporation from chloroform, methanol and dimethylformamide. 
The data crystal was cut from a larger crystal and had approximate dimensions; 0.30 x 
0.23 x 0.15 mm. The data were collected on a Rigaku SCX-Mini diffractometer with a 
Mercury 2+ CCD using a graphite monochromator with MoKα radiation (λ = 0.71073 
Å). A total of 1080 frames of data were collected using ω-scans with a scan range of 0.5° 
and a counting time of 25 seconds per frame. The data were collected at 100 K using a 
Rigaku XStream low temperature device. Details of crystal data, data collection and 
structure refinement are listed in Table 7.11. Data reduction was performed using the 
Rigaku Americas Corporation’s Crystal Clear version 1.40.1 The structure was solved by 
direct methods using SIR20042 and refined by full-matrix least-squares on F2 with 
anisotropic displacement parameters for the non-H atoms using SHELXL-2013.13 
Structure analysis was aided by use of the programs PLATON984 and WinGX.5 The 
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hydrogen atoms were calculated in ideal positions with isotropic displacement parameters 
set to 1.2xUeq of the attached atom (1.5xUeq for methyl hydrogen atoms).  
A molecule of chloroform was disordered. The disorder resulted in two principal 
conformations. The disorder was modelled by assigning the variable x to the site 
occupancy for one component and (1-x) to the site occupancy of the alternate component. 
The variable x was refined while restraining the geometry of the two components to be 
equivalent. A common isotropic displacement parameter was refined while refining x. In 
this way, the major component of the disordered solvent molecule consisting of atoms, 
Cl4, Cl5, Cl6 and C1b refined to a site occupancy of 53(1)%. The non-H atoms of both 
components were ultimately refined anisotropically with their displacement parameters 
restrained to be approximately isotropic. 
The function, Σw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(σ(Fo))2 + 
(0.086*P)2 + (3.5129*P)] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.2593, with R(F) 
equal to 0.0937 and a goodness of fit, S, = 1.16. Definitions used for calculating R(F), 
Rw(F2) and the goodness of fit, S, are given below.6 The data were checked for secondary 
extinction effects but no correction was necessary.  Neutral atom scattering factors and 
values used to calculate the linear absorption coefficient are from the International Tables 
for X-ray Crystallography (1992).7 All figures were generated using SHELXTL/PC.8 
Tables of positional and thermal parameters, bond lengths and angles, torsion angles and 
figures may be obtained from the CCDC by referencing CCDC number 1444558. 
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X-ray Experimental for 4.2b·TBAH2PO4 (2 C42H36N6O6 - 2 C16H36N1+ H2PO41- - 3 
CHCl3): Crystals grew as thin, yellow plates by layering a solution of 7b·TBAH2PO4 in 
CHCl3 with n-pentane. The data crystal had approximate dimensions; 0.27 x 0.16 x 0.08 
mm. The data were collected on an Agilent Technologies SuperNova Dual Source 
diffractometer using a µ-focus Cu Kα radiation source (λ = 1.5418Å) with collimating 
mirror monochromators. A total of 1035 frames of data were collected using ω-scans 
with a scan range of 0.5° and a counting time of 14 seconds per frame using a detector 
offset of +/- 41.1° and a counting time of 38 seconds per frame using a detector offset of 
+/- 108.3°. The data were collected at 100 K using an Oxford Cryostream low 
temperature device. Details of crystal data, data collection and structure refinement are 
listed in Table 7.12. Data collection, unit cell refinement and data reduction were 
performed using Agilent Technologies CrysAlisPro V 1.171.37.31.14 The structure was 
solved by direct methods using SIR979 and refined by full-matrix least-squares on F2 
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with anisotropic displacement parameters for the non-H atoms using SHELXL-2013.13 
Structure analysis was aided by use of the programs PLATON984 and WinGX.5 The 
hydrogen atoms were calculated in ideal positions with isotropic displacement parameters 
set to 1.2xUeq of the attached atom (1.5xUeq for methyl hydrogen atoms. 
The two tetra-n-butyl ammonium ions had highly anisotropic displacement 
parameters. One of the ions was refined with a disorder model. The disorder was 
modelled by assigning the variable x to the site occupancy for one component of the 
disorder and (1-x) to the site occupancy for the alternate component. The geometry of the 
two components was restrained by the extensive use of SADI instructions to maintain the 
C-C bonds and C-C-C angles to be equivalent. A common isotropic displacement 
parameter was assigned to the nitrogen atoms and the methylene carbon atoms while 
refining the variable x. A separate isotropic displacement parameter was refined for the 
methyl carbon atoms. 
There are several regions of unidentified disordered solvent. The solvent was 
badly disordered and could not be reliably identified but was probably a mixture of the 
solvents used for crystallization, chloroform and n-hexane. The quantity and identity of 
the solvent in these voids was in doubt. The squeezed out solvent was not included in the 
UNIT card. The contributions to the scattering factors due to this solvent molecule were 
removed by use of the utility SQUEEZE6 in PLATON98. PLATON98 was used as 
incorporated in WinGX. 
The function, Σw(|Fo|2 - |Fc|2)2, was minimized, where w = 1/[(σ(Fo))2 + 
(0.1*P)2] and P = (|Fo|2 + 2|Fc|2)/3.  Rw(F2) refined to 0.345, with R(F) equal to 0.126 
and a goodness of fit, S, = 1.61. Definitions used for calculating R(F), Rw(F2) and the 
goodness of fit, S, are given below.6 The data were checked for secondary extinction 
effects but no correction was necessary. Neutral atom scattering factors and values used 
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to calculate the linear absorption coefficient are from the International Tables for X-ray 
Crystallography (1992).7 All figures were generated using SHELXTL/PC.8 Tables of 
positional and thermal parameters, bond lengths and angles, torsion angles and figures 
may be obtained from the CCDC by referencing CCDC number 1444561. 
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7.2. STURCTURE REFINEMENT PARAMETERS 
Table 7.1: Crystal data and structure refinement parameters for 2.9b. 
Empirical formula  C18 H16 N2 O3 
Formula weight  308.33 
Temperature  298(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P 21/n 
Unit cell dimensions a = 8.9152(10) Å α= 90°. 
 b = 16.056(2) Å β= 107.031(3)°. 
 c = 11.6016(15) Å γ = 90°. 
Volume 1587.9(3) Å3 
Z 4 
Density (calculated) 1.290 Mg/m3 
Absorption coefficient 0.089 mm-1 
F(000) 648 
Crystal size 0.480 x 0.320 x 0.110 mm3 
Theta range for data collection 3.132 to 27.480°. 
Index ranges -11<=h<=11, -20<=k<=20, -15<=l<=10 
Reflections collected 9559 
Independent reflections 3600 [R(int) = 0.0263] 
Completeness to theta = 25.242° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.717 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3600 / 0 / 221 
Goodness-of-fit on F2 1.024 
Final R indices [I>2sigma(I)] R1 = 0.0447, wR2 = 0.1099 
R indices (all data) R1 = 0.0595, wR2 = 0.1206 
Extinction coefficient n/a 
Largest diff. peak and hole 0.163 and -0.212 e.Å-3 
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Table 7.2: Crystal data and structure refinement parameters for 2.14. 
Empirical formula  C19 H17 N5 O2 
Formula weight  347.38 
Temperature  100(2) K 
Wavelength  1.54180 Å 
Crystal system  Monoclinic 
Space group  P21/n 
Unit cell dimensions a = 15.9252(14) Å α= 90°. 
 b = 13.253(2) Å β= 116.594(9)°. 
 c = 17.3380(15) Å γ = 90°. 
Volume 3272.1(6) Å3 
Z 8 
Density (calculated) 1.410 Mg/m3 
Absorption coefficient 0.780 mm-1 
F(000) 1456 
Crystal size 0.30 x 0.20 x 0.10 mm 
Theta range for data collection 6.62 to 66.58°. 
Index ranges -18<=h<=16, -15<=k<=15, -19<=l<=20 
Reflections collected 37427 
Independent reflections 5740 [R(int) = 0.0431] 
Completeness to theta = 66.58° 99.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.930 and 0.786 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5740 / 0 / 517 
Goodness-of-fit on F2 1.290 
Final R indices [I>2sigma(I)] R1 = 0.0477, wR2 = 0.1133 
R indices (all data) R1 = 0.0677, wR2 = 0.1298 
Largest diff. peak and hole 0.211 and -0.290 e.Å-3  
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Table 7.3: Crystal data and structure refinement parameters for 2.15a. 
Empirical formula  C40.50 H41 N7 O5.50 
Formula weight  713.80 
Temperature  153(2) K 
Wavelength  0.71070 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 10.5529(4) Å α= 93.079(3)°. 
 b = 11.5600(5) Å β= 98.706(2)°. 
 c = 16.4194(9) Å γ = 113.756(2)°. 
Volume 1797.57(14) Å3 
Z 2 
Density (calculated) 1.319 Mg/m3 
Absorption coefficient 0.090 mm-1 
F(000) 754 
Crystal size 0.30 x 0.15 x 0.08 mm 
Theta range for data collection 1.94 to 25.00°. 
Index ranges -12<=h<=11, -13<=k<=13, -18<=l<=19 
Reflections collected 10189 
Independent reflections 6195 [R(int) = 0.0633] 
Completeness to theta = 25.00° 97.7 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6195 / 16 / 516 
Goodness-of-fit on F2 1.073 
Final R indices [I>2sigma(I)] R1 = 0.0794, wR2 = 0.1351 
R indices (all data) R1 = 0.1768, wR2 = 0.1686 
Largest diff. peak and hole 0.378 and -0.266 e.Å-3  
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Table 7.4: Crystal data and structure refinement parameters for 2.15b. 
Empirical formula  C49 H57 N11 O7 
Formula weight  912.06 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 21.787(3) Å α= 90°. 
 b = 10.6512(15) Å β= 114.832(3)°. 
 c = 22.247(3) Å γ = 90°. 
Volume 4685.3(12) Å3 
Z 4 
Density (calculated) 1.293 Mg/m3 
Absorption coefficient 0.089 mm-1 
F(000) 1936 
Crystal size 0.34 x 0.24 x 0.09 mm3 
Theta range for data collection 3.09 to 27.48°. 
Index ranges -28<=h<=28, -13<=k<=13, -28<=l<=28 
Reflections collected 62241 
Independent reflections 10735 [R(int) = 0.0999] 
Completeness to theta = 27.48° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.335 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10735 / 0 / 633 
Goodness-of-fit on F2 1.058 
Final R indices [I>2sigma(I)] R1 = 0.0642, wR2 = 0.1345 
R indices (all data) R1 = 0.1078, wR2 = 0.1541 
Largest diff. peak and hole 0.529 and -0.299 e. Å-3  
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Table 7.5: Crystal data and structure refinement parameters for 3.3b·2DMF. 
CCDC number  1012700 
Empirical formula  C36 H40 N6 O6 
Formula weight  652.74 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P 21/c 
Unit cell dimensions a = 8.3870(4) Å α= 90°. 
 b = 14.2432(5) Å β= 104.354(2)°. 
 c = 14.6816(7) Å γ = 90°. 
Volume 1699.08(13) Å3 
Z 2 
Density (calculated) 1.276 Mg/m3 
Absorption coefficient 0.088 mm-1 
F(000) 692 
Crystal size 0.320 x 0.300 x 0.250 mm 
Theta range for data collection 2.860 to 27.494°. 
Index ranges -10<=h<=10, -18<=k<=18, -19<=l<=19 
Reflections collected 29051 
Independent reflections 3904 [R(int) = 0.0546] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.873 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3904 / 38 / 247 
Goodness-of-fit on F2 1.027 
Final R indices [I>2sigma(I)] R1 = 0.0437, wR2 = 0.0989 
R indices (all data) R1 = 0.0696, wR2 = 0.1163 
Extinction coefficient n/a 
Largest diff. peak and hole 0.256 and -0.394 e.Å-3  
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Table 7.6: Crystal data and structure refinement parameters for 3.3b·2DMSO. 
CCDC number  1012698 
Empirical formula  C34 H38 N4 O6 S2 
Formula weight  662.80 
Temperature  153(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 22.6373(7) Å α= 90°. 
 b = 9.5570(3) Å β= 105.708(2)°. 
 c = 16.0764(5) Å γ = 90°. 
Volume 3348.15(18) Å3 
Z 4 
Density (calculated) 1.315 Mg/m3 
Absorption coefficient 0.209 mm-1 
F(000) 1400 
Crystal size 0.22 x 0.20 x 0.14 mm 
Theta range for data collection 1.87 to 27.50°. 
Index ranges -29<=h<=29, -12<=k<=12, -20<=l<=20 
Reflections collected 52202 
Independent reflections 3843 [R(int) = 0.0505] 
Completeness to theta = 27.50° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.857 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3843 / 3 / 259 
Goodness-of-fit on F2 1.046 
Final R indices [I>2sigma(I)] R1 = 0.0391, wR2 = 0.0975 
R indices (all data) R1 = 0.0512, wR2 = 0.1070 
Largest diff. peak and hole 0.324 and -0.252 e.Å-3 
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Table 7.7: Crystal data and structure refinement parameters for 3.4b·2DMF. 
CCDC number  1012699 
Empirical formula  C36 H40 N6 O6 
Formula weight  652.74 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  orthorhombic 
Space group  P b c a 
Unit cell dimensions a = 15.1665(12) Å α= 90°. 
 b = 17.7506(16) Å β= 90°. 
 c = 24.997(2) Å γ = 90°. 
Volume 6729.5(10) Å3 
Z 8 
Density (calculated) 1.289 Mg/m3 
Absorption coefficient 0.089 mm-1 
F(000) 2768 
Crystal size 0.200 x 0.110 x 0.100 mm 
Theta range for data collection 3.016 to 27.481°. 
Index ranges -19<=h<=19, -23<=k<=23, -31<=l<=32 
Reflections collected 81471 
Independent reflections 7708 [R(int) = 0.0981] 
Completeness to theta = 25.242° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.774 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7708 / 0 / 455 
Goodness-of-fit on F2 1.134 
Final R indices [I>2sigma(I)] R1 = 0.0676, wR2 = 0.1114 
R indices (all data) R1 = 0.1068, wR2 = 0.1226 
Extinction coefficient n/a 
Largest diff. peak and hole 0.253 and -0.266 e.Å-3  
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Table 7.8: Crystal data and structure refinement parameters for 3.3b·(TBA)2H2P2O7. 
CCDC number  1444559 
Empirical formula  C62.50 H99 Cl N6 O11 P2 
Formula weight  1207.86 
Temperature  100(2) K 
Wavelength  1.54184 Å 
Crystal system  monoclinic 
Space group  P 21/n 
Unit cell dimensions a = 19.5077(3) Å α= 90°. 
 b = 15.3419(3) Å β= 95.4010(10)°. 
 c = 22.1726(3) Å γ = 90°. 
Volume 6606.47(19) Å3 
Z 4 
Density (calculated) 1.214 Mg/m3 
Absorption coefficient 1.457 mm-1 
F(000) 2604 
Crystal size 0.160 x 0.110 x 0.060 mm3 
Theta range for data collection 2.886 to 74.239°. 
Index ranges -23<=h<=24, -17<=k<=18, -26<=l<=27 
Reflections collected 35854 
Independent reflections 13076 [R(int) = 0.0339] 
Completeness to theta = 67.684° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.961 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 13076 / 535 / 761 
Goodness-of-fit on F2 1.029 
Final R indices [I>2sigma(I)] R1 = 0.0603, wR2 = 0.1574 
R indices (all data) R1 = 0.0777, wR2 = 0.1710 
Extinction coefficient n/a 
Largest diff. peak and hole 1.034 and -0.466 e.Å-3 
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Table 7.9: Crystal data and structure refinement parameters for 3.4b·TBAH2PO4. 
CCDC number  1444560 
Empirical formula  C46.50 H64.50 Cl1.50 N5 O8 P 
Formula weight  905.67 
Temperature  100(2) K 
Wavelength  1.54184 Å 
Crystal system  triclinic 
Space group  P -1 
Unit cell dimensions a = 9.9599(4) Å α= 81.050(3)°. 
 b = 14.6932(6) Å β= 75.273(3)°. 
 c = 16.4802(5) Å γ = 88.017(3)°. 
Volume 2304.10(15) Å3 
Z 2 
Density (calculated) 1.305 Mg/m3 
Absorption coefficient 1.802 mm-1 
F(000) 966 
Crystal size 0.170 x 0.070 x 0.050 mm3 
Theta range for data collection 2.805 to 74.533°. 
Index ranges -12<=h<=12, -16<=k<=18, -20<=l<=19 
Reflections collected 24272 
Independent reflections 9074 [R(int) = 0.0371] 
Completeness to theta = 67.684° 99.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.863 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9074 / 6 / 607 
Goodness-of-fit on F2 1.047 
Final R indices [I>2sigma(I)] R1 = 0.0500, wR2 = 0.1188 
R indices (all data) R1 = 0.0641, wR2 = 0.1237 
Extinction coefficient n/a 
Largest diff. peak and hole 0.749 and -0.617 e.Å-3  
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Table 7.10: Crystal data and structure refinement for 4.1b·2DMF. 
CCDC number  1444557 
Empirical formula  C40 H44 Fe N6 O6 
Formula weight  760.66 
Temperature  133(2) K 
Wavelength  0.71073 Å 
Crystal system  monoclinic 
Space group  P 21/c 
Unit cell dimensions a = 12.5879(6) Å α= 90°. 
 b = 20.8699(10) Å β= 93.531(4)°. 
 c = 13.6448(8) Å γ = 90°. 
Volume 3577.8(3) Å3 
Z 4 
Density (calculated) 1.412 Mg/m3 
Absorption coefficient 0.480 mm-1 
F(000) 1600 
Crystal size 0.27 x 0.20 x 0.09 mm 
Theta range for data collection 1.621 to 27.595°. 
Index ranges -16<=h<=16, -27<=k<=27, -17<=l<=17 
Reflections collected 87367 
Independent reflections 8232 [R(int) = 0.1341] 
Completeness to theta = 25.242° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.867 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8232 / 0 / 500 
Goodness-of-fit on F2 1.013 
Final R indices [I>2sigma(I)] R1 = 0.0471, wR2 = 0.0897 
R indices (all data) R1 = 0.1007, wR2 = 0.1109 
Extinction coefficient n/a 
Largest diff. peak and hole 0.382 and -0.331 e.Å-3  
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Table 7.11: Crystal data and structure refinement parameters for 4.2b·2CHCl3. 
CCDC number  1444558 
Empirical formula  C44 H38 Cl6 N6 O6 
Formula weight  959.50 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  triclinic 
Space group  P -1 
Unit cell dimensions a = 10.1932(19) Å α= 72.773(4)°. 
 b = 12.318(2) Å β= 77.793(4)°. 
 c = 19.654(4) Å γ = 81.490(4)°. 
Volume 2294.1(7) Å3 
Z 2 
Density (calculated) 1.389 Mg/m3 
Absorption coefficient 0.428 mm-1 
F(000) 988 
Crystal size 0.300 x 0.230 x 0.150 mm 
Theta range for data collection 3.059 to 27.483°. 
Index ranges -13<=h<=13, -15<=k<=15, -25<=l<=25 
Reflections collected 23595 
Independent reflections 10438 [R(int) = 0.0717] 
Completeness to theta = 25.242° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.654 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10438 / 81 / 600 
Goodness-of-fit on F2 1.140 
Final R indices [I>2sigma(I)] R1 = 0.0937, wR2 = 0.2330 
R indices (all data) R1 = 0.1450, wR2 = 0.2589 
Extinction coefficient n/a 
Largest diff. peak and hole 0.945 and -1.034 e.Å-3  
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Table 7.12: Crystal data and structure refinement parameters for [4.2b·TBAH2PO4]2. 
CCDC number  1444561 
Empirical formula  C119 H151 Cl9 N14 O20 P2 
Formula weight  2478.52 
Temperature  100(2) K 
Wavelength  1.54184 Å 
Crystal system  triclinic 
Space group  P -1 
Unit cell dimensions a = 16.0755(7) Å α= 93.415(2)°. 
 b = 18.9299(7) Å β= 96.103(3)°. 
 c = 24.4976(6) Å γ = 111.261(4)°. 
Volume 6869.2(5) Å3 
Z 2 
Density (calculated) 1.198 Mg/m3 
Absorption coefficient 2.423 mm-1 
F(000) 2612 
Crystal size 0.270 x 0.160 x 0.080 mm3 
Theta range for data collection 2.950 to 74.200°. 
Index ranges -13<=h<=19, -23<=k<=22, -27<=l<=30 
Reflections collected 40560 
Independent reflections 26292 [R(int) = 0.0646] 
Completeness to theta = 67.684° 98.1 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00 and 0.560 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 26292 / 3337 / 1638 
Goodness-of-fit on F2 1.544 
Final R indices [I>2sigma(I)] R1 = 0.1255, wR2 = 0.3052 
R indices (all data) R1 = 0.1811, wR2 = 0.3446 
Extinction coefficient n/a 
Largest diff. peak and hole 1.140 and -1.260 e.Å-3 
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